
<html lang="en"     class="pb-page"  data-request-id="b40af15a-ad57-426c-8196-051bba79cf30"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-20;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b00767"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein" /></meta><meta name="dc.Creator" content="Petra  Dvořáková" /></meta><meta name="dc.Creator" content="Petr  Bušek" /></meta><meta name="dc.Creator" content="Tomáš  Knedlík" /></meta><meta name="dc.Creator" content="Jiří  Schimer" /></meta><meta name="dc.Creator" content="Tomáš  Etrych" /></meta><meta name="dc.Creator" content="Libor  Kostka" /></meta><meta name="dc.Creator" content="Lucie  Stollinová Šromová" /></meta><meta name="dc.Creator" content="Vladimír  Šubr" /></meta><meta name="dc.Creator" content="Pavel  Šácha" /></meta><meta name="dc.Creator" content="Aleksi  Šedo" /></meta><meta name="dc.Creator" content="Jan  Konvalinka" /></meta><meta name="dc.Description" content="Proteases are directly involved in cancer pathogenesis. Expression of fibroblast activation protein (FAP) is upregulated in stromal fibroblasts in more than 90% of epithelial cancers and is associa..." /></meta><meta name="Description" content="Proteases are directly involved in cancer pathogenesis. Expression of fibroblast activation protein (FAP) is upregulated in stromal fibroblasts in more than 90% of epithelial cancers and is associa..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 16, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00767" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00767" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00767" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00767" /></link>
        
    
    

<title>Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00767" /></meta><meta property="og:title" content="Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0006.jpeg" /></meta><meta property="og:description" content="Proteases are directly involved in cancer pathogenesis. Expression of fibroblast activation protein (FAP) is upregulated in stromal fibroblasts in more than 90% of epithelial cancers and is associated with tumor progression. FAP expression is minimal or absent in most normal adult tissues, suggesting its promise as a target for the diagnosis or treatment of various cancers. Here, we report preparation of a polymer conjugate (an iBody) containing a FAP-specific inhibitor as the targeting ligand. The iBody inhibits both human and mouse FAP with low nanomolar inhibition constants but does not inhibit close FAP homologues dipeptidyl peptidase IV, dipeptidyl peptidase 9, and prolyl oligopeptidase. We demonstrate the applicability of this iBody for the isolation of FAP from cell lysates and blood serum as well as for its detection by ELISA, Western blot, flow cytometry, and confocal microscopy. Our results show the iBody is a useful tool for FAP targeting in vitro and potentially also for specific anticancer drug delivery." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00767"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00767">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00767&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00767&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00767&amp;href=/doi/10.1021/acs.jmedchem.7b00767" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8385-8393</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00746" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00819" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Petra++Dvo%C5%99%C3%A1kov%C3%A1">Petra Dvořáková</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Petr++Bu%C5%A1ek">Petr Bušek</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tom%C3%A1%C5%A1++Knedl%C3%ADk">Tomáš Knedlík</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ji%C5%99%C3%AD++Schimer">Jiří Schimer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tom%C3%A1%C5%A1++Etrych">Tomáš Etrych</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-5908-5182" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Libor++Kostka">Libor Kostka</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lucie++Stollinov%C3%A1+%C5%A0romov%C3%A1">Lucie Stollinová Šromová</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vladim%C3%ADr++%C5%A0ubr">Vladimír Šubr</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pavel++%C5%A0%C3%A1cha">Pavel Šácha</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aleksi++%C5%A0edo">Aleksi Šedo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan++Konvalinka">Jan Konvalinka</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-0695-9266" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Institute of Organic Chemistry and Biochemistry of The Czech Academy of Sciences, Flemingovo nám 2, 16610 Prague 6, Czech Republic</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Cell Biology, Faculty of Science, Charles University, Viničná 7, 12843 Prague 2, Czech Republic</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, U Nemocnice 5, 12853 Prague 2, Czech Republic</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Biochemistry, Faculty of Science, Charles University, Hlavova 8, 12843 Prague 2, Czech Republic</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Institute of Macromolecular Chemistry, The Czech Academy of Sciences, Heyrovského nám 2, 16206 Prague 6, Czech Republic</span></div><div class="corresp-info"><strong>*</strong>For J.K.: phone, 00420 220 183 218; fax, 00420 220 183 578; E-mail, <a href="/cdn-cgi/l/email-protection#6f050e0141040001190e030601040e2f1a000c070d410c0e1c410c15"><span class="__cf_email__" data-cfemail="d4beb5bafabfbbbaa2b5b8bdbabfb594a1bbb7bcb6fab7b5a7fab7ae">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For A.Š.: phone, 00420 224 965 826; E-mail, <a href="/cdn-cgi/l/email-protection#4829242d233b21082b2d3b262d3c662b32"><span class="__cf_email__" data-cfemail="c9a8a5aca2baa089aaacbaa7acbde7aab3">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For P.Š.: phone, 00420 220 183 452; fax, 00420 220 183 578; E-mail, <a href="/cdn-cgi/l/email-protection#cabaabbcafa6b9aba9a2ab8aada7aba3a6e4a9a5a7"><span class="__cf_email__" data-cfemail="c0b0a1b6a5acb3a1a3a8a180a7ada1a9aceea3afad">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00767&amp;href=/doi/10.1021%2Facs.jmedchem.7b00767" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8385–8393</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 27, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 May 2017</li><li><span class="item_label"><b>Published</b> online</span>16 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 October 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00767" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00767</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8385%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPetra%2BDvo%25C5%2599%25C3%25A1kov%25C3%25A1%252C%2BPetr%2BBu%25C5%25A1ek%252C%2BTom%25C3%25A1%25C5%25A1%2BKnedl%25C3%25ADk%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D20%26contentID%3Dacs.jmedchem.7b00767%26title%3DInhibitor-Decorated%2BPolymer%2BConjugates%2BTargeting%2BFibroblast%2BActivation%2BProtein%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8393%26publicationDate%3DOctober%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00767"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2291</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00767" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Petra&quot;,&quot;last_name&quot;:&quot;Dvořáková&quot;},{&quot;first_name&quot;:&quot;Petr&quot;,&quot;last_name&quot;:&quot;Bušek&quot;},{&quot;first_name&quot;:&quot;Tomáš&quot;,&quot;last_name&quot;:&quot;Knedlík&quot;},{&quot;first_name&quot;:&quot;Jiří&quot;,&quot;last_name&quot;:&quot;Schimer&quot;},{&quot;first_name&quot;:&quot;Tomáš&quot;,&quot;last_name&quot;:&quot;Etrych&quot;},{&quot;first_name&quot;:&quot;Libor&quot;,&quot;last_name&quot;:&quot;Kostka&quot;},{&quot;first_name&quot;:&quot;Lucie&quot;,&quot;last_name&quot;:&quot;Stollinová Šromová&quot;},{&quot;first_name&quot;:&quot;Vladimír&quot;,&quot;last_name&quot;:&quot;Šubr&quot;},{&quot;first_name&quot;:&quot;Pavel&quot;,&quot;last_name&quot;:&quot;Šácha&quot;},{&quot;first_name&quot;:&quot;Aleksi&quot;,&quot;last_name&quot;:&quot;Šedo&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Konvalinka&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;8385-8393&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00767&quot;},&quot;abstract&quot;:&quot;Proteases are directly involved in cancer pathogenesis. Expression of fibroblast activation protein (FAP) is upregulated in stromal fibroblasts in more than 90% of epithelial cancers and is associated with tumor progression. FAP expression is minimal or absent in most normal adult tissues, suggesting its promise as a target for the diagnosis or treatment of various cancers. Here, we report preparation of a polymer conjugate (an iBody) containing a FAP-specific inhibitor as the targeting ligand. The iBody inhibits both human and mouse FAP with low nanomolar inhibition constants but does not inhibit close FAP homologues dipeptidyl peptidase IV, dipeptidyl peptidase 9, and prolyl oligopeptidase. We demonstrate the applicability of this iBody for the isolation of FAP from cell lysates and blood serum as well as for its detection by ELISA, Western blot, flow cytometry, and confocal microscopy. Our results show the iBody is a useful tool for FAP targeting in vitro and potentially also for specific anticancer drug d&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00767&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00767" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00767&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00767" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00767&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00767" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00767&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00767&amp;href=/doi/10.1021/acs.jmedchem.7b00767" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00767" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00767" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00767%26sid%3Dliteratum%253Aachs%26pmid%3D28953383%26genre%3Darticle%26aulast%3DDvo%25C5%2599%25C3%25A1kov%25C3%25A1%26date%3D2017%26atitle%3DInhibitor-Decorated%2BPolymer%2BConjugates%2BTargeting%2BFibroblast%2BActivation%2BProtein%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D20%26spage%3D8385%26epage%3D8393%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/jmcmar.2017.60.issue-20/20171026/jmcmar.2017.60.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/medium/jm-2017-007675_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00767&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Proteases are directly involved in cancer pathogenesis. Expression of fibroblast activation protein (FAP) is upregulated in stromal fibroblasts in more than 90% of epithelial cancers and is associated with tumor progression. FAP expression is minimal or absent in most normal adult tissues, suggesting its promise as a target for the diagnosis or treatment of various cancers. Here, we report preparation of a polymer conjugate (an iBody) containing a FAP-specific inhibitor as the targeting ligand. The iBody inhibits both human and mouse FAP with low nanomolar inhibition constants but does not inhibit close FAP homologues dipeptidyl peptidase IV, dipeptidyl peptidase 9, and prolyl oligopeptidase. We demonstrate the applicability of this iBody for the isolation of FAP from cell lysates and blood serum as well as for its detection by ELISA, Western blot, flow cytometry, and confocal microscopy. Our results show the iBody is a useful tool for FAP targeting in vitro and potentially also for specific anticancer drug delivery.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03736" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03736" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Proteases in tumor and stromal cells play an important role in cancer progression by promoting tumor cell invasion and metastasis as well as facilitating neovascularization.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Because of their pathogenic role and differential expression in tumor tissue, some proteases, such as matrix metalloproteinases, hold promise as therapeutic and diagnostic targets. However, several large-scale clinical trials testing low-molecular-weight matrix metalloproteinase inhibitors failed to show improvement in clinical outcomes. This was most likely due to the imperfect specificity of the tested compounds, on-target side effects caused by interference with the physiological functions of the proteases, and the incompletely understood involvement of the targeted proteolytic enzymes as well as their substitutability by other proteases in disease progression.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a></div><div class="NLM_p">Since its discovery in the late 1980s, fibroblast activation protein (FAP; seprase, surface expressed protease) has been considered an interesting potential target for cancer therapeutics and diagnostics.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> FAP is expressed in stromal fibroblasts in more than 90% of epithelial cancers,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and its expression is also increased in stromal cells in multiple myeloma<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and glioblastoma.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In addition, FAP is expressed in malignant cells in glioblastoma<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and pancreatic,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> breast,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> colorectal,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> cervical,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and oral squamous cell<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> carcinomas. Although the effects of FAP are tumor specific and in certain cancers FAP may even act as a tumor suppressor,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> it has been established in several cases that high FAP expression contributes to the invasiveness and increased proliferation of the tumor cells.<a onclick="showRef(event, 'ref14 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref16 ref17">(14, 16, 17)</a> Moreover, FAP in the bioptic material may be a prognostic marker of aggressive tumor progression, especially when expressed by cancer cells (recently reviewed in ref <a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">18</a>). Recent studies also demonstrated that FAP expression is increased in various nonmalignant disease states accompanied by extracellular matrix remodeling such as in idiopathic pulmonary fibrosis,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> liver cirrhosis,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> rheumatoid arthritis,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> myocardial infarction,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and advanced atherosclerotic plaques.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">With the exception of pancreatic alpha cells,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> mesenchymal bone marrow cells,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and endometrial stroma during the proliferative phase,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> FAP expression is minimal or absent in the majority of normal adult tissues.<a onclick="showRef(event, 'ref6 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref6 ref27 ref28">(6, 27, 28)</a> Its soluble form devoid of the cytoplasmic and transmembrane regions is physiologically present in blood plasma (known as antiplasmin-cleaving enzyme, APCE). The origin and function of blood plasma FAP are largely unknown.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Given the limited expression of FAP in human tissues under physiological conditions, FAP seems to be a promising molecule for targeting cancer stroma as well as some types of transformed cancer cells.</div><div class="NLM_p">FAP is a type II transmembrane protein belonging to the S9B oligopeptidase subfamily of serine proteases. It consists of 760 amino acids: 6 form the N-terminal cytoplasmic tail, 20 the transmembrane part, and the remaining 734 amino acids are part of a large extracellular C-terminal domain.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> FAP requires dimerization of two 97 kDa subunits for its catalytic activity<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and cleaves off dipeptides from the N-terminus of its substrates after a proline residue (N-Xxx-Pro-). In addition, FAP exhibits postproline endopeptidase activity,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> which is thought to contribute to the remodeling of the extracellular matrix.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Nevertheless, it is likely that at least some of the complex effects of FAP in cancer-associated fibroblasts and cancer cells are mediated by nonhydrolytic protein–protein interactions. For example, introduction of FAP endowed normal fibroblasts with an inflammatory phenotype, which was mediated by the activation of FAK–Src–JAK2 signaling pathway by the urokinase-type plasminogen activator receptor (uPAR), a known FAP-interacting membrane protein.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Similarly, the suppression of FAP in oral squamous cell carcinoma cells inactivated the PTEN/PI3K/AKT and Ras-ERK pathways and repressed the expression of genes regulating the epithelial–mesenchymal transition, thereby reducing the proliferation and invasiveness of these cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Thus, the involvement of FAP in the pathogenesis of human malignancies is complex and seems to be cancer-type specific, which may have contributed to the failure of early clinical trials assessing FAP targeting with the rather nonspecific low-molecular-weight inhibitor talabostat<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> or the humanized antibody sibrotuzumab.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">Recently, we have described novel biochemical tools called iBodies for the targeting of proteins with known ligands.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The iBodies are based on a water-soluble and biocompatible <i>N</i>-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier decorated with low-molecular-weight compounds such as enzyme inhibitors used as targeting ligands. The use of iBodies offers several advantages over classical approaches with antibodies. The iBodies are highly modular and versatile; conjugates containing virtually any desired compound can be easily prepared. Synthetic HPMA conjugates are well-characterized compounds for biomedical applications and have long been used as carriers for drug delivery to solid tumors, often making use of the enhanced permeability and retention (EPR) effect.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38-40)</a> Importantly, the molecular weight of the HPMA backbone can be easily adjusted to specifically tailor the pharmacokinetic properties. To prepare a new platform that would allow FAP targeting in cancer, we set out to develop FAP-targeting iBodies.</div><div class="NLM_p">Dipeptidyl peptidase IV (DPP-IV), the closest homologue of FAP, sharing 52% amino acid sequence identity, is a broadly expressed cell-surface serine protease involved in several physiological processes, including regulation of glucose metabolism<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and T-cell activation.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Besides its physiological roles, DPP-IV was implicated in the pathogenesis of several cancers, acting as a tumor suppressor or promotor depending on the tumor type (recently reviewed in ref <a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">43</a>). The high selectivity of anti-FAP iBodies is critical to avoid interference with DPP-IV and to decrease the risk of undesired side effects. Jansen et al. recently developed low nanomolar FAP inhibitors based on a (4-quinolinoyl)glycyl-2-cyanopyrrolidine scaffold, which showed high selectivity against related proteases, including DPP-IV and prolyl-specific proteases prolyl oligopeptidase (PREP) and dipeptidyl peptidase 9 (DPP9).<a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">(44-46)</a></div><div class="NLM_p last">In this work, we prepared anti-FAP iBody containing a highly specific FAP inhibitor as a targeting ligand and tested its utility using FAP-expressing malignant glioblastoma cells. We demonstrate that this iBody can be used for the specific detection of FAP in various biological matrices by a number of biochemical methods, and we show that it is suitable for the specific targeting and visualization of FAP as well as the inhibition of its enzymatic activity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73564" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73564" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Expression of Recombinant Human and Mouse FAP and DPP-IV</h3><div class="NLM_p">To test the selectivity of the compounds described in this study, we prepared recombinant human and mouse FAP and DPP-IV bearing cleavable N-terminal purification tags (SF-tag or Avi-tag) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a). All proteins were expressed in <i>Drosophila</i><i>S2</i> cells and purified via affinity chromatography according to previously published protocols (using Streptavidin Mutein matrix for Avi-tagged constructs<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> or Strep-Tactin resin for SF-tagged versions<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a>). Originally, all four proteins were prepared with an Avi-tag; however, the Avi-hFAP and Avi-mFAP expression yields were not sufficient for biochemical characterization and subsequent experiments. Therefore, we replaced the Avi-tag with the recently described SF-tag, which comprises two Strep-tags and a Flag-tag.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The resulting constructs, SF-hFAP and SF-mFAP, were expressed in larger quantities compared to their Avi-tagged counterparts and could be obtained in quantity and purity sufficient for their biochemical characterization, with overall yields of 0.7 and 0.2 mg, respectively (per 1 L of conditioned medium) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>b). Similarly, we obtained 0.1 and 0.2 mg of Avi-hDPP-IV and Avi-mDPP-IV, respectively. The kinetic properties of the SF-tagged and Avi-tagged proteins were virtually identical (data not shown).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/medium/jm-2017-007675_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0001.jpeg" id="GRAPHIC-d7e511-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design and purification of recombinant FAP and DPP-IV. (a) Schematic structures of the recombinant human and mouse FAP and DPP-IV proteins expressed in <i>Drosophila</i><i>S2</i> cells. The extracellular parts of human and mouse FAP containing Strep-tag II and Flag-tag were purified via Strep-Tactin affinity chromatography. The extracellular parts of human and mouse DPP-IV containing Avi-tag were purified via streptavidin mutein affinity purification. (b) A silver-stained SDS-PAGE gel showing a typical two-round affinity purification of recombinant SF-hFAP protein expressed in <i>Drosophila</i><i>S2</i> cells. Load, concentrated medium; FT, flow-through; W1–W2, wash fractions; E1–E3, elution fractions. Ten microliters were loaded onto the gel, except for Load, FT-1, and FT-2 (0.5 μL).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00767&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design, Synthesis, and Characterization of Anti-FAP iBody 1</h3><div class="NLM_p">To select the most suitable targeting ligand for FAP in terms of potency and selectivity, we prepared a small panel of FAP inhibitors (compounds <b>1</b>–<b>4</b>; <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> and <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a) and assessed their structure–activity relationships. Most importantly, we investigated the appropriate linkage of the targeting ligand to the polymer backbone. The compounds are based on the previously published structure of a FAP inhibitor with a (4-quinolinoyl)glycyl-2-cyanopyrrolidine scaffold<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> and contain a PEG linker for attachment to the HPMA copolymer. We then determined IC<sub>50</sub> values of compounds <b>1</b>–<b>4</b> for SF-hFAP using a FAP activity inhibition assay. Compounds <b>1</b>–<b>3</b> exhibited comparable inhibition constants (0.23, 0.28, and 0.37 nM), whereas compound <b>4</b> was substantially less potent (4.8 nM) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a). For further experiments, we chose compound <b>1</b> to avoid steric problems after conjugation (long linker) and ensure the best inhibitory properties (difluoro substitution at C4 of the proline derivative).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/medium/jm-2017-007675_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0005.jpeg" id="GRAPHIC-d7e576-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b>–<b>4</b>, Specific Inhibitors of FAP Modified with PEG Linkers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00767&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a*) described in ref <a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">47</a>; (a) SOCl<sub>2</sub>, MeOH, reflux; (b) NaH, <i>t</i>-butyl 2-bromoacetate, DMF, −80 °C to RT; (c) TFA; (d) TBTU, DIEA, NH<sub>2</sub>-PEG<sub>n</sub>-NH-BOC (n = 5, or n = 15), DMF; (e) 5 M NaOH/H<sub>2</sub>O, THF/MeOH; (f) (1) TSTU, DIEA, DMF, (2) (<i>S</i>)-2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethanaminium chloride or (<i>S</i>)-2-(2-cyanopyrrolidin-1-yl)-2-oxoethanaminium chloride; (g) Ts-OH, ACN.</p></p></figure><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/medium/jm-2017-007675_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of FAP inhibitors and anti-FAP polymer conjugate iBody <b>1</b> and their kinetic characterization. (a) The effect of prolyl moiety modification of the (4-quinolinoyl)glycyl-2-cyanopyrrolidine scaffold and PEG linker length on the kinetic properties of the tested inhibitors. The IC<sub>50</sub> values for modified inhibitors with or without fluorine substitution and PEG linkers of various lengths are presented as mean ± standard deviation. Measurements were performed in duplicate. (b) Schematic structure of anti-FAP polymer conjugate (iBody <b>1</b>) containing an ATTO488 fluorophore, an affinity anchor (biotin), and compound <b>1</b>, the FAP-specific inhibitor. (c) Comparison of IC<sub>50</sub> values of the FAP inhibitor and the anti-FAP iBody toward recombinant FAP, DPP-IV, DPP9, and PREP (IC<sub>50</sub> values are presented as mean ± standard deviation).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00767&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>1</b>, together with an ATTO488 fluorophore and the affinity anchor biotin, were conjugated to the HPMA copolymer carrier, yielding an HPMA copolymer conjugate targeting FAP (iBody <b>1</b>: <i>M</i><sub>n</sub> = 110600 g/mol, <i>M</i><sub>w</sub> = 149900 g/mol, <i>Đ</i> = 1.36; <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b). As a negative control, a corresponding conjugate lacking the FAP inhibitor was prepared (iBody <b>2</b>: <i>M</i><sub>n</sub> = 80900 g/mol, <i>M</i><sub>w</sub> = 131000 g/mol, <i>Đ</i> = 1.62). Attachment of compound <b>1</b> to the copolymer chain led to an increase in the IC<sub>50</sub> value [IC<sub>50</sub>(iBody <b>1</b>) = 1.1 nM] (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>c). Importantly, using a DPP-IV activity assay, we determined that iBody <b>1</b> is highly selective for FAP with IC<sub>50</sub> for the FAP homologue DPP-IV more than 4 orders of magnitude higher (IC<sub>50</sub> > 10 μM) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>c). We also determined the IC<sub>50</sub> values for iBody <b>1</b> toward mouse FAP and mouse DPP-IV and observed similar selectivity for FAP (IC<sub>50</sub> = 3.0 nM and IC<sub>50</sub> > 10 μM, respectively). In addition, iBody <b>1</b> did not inhibit recombinant prolyl oligopeptidase (PREP) and dipeptidyl peptidase 9 (DPP9) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>c).</div></div><div id="sec2-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Use of Anti-FAP iBody <b>1</b> for Detection and Visualization of FAP</h3><div class="NLM_p">We used surface plasmon resonance (SPR) to evaluate the interaction between iBody <b>1</b> and FAP (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a). iBody <b>1</b> was immobilized to a neutravidin layer via biotin, and four concentrations of recombinant SF-hFAP were loaded. The SPR analysis indicated a relatively high association rate (<i>k</i><sub>on</sub> = 3860 M<sup>–1</sup> s<sup>–1</sup>) and remarkably low dissociation rate (<i>k</i><sub>off</sub> < 2 × 10<sup>–5</sup> s<sup>–1</sup>), which was under the detection limit of our SPR instrument. The resulting dissociation constant (<i>K</i><sub>D</sub> < 6 nM) is comparable with the IC<sub>50</sub> value obtained from the FAP activity assay. Concordantly, we confirmed that inhibition of FAP enzymatic activity persists even when FAP-containing cell lysates preincubated with effective concentrations of anti-FAP iBody were diluted to decrease the iBody concentration prior to the enzymatic assay. In contrast, the inhibition by the low-molecular-weight (4-quinolinoyl)glycyl-2-cyanopyrrolidine-based FAP inhibitors was reversible in the same experimental setup (data not shown).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/medium/jm-2017-007675_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Application of anti-FAP iBody <b>1</b> in biochemical methods. (a) SPR analysis of SF-hFAP binding to immobilized iBody <b>1</b> (<i>K</i><sub>D</sub> < 6 nM). (b) Affinity isolation of FAP from FAP-transfected U251 (U251_FAP+) cell lysate using iBody <b>1</b>. iBody <b>2</b> (lacking FAP inhibitor) and blank streptavidin agarose (NC-SA) were used as negative controls. Load = U251_FAP+ cell lysate. (c) Sandwich ELISA for quantification of FAP using iBody <b>1</b> and anti-FAP F-19 antibody as a detection “agent” and a capture antibody, respectively. Each sample was measured in triplicate; values are presented as the mean ± standard deviation. (d) Western blot visualization of FAP using iBody <b>1</b> followed by an IRDye 800CW streptavidin conjugate. Purified recombinant human FAP (SF-hFAP) and a lysate of U251_FAP+ cells were used. The right section refers to the membrane probed with IRDye 800CW streptavidin conjugate only.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00767&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We tested the anti-FAP conjugate in several biochemical applications. Using iBody <b>1</b> immobilized to streptavidin agarose via biotin, we pulled down FAP from a cell lysate of U251 cells stably transfected with human FAP (U251_FAP+; see the “Biochemical Methods” section in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00767/suppl_file/jm7b00767_si_001.pdf" class="ext-link">Supporting Information</a> for the discussion of the cell line denomination) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b). As negative controls, we used iBody <b>2</b>, which lacks the FAP inhibitor, and blank streptavidin agarose (NC-SA) to show potential nonspecific binding to HPMA copolymer backbone and/or the streptavidin agarose resin (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b). The presence of isolated FAP was verified by LC-MS/MS, which detected FAP protein in the iBody <b>1</b> elution sample. Using the same setup, we also successfully isolated FAP protein from human blood plasma (verified by LC-MS/MS; data not shown), further confirming the functionality of anti-FAP conjugates in complex biological samples.</div><div class="NLM_p">Additionally, we developed sandwich ELISA for FAP quantification employing iBody <b>1</b> as a substitute for the detection antibody (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>c). Recombinant SF-hFAP was first captured by the FAP-specific monoclonal antibody F-19 and then detected with iBody <b>1</b>, followed by incubation with neutravidin–HRP conjugate. The detection limit of this newly developed ELISA was as low as 0.4 ng/mL of FAP.</div><div class="NLM_p last">iBody <b>1</b> (followed by IRDye 800CW streptavidin conjugate) could also be used to visualize FAP on a “semi-native” Western blot (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>d). Both recombinant SF-tagged FAP (SF-hFAP) and endogenous full-length FAP migrated at around 130 kDa, corresponding to FAP dimers; the detection limit was about 50 ng of FAP (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>d).</div></div><div id="sec2-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Application of Anti-FAP iBody 1 for Imaging of FAP-Expressing Cells</h3><div class="NLM_p">We tested the suitability of iBody <b>1</b> as a tool for the specific imaging of FAP-positive cells using confocal microscopy (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a,d) and flow cytometry (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b,c). Live cells expressing (U251_FAP+) or not expressing (U251_FAP−) FAP were incubated with anti-FAP iBody <b>1</b>; iBody <b>2</b>, which lacks the FAP inhibitor, was used as a negative control. Confocal microscopy imaging showed that iBody <b>1</b> binds only to FAP-expressing cells and not to cells lacking FAP, whereas control iBody <b>2</b> did not bind to any of the cells analyzed (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a). Upon binding to FAP on the cell surface, iBody <b>1</b> underwent slow internalization, as evidenced by the accumulation of the signal inside cells after prolonged incubation. Similar results were obtained with cells transfected with mouse FAP (data not shown).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/medium/jm-2017-007675_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Detection and visualization of FAP on cells using anti-FAP iBody <b>1</b>. (a) Confocal microscopy analysis of cells expressing and not expressing FAP. Cells with inducible FAP expression were incubated with 200 nM iBody <b>1</b> (at 37 °C for 1 h), which was then visualized by confocal microscopy; the cell nuclei were stained with Hoechst H34580 dye. (b) Flow cytometry detection of FAP expression in GL261 cells transfected with mouse FAP but not in cells transfected with the closely related mouse DPP-IV. Nontransfected GL261 cells stained with iBody <b>1</b> and streptavidin–PE conjugate, and FAP-GL261 transfectants stained with streptavidin–PE conjugate only were used as negative controls. (c) Flow cytometry detection of endogenous FAP expression in human fibroblasts and U87 glioma cells using anti-FAP iBody <b>1</b>. GL261 cells incubated with iBody <b>1</b> and streptavidin–PE conjugate and human fibroblasts incubated with streptavidin–PE conjugate only were used as negative controls. (d) Immunohistochemistry on frozen sections of a tumor (delineated by a dashed line) generated by xenotransplantation of FAP-transfected glioma cells into mouse brain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00767&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The binding of anti-FAP iBody <b>1</b> to mouse FAP was also confirmed by flow cytometry. Anti-FAP iBody <b>1</b> strongly stained mouse GL261 glioma cells transfected with mouse FAP, whereas neither the FAP-negative parental cell line GL261 nor Gl261 cells transfected with mouse DPP-IV were stained by the conjugate (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b). We further analyzed the utility of the compounds in detecting endogenous levels of FAP expression. Using flow cytometry, FAP expression was visualized in cultured human fibroblasts and human glioblastoma U87 cells, which are known to express the protein,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> by anti-FAP iBody <b>1</b> followed by an amplification step with a streptavidin–phycoerythrin conjugate (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>c). Finally, anti-FAP iBody <b>1</b> was used to visualize FAP-transfected tumor cells in frozen tissue sections of glioma tumor xenografts (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>d).</div><div class="NLM_p last">Collectively, these data suggest the applicability of anti-FAP iBodies in a broad spectrum of methodologies traditionally utilizing antibodies.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76612" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76612" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Multiple proteases are involved in oncogenesis. FAP, along with other proteases, is proposed to participate in the processes of cell adhesion, invasion, migration, and tumor neovascularization.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> However, in contrast to most other cancer-associated proteases, FAP is expressed very sparsely in healthy adult tissues. In cancerous tissues, FAP is characteristically present in stromal cells as well as in the transformed elements of several malignancies.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> This makes FAP a promising potential target to exploit for cancer therapeutics and/or diagnostics. Recently, we described the iBody concept for specific targeting of enzymes.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In this work, we aimed to prepare anti-FAP iBodies and demonstrate their potential to specifically bind FAP and FAP-expressing cells.</div><div class="NLM_p">To identify the most potent and specific FAP-targeting ligand, we synthesized and characterized four FAP inhibitors based on the (4-quinolinoyl)glycyl-2-cyanopyrrolidine scaffold, which has high potency and selectivity for FAP.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The inhibitors were synthesized with PEG linkers of two different lengths, as we had previously observed that short linkers impaired binding of the protein target to the inhibitor molecule “immobilized” on the polymer backbone. We prepared inhibitors with or without a 4,4-difluoro substitution of the 2-cyanopyrrolidine moiety, as Jansen et al. showed that this substitution leads to more potent FAP binding and improved selectivity with respect to the close FAP homologue prolyl oligopeptidase.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Conjugation of compound <b>1</b> to the HPMA copolymer resulted in a 5-fold increase in the IC<sub>50</sub> value. This was somewhat surprising, as we observed a significant drop in IC<sub>50</sub> value for the iBody targeting GCPII.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Nevertheless, anti-FAP iBody <b>1</b> is a low nanomolar binder of FAP, which is still more than sufficient for effective in vitro and in vivo targeting. Highly specific discrimination between FAP and its close homologue DPP-IV, an almost ubiquitously expressed multifunctional protease,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> is essential to prevent off-target effects of anti-FAP iBodies in vivo. We showed that iBody <b>1</b> is highly selective for FAP, exhibiting a more than four-order-of-magnitude lower IC<sub>50</sub> for FAP than for DPP-IV. Therefore, even hundred nanomolar concentrations should lead to specific FAP targeting. We also verified that IC<sub>50</sub> values of iBody <b>1</b> toward other FAP homologues, prolyl oligopeptidase (PREP) and dipeptidyl peptidase 9 (DPP9), are more than three-orders-of-magnitude higher than for FAP itself, meaning that iBody <b>1</b> keeps the selectivity for FAP over these predominantly intracellularly localized homologues as well.</div><div class="NLM_p">In contrast to antibodies, which target surface epitopes, the binding of iBodies relies on a specific interaction between the inhibitor molecule and the active site of the enzyme, which is usually the most conserved part of a protein molecule. Therefore, we expected anti-FAP iBody to bind FAP orthologues with similar affinity. Indeed, we found that iBody <b>1</b> interacts with mouse FAP with an inhibition constant comparable to that of human FAP. This extends the applicability of anti-FAP iBodies, suggesting that they can be used as a versatile instrument for animal model experiments in preclinical translational studies.</div><div class="NLM_p">We used various biochemical methods to assess the potential of iBody <b>1</b> for FAP targeting in vitro. Using SPR, we characterized iBody <b>1</b> binding to FAP and determined its <i>K</i><sub>D</sub>. Importantly, these results suggested the formation of a stable complex between FAP and its targeting iBody despite the fact that inhibition by the low-molecular-weight (4-quinolinoyl)glycyl-2-cyanopyrrolidine-based FAP inhibitors is reversible.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> When bound to streptavidin agarose resin, iBody <b>1</b> specifically pulled down FAP from complex protein matrices, including cell lysate and human blood plasma. As seen in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b, the negative control experiment with blank streptavidin agarose showed that the nonspecifically isolated proteins are adsorbed to the agarose resin and not to the HPMA conjugate backbone. For quantitative assays of FAP, we developed a sandwich ELISA using iBody <b>1</b> in place of the detection antibody (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>c). Even without optimizing the assay, the limit of detection of the antibody–iBody sandwich ELISA was comparable to that of the commercially available ELISA (Human FAP DuoSet ELISA, no. DY3715; R&D Systems, Inc.). FAP could also be detected on Western blot, which is somewhat surprising as iBody binding requires an intact active site, while SDS-PAGE and blotting generally lead to protein structure destabilization. However, FAP apparently preserved its native structure during these processes and was recognized by iBody <b>1</b>. The observed FAP band migrating at about 130 kDa corresponds to the dimeric form of FAP, suggesting that the FAP dimer was not dissociated in the used experimental setup.</div><div class="NLM_p last">Next, we tested iBody <b>1</b> in cell culture experiments. Live cell imaging using confocal microscopy confirmed the high selectivity of anti-FAP iBody for FAP and revealed negligible nonspecific binding to cells. Up to micromolar concentrations of the anti-FAP polymer conjugate did not stain cells not expressing FAP. Our data showed that the FAP-iBody complex is internalized, which is beneficial for future drug delivery concepts exploiting FAP iBodies in cancer therapy. In addition to cell culture experiments with human FAP, we also showed that iBody <b>1</b> specifically stained GL261 cells transfected with mouse FAP, confirming its possible use in mouse models. Finally, we used iBody <b>1</b> to detect and visualize FAP on cells within complex tissue by performing immunohistochemistry experiments with frozen tissue sections.</div></div><div id="sec99" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73860" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73860" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We designed, synthesized, and characterized a novel type of a highly selective FAP targeting agent, an iBody based on an HPMA copolymer decorated with a FAP inhibitor. The specificity, modularity, and versatility of the anti-FAP iBody make it suitable for a broad spectrum of biochemical and biomedical applications. Thus, anti-FAP iBodies may represent an attractive theranostic tool for future in vivo imaging and selective drug delivery into the tumor microenvironment.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry</h3><div class="NLM_p">All chemicals were purchased from Sigma-Aldrich, unless stated otherwise. All inhibitors tested in the biological assays were purified using preparative scale HPLC Jasco PU-975 (flow rate 10 mL/min, water phase containing 0.1% of TFA; gradient shown for each compound, including <i>R</i><sub>t</sub>) equipped with UV detector UV-975 and with column Waters YMC-PACK ODS-AM C18 prep column, 5 μm, 20 mm × 250 mm. The purity of compounds was tested on analytical Jasco PU-1580 HPLC (flow rate 1 mL/min, invariable gradient 2–100% ACN in 30 min, <i>R</i><sub>t</sub> shown for each compound, water phase contained 0.1% of TFA) with column Watrex C18 analytical column, 5 μm, 250 mm × 5 mm. The final inhibitors were all at least of 99% purity. Structure was further confirmed by HRMS at LTQ Orbitrap XL (Thermo Fisher Scientific) and by NMR (Bruker Avance I 400 MHz).</div><div id="sec4-1-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> (<i>S</i>)-1-((4-((2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-7-yl)oxy)-2-oxo-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-pentadecaoxa-3-azapentacontan-50-aminium 2,2,2-Trifluoroacetate (<b>1</b>)</h4><div class="NLM_p last">The crude evaporated reaction mixture of compound <b>10a</b> was dissolved in 1.5 mL of ACN and 400 mg of <i>p</i>-toluenesulfonic acid were added in one portion. The reaction was left stirring overnight, after which it was evaporated and the product was isolated using preparative scale HPLC (grad, 10–40% ACN in 50 min; <i>R</i><sub>t</sub> = 36 min) 133 mg isolated upon dry freezing (isolated yield over two steps = 57%). Analytical HPLC: <i>R</i><sub>t</sub> = 16.5 min. HRMS: (ESI+) <i>m</i>/<i>z</i> for C<sub>51</sub>H<sub>83</sub>O<sub>19</sub>N<sub>6</sub>F<sub>2</sub> [M + H]<sup>+</sup> calcd 1121.56756, found 1121.56767.</div></div><div id="sec4-1-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> (<i>S</i>)-1-((4-((2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-7-yl)oxy)-2-oxo-6,9,12,15,18-pentaoxa-3-azaicosan-20-aminium 2,2,2-trifluoroacetate (<b>2</b>)</h4><div class="NLM_p last">The crude evaporated intermediate from previous reaction (compound <b>10b</b>) was dissolved in 1 mL of ACN and 100 mg of <i>p</i>-toluenesulfonic acid was added in one portion. The reaction mixture was left stirring overnight, after which it was evaporated and the product purified (gradient, 10–40 ACN in 50 min; <i>R</i><sub>t</sub> = 29 min) 6 mg of oily yellowish substance obtained upon dry freezing (isolated yield = 30%). Analytical HPLC: <i>R</i><sub>t</sub> = 14.0 min. HRMS: (ESI+) <i>m</i>/<i>z</i> for C<sub>31</sub>H<sub>43</sub>O<sub>9</sub>N<sub>6</sub>F<sub>2</sub> [M + H]<sup>+</sup> calcd 681.30449, found 681.30541.</div></div><div id="sec4-1-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> (<i>S</i>)-1-((4-((2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-7-yl)oxy)-2-oxo-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-pentadecaoxa-3-azapentacontan-50-aminium 2,2,2-trifluoroacetate (<b>3</b>)</h4><div class="NLM_p last">Crude evaporated reaction mixture from the previous reaction (compound <b>10c</b>; product theoretically 79 μmol, 1.0 equiv) was dissolved in 2 mL of ACN and 150 mg of Tos-OH·H<sub>2</sub>O (790 μmol, 10.0 equiv) were added in one portion and the deprotection was left to proceed overnight. The reaction mixture was then evaporated, and the crude product was purified on a preparative scale HPLC (grad, 10–40% ACN in 50 min; <i>R</i><sub>t</sub> = 36 min). (Note: deprotection with TFA leads to a major side reaction where isobutylene is added on the nitrile group.) Analytical HPLC: <i>R</i><sub><i>t</i></sub> = 16.1 min. HRMS: (ESI+) <i>m</i>/<i>z</i> for C<sub>51</sub>H<sub>85</sub>O<sub>19</sub>N<sub>6</sub> [M + H]<sup>+</sup> calcd 1085.58640, found 1085.58646.</div></div><div id="sec4-1-4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> (<i>S</i>)-1-((4-((2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-7-yl)oxy)-2-oxo-6,9,12,15,18-pentaoxa-3-azaicosan-20-aminium 2,2,2-trifluoroacetate (<b>4</b>)</h4><div class="NLM_p last">First, 30 mg of compound <b>10d</b> (40 μmol, 1.0 equiv) were dissolved in 750 μL of ACN and 23 mg of Tos-OH·H<sub>2</sub>O were added in one portion. The reaction mixture was monitored by analytical HPLC. After 16 h, the reaction mixture was evaporated and the product was purified using preparative scale HPLC (gradient, 20–60% ACN in 50 min; <i>R</i><sub>t</sub> = 30 min) 17 mg of oily yellowish substance obtained upon dry freezing (isolated yield = 56%). Note: the reaction does undergo the deprotection using TFA as well, however, it is much less clean, probably due to addition of <i>t</i>-butyl cation on nitrile group. Analytical HPLC: <i>R</i><sub>t</sub> = 14.2 min. HRMS: (ESI+) <i>m</i>/<i>z</i> for C<sub>31</sub>H<sub>45</sub>O<sub>9</sub>N<sub>6</sub> [M + H]<sup>+</sup> calcd 645.32425, found 645.32420.</div></div><div id="sec4-1-5" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> iBody 1</h4><div class="NLM_p last">Copolymer precursor poly(HPMA-<i>co</i>-Ma-β-Ala-TT) (15 mg; <i>M</i><sub>n</sub> = 61700 g/mol, <i>M</i><sub>w</sub> = 66600 g/mol, <i><i>Đ</i></i> = 1.08; 11.7 mol % TT; the preparation is described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00767/suppl_file/jm7b00767_si_001.pdf" class="ext-link">Supporting Information</a>), compound <b>1</b> (3.78 mg dissolved in 36 μL of DMSO), ATTO488-NH<sub>2</sub> (0.75 mg), and <i>N</i>-(2-aminoethyl)biotinamid hydrobromide (biotin-NH<sub>2</sub>) (2 mg) were dissolved in 0.1 mL of <i>N</i>,<i>N</i>-dimethylacetamide (DMA). Then 4.9 μL of <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) was added. Reaction was carried out for 4 h at room temperature, and then 2 μL of 1-aminopropan-2-ol was added and the reaction was stirred for 10 min. Copolymer conjugate poly(HPMA-<i>co</i>-Ma-β-Ala-compound<b>1</b>-<i>co</i>-Ma-β-Ala-ATTO488-<i>co</i>-Ma-β-Ala-NH-biotin) (iBody <b>1</b>) was isolated by precipitation into a mixture of acetone:diethyl ether (3:1), filtered off, washed with acetone and diethyl ether, and dried in vacuum. Polymer conjugate was purified on chromatography column Sephadex LH-20 in methanol, precipitated into diethyl ether, filtered off, and dried in vacuum. Yield of the iBody <b>1</b> (<i>M</i><sub>n</sub> = 110600 g/mol, <i>M</i><sub>w</sub> = 149900 g/mol, <i>Đ</i> = 1.36) was 17 mg, and the content of compound <b>1</b> was 13.6 wt %, the content of biotin was 4.8 wt %, and the content of ATTO488 was 2.3 wt %.</div></div><div id="sec4-1-6" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> iBody 2</h4><div class="NLM_p last">Polymer precursor (50 mg; <i>M</i><sub>n</sub> = 59600 g/mol, <i>M</i><sub>w</sub> = 72700 g/mol, <i><i>Đ</i></i> = 1.22; 11.7 mol % TT; the preparation described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00767/suppl_file/jm7b00767_si_001.pdf" class="ext-link">Supporting Information</a>), ATTO488 (2.5 mg), and biotin-NH<sub>2</sub> (6 mg) were dissolved in 0.5 mL of DMSO and then 6.8 μL of <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) was added. Reaction was carried out for 4 h at room temperature, and then 2 μL of 1-aminopropan-2-ol was added and the reaction was stirred for 10 min. Copolymer conjugate poly(HPMA-<i>co</i>-Ma-β-Ala-ATTO488-<i>co</i>-Ma-β-Ala-NH-biotin) (iBody <b>2</b>) was isolated by precipitation into a mixture of acetone:diethyl ether (3:1), filtered off, washed with acetone and diethyl ether, and dried in vacuum. Polymer conjugate was purified on chromatography column Sephadex LH-20 in methanol, precipitated into diethyl ether, filtered off, and dried in vacuum. Yield of the iBody <b>2</b> (<i>M</i><sub>n</sub> = 80900 g/mol, <i>M</i><sub>w</sub> = 131000 g/mol, <i>Đ</i> = 1.62) was 40 mg, the content of ATTO488 was 4.1 wt %, and the content of biotin was 5.4 wt %.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00767">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00767" class="ext-link">10.1021/acs.jmedchem.7b00767</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthesis of intermediate compounds, polymers, and polymer conjugates; biochemical methods (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00767/suppl_file/jm7b00767_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00767/suppl_file/jm7b00767_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00767/suppl_file/jm7b00767_si_001.pdf">jm7b00767_si_001.pdf (304.76 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00767/suppl_file/jm7b00767_si_002.csv">jm7b00767_si_002.csv (0.47 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00767" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pavel Šácha</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry and Biochemistry of The Czech Academy of Sciences, Flemingovo nám 2, 16610 Prague 6, Czech Republic</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Faculty of Science, Charles
University, Hlavova 8, 12843 Prague 2, Czech Republic</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#36465740535a4557555e5776515b575f5a1855595b"><span class="__cf_email__" data-cfemail="07776671626b7466646f6647606a666e6b2964686a">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aleksi Šedo</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, U Nemocnice 5, 12853 Prague 2, Czech Republic</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#90f1fcf5fbe3f9d0f3f5e3fef5e4bef3ea"><span class="__cf_email__" data-cfemail="3e5f525b554d577e5d5b4d505b4a105d44">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Konvalinka</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry and Biochemistry of The Czech Academy of Sciences, Flemingovo nám 2, 16610 Prague 6, Czech Republic</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Faculty of Science, Charles
University, Hlavova 8, 12843 Prague 2, Czech Republic</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0695-9266" title="Orcid link">http://orcid.org/0000-0003-0695-9266</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1e747f7030757170687f727770757f5e6b717d767c307d7f6d307d64"><span class="__cf_email__" data-cfemail="a6ccc7c888cdc9c8d0c7cacfc8cdc7e6d3c9c5cec488c5c7d588c5dc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Petra Dvořáková</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry and Biochemistry of The Czech Academy of Sciences, Flemingovo nám 2, 16610 Prague 6, Czech Republic</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Cell Biology, Faculty of Science, Charles
University, Viničná 7, 12843 Prague 2, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Petr Bušek</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, U Nemocnice 5, 12853 Prague 2, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomáš Knedlík</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry and Biochemistry of The Czech Academy of Sciences, Flemingovo nám 2, 16610 Prague 6, Czech Republic</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Faculty of Science, Charles
University, Hlavova 8, 12843 Prague 2, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiří Schimer</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry and Biochemistry of The Czech Academy of Sciences, Flemingovo nám 2, 16610 Prague 6, Czech Republic</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Faculty of Science, Charles
University, Hlavova 8, 12843 Prague 2, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomáš Etrych</span> - <span class="hlFld-Affiliation affiliation">Institute
of Macromolecular Chemistry, The Czech Academy
of Sciences, Heyrovského nám 2, 16206 Prague 6, Czech Republic</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5908-5182" title="Orcid link">http://orcid.org/0000-0001-5908-5182</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Libor Kostka</span> - <span class="hlFld-Affiliation affiliation">Institute
of Macromolecular Chemistry, The Czech Academy
of Sciences, Heyrovského nám 2, 16206 Prague 6, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucie Stollinová Šromová</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, U Nemocnice 5, 12853 Prague 2, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vladimír Šubr</span> - <span class="hlFld-Affiliation affiliation">Institute
of Macromolecular Chemistry, The Czech Academy
of Sciences, Heyrovského nám 2, 16206 Prague 6, Czech Republic</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>P.D., P.B., and T.K. contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): A patent application (PCT/CZ2016/05003) has been filed related to this work.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Jana Starková, Karolı́na Šrámková, Květoslava Vlašicová, and Karin Roubı́čková for their excellent technical support, Stanislava Matějková and Štefan Štanga for elemental analyses, Martin Hubálek for protein mass spectrometry, and Hillary Hoffman for language editing. This work was supported by IOCB and Gilead Research Center Prague, grant no. 15-31379A from the Ministry of Health of the Czech Republic, UNCE 204013, and Progres Q28 projects from the Charles University, grant no. LM2015064 of the EATRIS-CZ and InterBioMed project LO 1302 from the Ministry of Education of the Czech Republic.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i21" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i21"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i22" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i22"> Abbreviations Used</h2><tr><td class="NLM_term">FAP</td><td class="NLM_def"><p class="first last">fibroblast activation protein</p></td></tr><tr><td class="NLM_term">DPP-IV</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase-IV</p></td></tr><tr><td class="NLM_term">SF-hFAP</td><td class="NLM_def"><p class="first last">extracellular portion of human FAP (aa 26-760) with N-terminal SF-tag</p></td></tr><tr><td class="NLM_term">SF-mFAP</td><td class="NLM_def"><p class="first last">extracellular portion of mouse FAP (aa 26–761) with N-terminal SF-tag</p></td></tr><tr><td class="NLM_term">Avi-hDPP-IV</td><td class="NLM_def"><p class="first last">extracellular portion of human DPP-IV (aa 29-766) with N-terminal Avi-tag</p></td></tr><tr><td class="NLM_term">Avi-mDPP-IV</td><td class="NLM_def"><p class="first last">extracellular portion of mouse DPP-IV (aa 29-760) with N-terminal Avi-tag</p></td></tr><tr><td class="NLM_term">DPP9</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase 9</p></td></tr><tr><td class="NLM_term">PREP</td><td class="NLM_def"><p class="first last">prolyl oligopeptidase</p></td></tr><tr><td class="NLM_term">HPMA</td><td class="NLM_def"><p class="first last"><i>N</i>-(2-hydroxypropyl)methacrylamide</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Sevenich, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. A.</span><span> </span><span class="NLM_article-title">Pericellular proteolysis in cancer</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2331</span><span class="NLM_x">–</span> <span class="NLM_lpage">2347</span><span class="refDoi"> DOI: 10.1101/gad.250647.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1101%2Fgad.250647.114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=2331-2347&author=L.+Sevenichauthor=J.+A.+Joyce&title=Pericellular+proteolysis+in+cancer&doi=10.1101%2Fgad.250647.114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1101%2Fgad.250647.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.250647.114%26sid%3Dliteratum%253Aachs%26aulast%3DSevenich%26aufirst%3DL.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26atitle%3DPericellular%2520proteolysis%2520in%2520cancer%26jtitle%3DGenes%2520Dev.%26date%3D2014%26volume%3D28%26spage%3D2331%26epage%3D2347%26doi%3D10.1101%2Fgad.250647.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Bonnans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werb, Z.</span><span> </span><span class="NLM_article-title">Remodelling the extracellular matrix in development and disease</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">786</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span><span class="refDoi"> DOI: 10.1038/nrm3904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1038%2Fnrm3904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=25415508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKmtbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=786-801&author=C.+Bonnansauthor=J.+Chouauthor=Z.+Werb&title=Remodelling+the+extracellular+matrix+in+development+and+disease&doi=10.1038%2Fnrm3904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Remodelling the extracellular matrix in development and disease</span></div><div class="casAuthors">Bonnans, Caroline; Chou, Jonathan; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">786-801</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The extracellular matrix (ECM) is a highly dynamic structure that is present in all tissues and continuously undergoes controlled remodelling.  This process involves quant. and qual. changes in the ECM, mediated by specific enzymes that are responsible for ECM degrdn., such as metalloproteinases.  The ECM interacts with cells to regulate diverse functions, including proliferation, migration and differentiation.  ECM remodelling is crucial for regulating the morphogenesis of the intestine and lungs, as well as of the mammary and submandibular glands.  Dysregulation of ECM compn., structure, stiffness and abundance contributes to several pathol. conditions, such as fibrosis and invasive cancer.  A better understanding of how the ECM regulates organ structure and function and of how ECM remodelling affects disease progression will contribute to the development of new therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgvNjm5IvLgLVg90H21EOLACvtfcHk0lhk18gWOstztw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKmtbbF&md5=623492080876fee0ffa62b9f0dc1937c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm3904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3904%26sid%3Dliteratum%253Aachs%26aulast%3DBonnans%26aufirst%3DC.%26aulast%3DChou%26aufirst%3DJ.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DRemodelling%2520the%2520extracellular%2520matrix%2520in%2520development%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D786%26epage%3D801%26doi%3D10.1038%2Fnrm3904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Basset, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellocq, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limacher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podhajcer, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rio, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambon, P.</span><span> </span><span class="NLM_article-title">A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">704</span><span class="refDoi"> DOI: 10.1038/348699a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1038%2F348699a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1990&pages=699-704&author=P.+Bassetauthor=J.+P.+Bellocqauthor=C.+Wolfauthor=I.+Stollauthor=P.+Hutinauthor=J.+M.+Limacherauthor=O.+L.+Podhajcerauthor=M.+P.+Chenardauthor=M.+C.+Rioauthor=P.+Chambon&title=A+novel+metalloproteinase+gene+specifically+expressed+in+stromal+cells+of+breast+carcinomas&doi=10.1038%2F348699a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F348699a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F348699a0%26sid%3Dliteratum%253Aachs%26aulast%3DBasset%26aufirst%3DP.%26aulast%3DBellocq%26aufirst%3DJ.%2BP.%26aulast%3DWolf%26aufirst%3DC.%26aulast%3DStoll%26aufirst%3DI.%26aulast%3DHutin%26aufirst%3DP.%26aulast%3DLimacher%26aufirst%3DJ.%2BM.%26aulast%3DPodhajcer%26aufirst%3DO.%2BL.%26aulast%3DChenard%26aufirst%3DM.%2BP.%26aulast%3DRio%26aufirst%3DM.%2BC.%26aulast%3DChambon%26aufirst%3DP.%26atitle%3DA%2520novel%2520metalloproteinase%2520gene%2520specifically%2520expressed%2520in%2520stromal%2520cells%2520of%2520breast%2520carcinomas%26jtitle%3DNature%26date%3D1990%26volume%3D348%26spage%3D699%26epage%3D704%26doi%3D10.1038%2F348699a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Cathcart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulkoski-Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span> </span><span class="NLM_article-title">Targeting matrix metalloproteinases in cancer: bringing new life to old ideas</span> <span class="citation_source-journal">Genes Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1016/j.gendis.2014.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2Fj.gendis.2014.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=26097889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A280%3ADC%252BC2srotlKmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=26-34&author=J.+Cathcartauthor=A.+Pulkoski-Grossauthor=J.+Cao&title=Targeting+matrix+metalloproteinases+in+cancer%3A+bringing+new+life+to+old+ideas&doi=10.1016%2Fj.gendis.2014.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas</span></div><div class="casAuthors">Cathcart Jillian; Pulkoski-Gross Ashleigh; Cao Jian</div><div class="citationInfo"><span class="NLM_cas:title">Genes & diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-34</span>
        ISSN:<span class="NLM_cas:issn">2352-4820</span>.
    </div><div class="casAbstract">Since the identification of matrix metalloproteinases (MMPs), a family of zinc-dependent endopeptidases, as being a driving factor for cancer progression and patient prognosis, MMPs have been studied extensively.  Although early programs targeting MMPs were largely unsuccessful in clinical trials, they remain a viable and highly desirable therapeutic target based on preclinical studies and their role in disease progression.  As information regarding the structure and function of these proteinases is compiled and biotechnology evolves, tools to develop better inhibitors is within our grasp.  Improved methods for high throughput screening and in silico drug design programs have identified compounds which are highly potent, have high binding affinities, and exhibit favorable pharmacokinetic profiles.  More recently, advances in drug delivery methods or compounds which bind outside the active site have brought new light to the field.  In this review, we highlight the role of MMPs in cancer, clinical trials for MMP inhibitors, and novel approaches to targeting MMPs in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEJ37PEUcnpYxhnOQkIHOxfW6udTcc2eY_KgqOo4gSkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srotlKmtw%253D%253D&md5=195802fe3f5c6881cdc9202d2ea3d957</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.gendis.2014.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gendis.2014.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DCathcart%26aufirst%3DJ.%26aulast%3DPulkoski-Gross%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DJ.%26atitle%3DTargeting%2520matrix%2520metalloproteinases%2520in%2520cancer%253A%2520bringing%2520new%2520life%2520to%2520old%2520ideas%26jtitle%3DGenes%2520Dis.%26date%3D2015%26volume%3D2%26spage%3D26%26epage%3D34%26doi%3D10.1016%2Fj.gendis.2014.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Zucker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. T.</span><span> </span><span class="NLM_article-title">Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6642</span><span class="NLM_x">–</span> <span class="NLM_lpage">6650</span><span class="refDoi"> DOI: 10.1038/sj.onc.1204097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1038%2Fsj.onc.1204097" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=6642-6650&author=S.+Zuckerauthor=J.+Caoauthor=W.+T.+Chen&title=Critical+appraisal+of+the+use+of+matrix+metalloproteinase+inhibitors+in+cancer+treatment&doi=10.1038%2Fsj.onc.1204097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1204097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1204097%26sid%3Dliteratum%253Aachs%26aulast%3DZucker%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DW.%2BT.%26atitle%3DCritical%2520appraisal%2520of%2520the%2520use%2520of%2520matrix%2520metalloproteinase%2520inhibitors%2520in%2520cancer%2520treatment%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D6642%26epage%3D6650%26doi%3D10.1038%2Fsj.onc.1204097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">7235</span><span class="NLM_x">–</span> <span class="NLM_lpage">7239</span><span class="refDoi"> DOI: 10.1073/pnas.87.18.7235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1073%2Fpnas.87.18.7235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=2402505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADyaK3cXmtV2isbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=7235-7239&author=P.+Garin-Chesaauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Cell+surface+glycoprotein+of+reactive+stromal+fibroblasts+as+a+potential+antibody+target+in+human+epithelial+cancers&doi=10.1073%2Fpnas.87.18.7235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers</span></div><div class="casAuthors">Garin-Chesa, Pilar; Old, Lloyd J.; Rettig, Wolfgang J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7235-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The F19 antigen is a cell surface glycoprotein (mol. wt. 95,000) of human sarcomas and proliferating cultured fibroblasts that is absent from resting fibroblasts in normal adult tissues.  Normal and malignant epithelial cells are also F19-.  The present immunohistochem. study describes induction of F19 in the reactive mesenchyme of epithelial tumors.  F19+ fibroblasts were found in primary and metastatic carcinomas, including colorectal, breast, ovarian, bladder, and lung carcinomas.  The stroma of benign colorectal adenomas, fibrocystic disease, and fibroadenomas of breast, benign prostate hyperplasia, bladder carcinomas, and benign ovarian tumors showed no or only moderate nos. of F19+ fibroblasts.  Anal. of dermal incision wounds revealed that F19 was strongly induced during scar formation.  Comparison of F19 with the extracellular matrix protein tenascin, a putative marker of tumor mesenchyme, showed a cellular staining pattern for F19 vs. the extracellular matrix pattern for tenascin and widespread expression of tenascin in F19- normal tissues and benign tumors.  The F19+ phenotype may correlate with specialized fibroblast functions in wound healing and malignant tumor growth.  Because of its abundance in tumor mesenchyme, F19 may serve as a target for antibodies labeled with radioisotopes or toxic agents, or inflammatogenic antibodies, in carcinoma patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9_KYVTgRj8LVg90H21EOLACvtfcHk0lgV5ycm2b6j5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtV2isbw%253D&md5=957bd13237f20c4f1e95a7a1b2204081</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.87.18.7235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.87.18.7235%26sid%3Dliteratum%253Aachs%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DCell%2520surface%2520glycoprotein%2520of%2520reactive%2520stromal%2520fibroblasts%2520as%2520a%2520potential%2520antibody%2520target%2520in%2520human%2520epithelial%2520cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1990%26volume%3D87%26spage%3D7235%26epage%3D7239%26doi%3D10.1073%2Fpnas.87.18.7235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaughnessy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaccoby, S.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1111/j.1365-2141.2006.05976.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1111%2Fj.1365-2141.2006.05976.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=16512833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFaktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2006&pages=83-92&author=Y.+Geauthor=F.+G.+Zhanauthor=B.+Barlogieauthor=J.+Epsteinauthor=J.+Shaughnessyauthor=S.+Yaccoby&title=Fibroblast+activation+protein+%28FAP%29+is+upregulated+in+myelomatous+bone+and+supports+myeloma+cell+survival&doi=10.1111%2Fj.1365-2141.2006.05976.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival</span></div><div class="casAuthors">Ge, Yun; Zhan, Fenghuang; Barlogie, Bart; Epstein, Joshua; Shaughnessy, John, Jr.; Yaccoby, Shmuel</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-92</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The microenvironment plays a crit. role in facilitating cancer progression and metastasis.  We previously demonstrated the ability of osteoclasts to support primary myeloma plasma cell (MM PC) growth.  Our study on the role of the bone marrow (BM) microenvironment in myeloma, using global gene expression profiling, has identified fibroblast activation protein (FAP) as one of 28 genes significantly overexpressed in cocultured osteoclasts.  Because FAP has been previously implicated in tumorigenesis and shown to be selectively expressed by the reactive stroma of epithelial tumors, we focused our study on the role of this serine protease in myeloma.  Using quant. polymerase chain reaction amplification, we demonstrated upregulation of FAP by cocultured osteoclasts and mesenchymal stem cells, and in whole myelomatous human bone in SCID-hu mice.  Immunohistochem. anal. of myelomatous bone sections revealed FAP expression by osteoclasts, osteogenic cells, fibrotic stroma and certain adipocytes and vascular endothelial cells.  FAP was not expressed in PCs by all these methods.  Inhibition of FAP expression with the use of small-interference RNA reduced MM PC survival in cocultures.  Our results indicate that FAP is crit. for the interaction of MM cells with the BM microenvironment - a potential therapeutic target in myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRKLTZGv4ItLVg90H21EOLACvtfcHk0ljpx2mO9J2Djg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFaktbg%253D&md5=154862801f747c44fa47df2980eb9d75</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2006.05976.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2006.05976.x%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DF.%2BG.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DEpstein%26aufirst%3DJ.%26aulast%3DShaughnessy%26aufirst%3DJ.%26aulast%3DYaccoby%26aufirst%3DS.%26atitle%3DFibroblast%2520activation%2520protein%2520%2528FAP%2529%2520is%2520upregulated%2520in%2520myelomatous%2520bone%2520and%2520supports%2520myeloma%2520cell%2520survival%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2006%26volume%3D133%26spage%3D83%26epage%3D92%26doi%3D10.1111%2Fj.1365-2141.2006.05976.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Busek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaziova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matrasova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syrucek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zemanova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krepela, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belacek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedo, A.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma</span> <span class="citation_source-journal">Tumor Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">13961</span><span class="NLM_x">–</span> <span class="NLM_lpage">13971</span><span class="refDoi"> DOI: 10.1007/s13277-016-5274-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1007%2Fs13277-016-5274-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=27492457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlejtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=13961-13971&author=P.+Busekauthor=E.+Balaziovaauthor=I.+Matrasovaauthor=M.+Hilserauthor=R.+Tomasauthor=M.+Syrucekauthor=Z.+Zemanovaauthor=E.+Krepelaauthor=J.+Belacekauthor=A.+Sedo&title=Fibroblast+activation+protein+alpha+is+expressed+by+transformed+and+stromal+cells+and+is+associated+with+mesenchymal+features+in+glioblastoma&doi=10.1007%2Fs13277-016-5274-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma</span></div><div class="casAuthors">Busek, Petr; Balaziova, Eva; Matrasova, Ivana; Hilser, Marek; Tomas, Robert; Syrucek, Martin; Zemanova, Zuzana; Krepela, Evzen; Belacek, Jaromir; Sedo, Aleksi</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">13961-13971</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Glioblastomas are deadly neoplasms resistant to current treatment modalities.  Fibroblast activation protein (FAP) is a protease which is not expressed in most of the normal adult tissues but is characteristically present in the stroma of extracranial malignancies.  FAP is considered a potential therapeutic target and is assocd. with a worse patient outcome in some cancers.  The FAP localization in the glioma microenvironment and its relation to patient survival are unknown.  By analyzing 56 gliomas and 15 non-tumorous brain samples, we demonstrate increased FAP expression in a subgroup of high-grade gliomas, in particular on the protein level.  FAP expression was most elevated in the mesenchymal subtype of glioblastoma.  It was neither assocd. with glioblastoma patient survival in our patient cohort nor in publicly available datasets.  FAP was expressed in both transformed and stromal cells; the latter were frequently localized around dysplastic blood vessels and commonly expressed mesenchymal markers.  In a mouse xenotransplantation model, FAP was expressed in glioma cells in a subgroup of tumors that typically did not express the astrocytic marker GFAP.  Endogenous FAP was frequently upregulated and part of the FAP+ host cells coexpressed the CXCR4 chemokine receptor.  In summary, FAP is expressed by several constituents of the glioblastoma microenvironment, including stromal non-malignant mesenchymal cells recruited to and/or activated in response to glioma growth.  The limited expression of FAP in healthy tissues together with its presence in both transformed and stromal cells suggests that FAP may be a candidate target for specific delivery of therapeutic agents in glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6zANoeaouHLVg90H21EOLACvtfcHk0ljpx2mO9J2Djg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlejtLfO&md5=87c12c033d2ac230da4b7e7d94928398</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs13277-016-5274-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-016-5274-9%26sid%3Dliteratum%253Aachs%26aulast%3DBusek%26aufirst%3DP.%26aulast%3DBalaziova%26aufirst%3DE.%26aulast%3DMatrasova%26aufirst%3DI.%26aulast%3DHilser%26aufirst%3DM.%26aulast%3DTomas%26aufirst%3DR.%26aulast%3DSyrucek%26aufirst%3DM.%26aulast%3DZemanova%26aufirst%3DZ.%26aulast%3DKrepela%26aufirst%3DE.%26aulast%3DBelacek%26aufirst%3DJ.%26aulast%3DSedo%26aufirst%3DA.%26atitle%3DFibroblast%2520activation%2520protein%2520alpha%2520is%2520expressed%2520by%2520transformed%2520and%2520stromal%2520cells%2520and%2520is%2520associated%2520with%2520mesenchymal%2520features%2520in%2520glioblastoma%26jtitle%3DTumor%2520Biol.%26date%3D2016%26volume%3D37%26spage%3D13961%26epage%3D13971%26doi%3D10.1007%2Fs13277-016-5274-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Shi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, M. H.</span><span> </span><span class="NLM_article-title">Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">840</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span><span class="refDoi"> DOI: 10.3748/wjg.v18.i8.840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.3748%2Fwjg.v18.i8.840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=22371645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC38XjslOlsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=840-846&author=M.+Shiauthor=D.+H.+Yuauthor=Y.+Chenauthor=C.+Y.+Zhaoauthor=J.+Zhangauthor=Q.+H.+Liuauthor=C.+R.+Niauthor=M.+H.+Zhu&title=Expression+of+fibroblast+activation+protein+in+human+pancreatic+adenocarcinoma+and+its+clinicopathological+significance&doi=10.3748%2Fwjg.v18.i8.840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance</span></div><div class="casAuthors">Shi, Min; Yu, Dang-Hui; Chen, Ying; Zhao, Chen-Yan; Zhang, Jing; Liu, Qing-Hua; Ni, Can-Rong; Zhu, Ming-Hua</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">840-846</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Co., Ltd.</span>)
        </div><div class="casAbstract">Aim: To examine fibroblast activation protein (FAP) expression in pancreatic ductal adenocarcinoma (PDAC) and to analyze its relationship with the clinicopathol. of PDAC.  Methods: FAP expression was examd. in 134 PDAC specimens by immunohistochem. and in four pancreatic cancer cell lines (SW1990, Miapaca-2, AsPC-1 and BxPC-3) by Western blotting assay.  We also analyzed the assocn. between FAP expression in PDAC cells and the clinicopathol. of PDAC patients.  Results: The results showed that the FAP was expressed in both stromal fibroblast cells (98/134, 73.1%) and carcinoma cells (102/134, 76.1 %).  All 4 pancreatic cancer cell lines expressed FAP protein at different levels.  Protein bands corresponding to the proteolytically active 170-kDa seprase dimer and its 88-kDa seprase subunit were identified.  Higher FAP expression in carcinoma cells was assocd. with tumor size (P < 0.001), fibrotic focus (P = 0.003), perineural invasion (P = 0.009) and worse clin. outcome (P = 0.0085).  Conclusion: FAP is highly expressed in carcinoma cells and fibroblasts in PDAC tissues and its expression is assocd. with desmoplasia and worse prognosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxNJB6yGpISbVg90H21EOLACvtfcHk0ljpx2mO9J2Djg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjslOlsr4%253D&md5=3e73023ef7a37f9d8eba9decdf4b72e6</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v18.i8.840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v18.i8.840%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DD.%2BH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DC.%2BY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DQ.%2BH.%26aulast%3DNi%26aufirst%3DC.%2BR.%26aulast%3DZhu%26aufirst%3DM.%2BH.%26atitle%3DExpression%2520of%2520fibroblast%2520activation%2520protein%2520in%2520human%2520pancreatic%2520adenocarcinoma%2520and%2520its%2520clinicopathological%2520significance%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2012%26volume%3D18%26spage%3D840%26epage%3D846%26doi%3D10.3748%2Fwjg.v18.i8.840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Busek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanickova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrabal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brabec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fric, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavoral, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kmochova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laclav, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunganic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedo, A.</span><span> </span><span class="NLM_article-title">Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma</span> <span class="citation_source-journal">Pancreatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">838</span><span class="refDoi"> DOI: 10.1016/j.pan.2016.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2Fj.pan.2016.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=829-838&author=P.+Busekauthor=Z.+Vanickovaauthor=P.+Hrabalauthor=M.+Brabecauthor=P.+Fricauthor=M.+Zavoralauthor=J.+Skrhaauthor=K.+Kmochovaauthor=M.+Laclavauthor=B.+Bunganicauthor=K.+Augustynsauthor=P.+Van+der+Vekenauthor=A.+Sedo&title=Increased+tissue+and+circulating+levels+of+dipeptidyl+peptidase-IV+enzymatic+activity+in+patients+with+pancreatic+ductal+adenocarcinoma&doi=10.1016%2Fj.pan.2016.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.pan.2016.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pan.2016.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DBusek%26aufirst%3DP.%26aulast%3DVanickova%26aufirst%3DZ.%26aulast%3DHrabal%26aufirst%3DP.%26aulast%3DBrabec%26aufirst%3DM.%26aulast%3DFric%26aufirst%3DP.%26aulast%3DZavoral%26aufirst%3DM.%26aulast%3DSkrha%26aufirst%3DJ.%26aulast%3DKmochova%26aufirst%3DK.%26aulast%3DLaclav%26aufirst%3DM.%26aulast%3DBunganic%26aufirst%3DB.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DSedo%26aufirst%3DA.%26atitle%3DIncreased%2520tissue%2520and%2520circulating%2520levels%2520of%2520dipeptidyl%2520peptidase-IV%2520enzymatic%2520activity%2520in%2520patients%2520with%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DPancreatology%26date%3D2016%26volume%3D16%26spage%3D829%26epage%3D838%26doi%3D10.1016%2Fj.pan.2016.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kelly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kechelava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozypal, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korourian, S.</span><span> </span><span class="NLM_article-title">Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers</span> <span class="citation_source-journal">Mod. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=9758365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A280%3ADyaK1cvivFegsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1998&pages=855-863&author=T.+Kellyauthor=S.+Kechelavaauthor=T.+L.+Rozypalauthor=K.+W.+Westauthor=S.+Korourian&title=Seprase%2C+a+membrane-bound+protease%2C+is+overexpressed+by+invasive+ductal+carcinoma+cells+of+human+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers</span></div><div class="casAuthors">Kelly T; Kechelava S; Rozypal T L; West K W; Korourian S</div><div class="citationInfo"><span class="NLM_cas:title">Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">855-63</span>
        ISSN:<span class="NLM_cas:issn">0893-3952</span>.
    </div><div class="casAbstract">The increased cell surface expression of the serine integral membrane protease, seprase, has been associated with the invasive behavior of human melanoma cell lines in vitro.  The present study investigates the expression of seprase in malignant, premalignant, benign, and normal human breast tissues.  The 170-kDa gelatinase activity of seprase was identified in extracts of infiltrating ductal carcinomas (IDC).  Protein bands corresponding to the proteolytically active 170-kDa seprase dimer and its 97-kDa seprase subunit protein were identified by immunoblot analysis of IDC extracts using an antiserum elicited against immunoaffinity-purified seprase.  Immunohistochemical analysis of seprase expression in 41 formalin-fixed and paraffin-embedded specimens of human breast tissue revealed preferential immunoreactivity with the malignant cells of IDC (27 cases).  Within individual IDC specimens, the stromal cells or morphologically normal epithelium revealed low labeling that was always significantly less than the labeling of neoplastic cells.  Lymph node metastases of IDC cells were also strongly positive, but the lymphoid tissue in affected nodes was not stained.  Neoplastic cells in DC in situ (5 cases) exhibited variable levels of staining.  Epithelial cells of benign fibroadenoma specimens (2 cases) and benign proliferative breast disease (5 cases) exhibited little or no immunoreactivity.  Epithelial cells of normal breast tissue (1 case) were not stained.  The overexpression of seprase by DC cells is consistent with seprase having a role in facilitating invasion and metastasis of IDC of the breast.  The cell surface localization of seprase could be used to target therapeutic agents to malignant breast cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXFZ5CzApM6g8IxFYvehhofW6udTcc2eaDpvZQc-eLJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvivFegsA%253D%253D&md5=b348b49ed7e1645600038f4abfbcb410</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DT.%26aulast%3DKechelava%26aufirst%3DS.%26aulast%3DRozypal%26aufirst%3DT.%2BL.%26aulast%3DWest%26aufirst%3DK.%2BW.%26aulast%3DKorourian%26aufirst%3DS.%26atitle%3DSeprase%252C%2520a%2520membrane-bound%2520protease%252C%2520is%2520overexpressed%2520by%2520invasive%2520ductal%2520carcinoma%2520cells%2520of%2520human%2520breast%2520cancers%26jtitle%3DMod.%2520Pathol.%26date%3D1998%26volume%3D11%26spage%3D855%26epage%3D863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Iwasa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsumata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooi, A.</span><span> </span><span class="NLM_article-title">Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">199</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/S0304-3835(03)00315-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2FS0304-3835%2803%2900315-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=12963128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVylsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2003&pages=91-98&author=S.+Iwasaauthor=X.+Jinauthor=K.+Okadaauthor=M.+Mitsumataauthor=A.+Ooi&title=Increased+expression+of+seprase%2C+a+membrane-type+serine+protease%2C+is+associated+with+lymph+node+metastasis+in+human+colorectal+cancer&doi=10.1016%2FS0304-3835%2803%2900315-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer</span></div><div class="casAuthors">Iwasa, Satoshi; Jin, Xin; Okada, Kyoko; Mitsumata, Masako; Ooi, Akishi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">199</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Seprase is a membrane-bound serine proteinase with gelatinase activity, which may be involved in cancer invasion and metastasis.  We examd. seprase expression in colorectal cancer specimens obtained from 109 patients.  Seprase immunoreactivity was found in cancer cells and adjacent stromal cells.  Immunoblotting showed higher levels of seprase protein in colorectal cancer tissue than in normal colorectal tissue.  A semiquant. assessment of the immunohistochem. results revealed a significant correlation between seprase expression and lymph node metastasis.  These results suggested that an abundant expression of seprase in colorectal cancer tissue is assocd. with lymph node metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowKXBr8wGFDLVg90H21EOLACvtfcHk0ljE6Nz23K07oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVylsLs%253D&md5=884618a04d7df606b0733369880811c1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0304-3835%2803%2900315-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3835%252803%252900315-X%26sid%3Dliteratum%253Aachs%26aulast%3DIwasa%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DMitsumata%26aufirst%3DM.%26aulast%3DOoi%26aufirst%3DA.%26atitle%3DIncreased%2520expression%2520of%2520seprase%252C%2520a%2520membrane-type%2520serine%2520protease%252C%2520is%2520associated%2520with%2520lymph%2520node%2520metastasis%2520in%2520human%2520colorectal%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2003%26volume%3D199%26spage%3D91%26epage%3D98%26doi%3D10.1016%2FS0304-3835%2803%2900315-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsumata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooi, A.</span><span> </span><span class="NLM_article-title">Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3195</span><span class="NLM_x">–</span> <span class="NLM_lpage">3198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=12926053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVChur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=3195-3198&author=X.+Jinauthor=S.+Iwasaauthor=K.+Okadaauthor=M.+Mitsumataauthor=A.+Ooi&title=Expression+patterns+of+seprase%2C+a+membrane+serine+protease%2C+in+cervical+carcinoma+and+cervical+intraepithelial+neoplasm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm</span></div><div class="casAuthors">Jin, Xin; Iwasa, Satoshi; Okada, Kyoko; Mitsumata, Masako; Ooi, Akishi</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">3195-3198</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Seprase is a membrane-bound serine proteinase with gelatinase activity, which may be involved in cancer invasion and metastasis.  Patients and Methods: The authors examd. the seprase expression patterns in invasive or preinvasive squamous epithelial lesions.  Results and Conclusion: No seprase immunoreactivity was found in the atypical epithelial cells and subepithelial stromal cells of CIN1 and 2 lesions.  No seprase expression could be detected even in CIN3 lesions.  However, in contrast to CIN1 and 2, seprase immunoreactivity was occasionally obsd. in the subepithelial stromal cells that were assocd. with moderate or severe inflammatory infiltrates.  Some microinvasive carcinomas and all invasive carcinomas showed seprase immunoreactivity in the cancer cells with various degrees of seprase pos. stromal cells.  Seprase may be an early marker of tumor invasion in squamous lesions of the uterine cervix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLpiTHhlVCnrVg90H21EOLACvtfcHk0ljE6Nz23K07oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVChur4%253D&md5=c822bb883328ad846cd5b0ccc05c9c4d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DX.%26aulast%3DIwasa%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DMitsumata%26aufirst%3DM.%26aulast%3DOoi%26aufirst%3DA.%26atitle%3DExpression%2520patterns%2520of%2520seprase%252C%2520a%2520membrane%2520serine%2520protease%252C%2520in%2520cervical%2520carcinoma%2520and%2520cervical%2520intraepithelial%2520neoplasm%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26spage%3D3195%26epage%3D3198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, X.</span><span> </span><span class="NLM_article-title">Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1155</span><span class="refDoi"> DOI: 10.1038/cddis.2014.122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1038%2Fcddis.2014.122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=24722280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmslWrt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1155&author=H.+Wangauthor=Q.+Wuauthor=Z.+Liuauthor=X.+Luoauthor=Y.+Fanauthor=Y.+Liuauthor=Y.+Zhangauthor=S.+Huaauthor=Q.+Fuauthor=M.+Zhaoauthor=Y.+Chenauthor=W.+Fangauthor=X.+Lv&title=Downregulation+of+FAP+suppresses+cell+proliferation+and+metastasis+through+PTEN%2FPI3K%2FAKT+and+Ras-ERK+signaling+in+oral+squamous+cell+carcinoma&doi=10.1038%2Fcddis.2014.122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma</span></div><div class="casAuthors">Wang, H.; Wu, Q.; Liu, Z.; Luo, X.; Fan, Y.; Liu, Y.; Zhang, Y.; Hua, S.; Fu, Q.; Zhao, M.; Chen, Y.; Fang, W.; Lv, X.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1155</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">It is largely recognized that fibroblast activation protein (FAP) is expressed in cancer-assocd. fibroblasts (CAFs) of many human carcinomas.  Furthermore, FAP was recently also reported to be expressed in carcinoma cells of the breast, stomach, pancreatic ductal adenocarcinoma, colorectum, and uterine cervix.  The carcinoma cell expression pattern of FAP has been described in several types of cancers, but the role of FAP in oral squamous cell carcinoma (OSCC) is unknown.  The role of endogenous FAP in epithelium-derived tumors and mol. mechanisms has also not been reported.  In this study, FAP was found to be expressed in carcinoma cells of OSCC and was upregulated in OSCC tissue samples compared with benign tissue samples using immunohistochem.  In addn., its expression level was closely correlated with overall survival of patients with OSCC.  Silencing FAP inhibited the growth and metastasis of OSCC cells in vitro and in vivo.  Mechanistically, knockdown of FAP inactivated PTEN/PI3K/AKT and Ras-ERK and its downstream signaling regulating proliferation, migration, and invasion in OSCC cells, as the inhibitory effects of FAP on the proliferation and metastasis could be rescued by PTEN silencing.  Our study suggests that FAP acts as an oncogene and may be a potential therapeutic target for patients with OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs6rCzKYMH07Vg90H21EOLACvtfcHk0ljs6wy0YT2fYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmslWrt74%253D&md5=a707a92b74ab7b3396051cee1442b9ed</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.122%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DFu%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DW.%26aulast%3DLv%26aufirst%3DX.%26atitle%3DDownregulation%2520of%2520FAP%2520suppresses%2520cell%2520proliferation%2520and%2520metastasis%2520through%2520PTEN%252FPI3K%252FAKT%2520and%2520Ras-ERK%2520signaling%2520in%2520oral%2520squamous%2520cell%2520carcinoma%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1155%26doi%3D10.1038%2Fcddis.2014.122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ramirez-Montagut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blachere, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sviderskaya, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, A. N.</span><span> </span><span class="NLM_article-title">FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5435</span><span class="NLM_x">–</span> <span class="NLM_lpage">5446</span><span class="refDoi"> DOI: 10.1038/sj.onc.1207730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1038%2Fsj.onc.1207730" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=5435-5446&author=T.+Ramirez-Montagutauthor=N.+E.+Blachereauthor=E.+V.+Sviderskayaauthor=D.+C.+Bennettauthor=W.+J.+Rettigauthor=P.+Garin-Chesaauthor=A.+N.+Houghton&title=FAPalpha%2C+a+surface+peptidase+expressed+during+wound+healing%2C+is+a+tumor+suppressor&doi=10.1038%2Fsj.onc.1207730"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207730%26sid%3Dliteratum%253Aachs%26aulast%3DRamirez-Montagut%26aufirst%3DT.%26aulast%3DBlachere%26aufirst%3DN.%2BE.%26aulast%3DSviderskaya%26aufirst%3DE.%2BV.%26aulast%3DBennett%26aufirst%3DD.%2BC.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DHoughton%26aufirst%3DA.%2BN.%26atitle%3DFAPalpha%252C%2520a%2520surface%2520peptidase%2520expressed%2520during%2520wound%2520healing%252C%2520is%2520a%2520tumor%2520suppressor%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D5435%26epage%3D5446%26doi%3D10.1038%2Fsj.onc.1207730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span> </span><span class="NLM_article-title">Ultrasensitive fluorescent probes reveal an adverse action of dipeptide peptidase IV and fibroblast activation protein during proliferation of cancer cells</span> <span class="citation_source-journal">Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">8309</span><span class="NLM_x">–</span> <span class="NLM_lpage">8314</span><span class="refDoi"> DOI: 10.1021/acs.analchem.6b02231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.analchem.6b02231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1WntLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2016&pages=8309-8314&author=Q.+Gongauthor=W.+Shiauthor=L.+Liauthor=X.+Wuauthor=H.+Ma&title=Ultrasensitive+fluorescent+probes+reveal+an+adverse+action+of+dipeptide+peptidase+IV+and+fibroblast+activation+protein+during+proliferation+of+cancer+cells&doi=10.1021%2Facs.analchem.6b02231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Ultrasensitive Fluorescent Probes Reveal an Adverse Action of Dipeptide Peptidase IV and Fibroblast Activation Protein during Proliferation of Cancer Cells</span></div><div class="casAuthors">Gong, Qiuyu; Shi, Wen; Li, Lihong; Wu, Xiaofeng; Ma, Huimin</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8309-8314</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dipeptide peptidase IV (DPPIV) and fibroblast activation protein (FAP) are isoenzymes.  Evidence shows that DPPIV is related to antitumor immunity, and FAP may be a drug target in cancer therapy, making it seem that the two enzymes might have a synergistic role during the proliferation of cancer cells.  Surprisingly, herein, the authors find an adverse action of DPPIV and FAP in the proliferation process by analyzing their changes with two tailor-made ultrasensitive fluorescent probes.  First, the up-regulation of DPPIV and down-regulation of FAP in cancer cells under the stimulation of genistein are detected.  Then, the authors find that MGC803 cells with a higher FAP but lower DPPIV level than SGC7901 cells exhibit a faster proliferation rate.  Importantly, inhibiting the DPPIV expression with siRNA increases the proliferation rate of MGC803 cells, whereas the FAP inhibition decreases the rate.  These findings suggest that the two enzymes play an adverse role during the proliferation of cancer cells, which provides the authors a new viewpoint for cancer studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUcJ3nvdooBbVg90H21EOLACvtfcHk0lgnWmijTc9Mxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1WntLjM&md5=a2384c3586884532b9d36364b3dd40ca</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.analchem.6b02231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.analchem.6b02231%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DH.%26atitle%3DUltrasensitive%2520fluorescent%2520probes%2520reveal%2520an%2520adverse%2520action%2520of%2520dipeptide%2520peptidase%2520IV%2520and%2520fibroblast%2520activation%2520protein%2520during%2520proliferation%2520of%2520cancer%2520cells%26jtitle%3DAnal.%2520Chem.%26date%3D2016%26volume%3D88%26spage%3D8309%26epage%3D8314%26doi%3D10.1021%2Facs.analchem.6b02231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Tulley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. T.</span><span> </span><span class="NLM_article-title">Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-beta signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">15280</span><span class="NLM_x">–</span> <span class="NLM_lpage">15296</span><span class="refDoi"> DOI: 10.1074/jbc.M114.568501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1074%2Fjbc.M114.568501" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=15280-15296&author=S.+Tulleyauthor=W.+T.+Chen&title=Transcriptional+regulation+of+seprase+in+invasive+melanoma+cells+by+transforming+growth+factor-beta+signaling&doi=10.1074%2Fjbc.M114.568501"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.568501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.568501%26sid%3Dliteratum%253Aachs%26aulast%3DTulley%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DW.%2BT.%26atitle%3DTranscriptional%2520regulation%2520of%2520seprase%2520in%2520invasive%2520melanoma%2520cells%2520by%2520transforming%2520growth%2520factor-beta%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D15280%26epage%3D15296%26doi%3D10.1074%2Fjbc.M114.568501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0116683</span><span class="refDoi"> DOI: 10.1371/journal.pone.0116683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1371%2Fjournal.pone.0116683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=25775399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1OisrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0116683&author=F.+Liuauthor=L.+Qiauthor=B.+Liuauthor=J.+Liuauthor=H.+Zhangauthor=D.+Cheauthor=J.+Caoauthor=J.+Shenauthor=J.+Gengauthor=Y.+Biauthor=L.+Yeauthor=B.+Panauthor=Y.+Yu&title=Fibroblast+activation+protein+overexpression+and+clinical+implications+in+solid+tumors%3A+a+meta-analysis&doi=10.1371%2Fjournal.pone.0116683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis</span></div><div class="casAuthors">Liu, Fang; Qi, Li; Liu, Bao; Liu, Jie; Zhang, Hua; Che, De Hai; Cao, Jing Yan; Shen, Jing; Geng, Jian Xiong; Bi, Yi; Ye, Lie Guang; Pan, Bo; Yu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e0116683/1-e0116683/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Objective: Fibroblast activation protein (FAP) plays a vital role in tumor invasion and metastasis.  Previous studies have reported its prognostic value in different tumors.  However, the results of these reports remain controversial.  In this study, a meta-anal. was performed to clarify this issue.  Methods: A search of the PubMed, Embase and CNKI databases was conducted to analyze relevant articles.  The outcomes included the relations between FAP expression and histol. differentiation, tumor invasion, lymph node metastasis, distant metastasis and overall survival (OS).  Sensitivity anal. by FAP expression in different cells and tumor types were further subjected to sensitivity analyses as subgroups.  Pooled odds ratios (ORs) and hazard ratios (HRs) were evaluated using the random-effects model.  Results: The global anal. included 15 studies concerning various solid tumors.  For global anal., FAP overexpression in tumor tissue displayed significant assocns. with poor OS and tumor progression (OS: HR = 2.18, P = 0.004; tumor invasion: OR = 4.48, P = 0.007; and lymph node metastasis: OR = 3.80, P = 0.004).  The subgroup analyses yielded two no-table results.  First, the relation between FAP overexpression and poor OS and tumor lymph node metastasis was closer in the patients with FAP expression in tumor cells.  Second, the pooled analyses of colorectal cancers or pancreatic cancers all indicated that FAP overexpression was assocd. with a detrimental OS (HR: 1.72, P = 0.009; HR: 3.18, P = 0.005, resp.).  The magnitude of this effect was not statistically significant compared with that in patients with non-colorectal cancers or non-pancreatic cancers.  These analyses did not display a statistically significant correlation between FAP expression and histol. differentiation and distant metastasis in all of the groups.  Conclusions: FAP expression is assocd. with worse prognosis in solid tumors, and this assocn. is particularly pronounced if FAP overexpression is found in the tumor cells rather than the stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBfoME4lxADLVg90H21EOLACvtfcHk0lgnWmijTc9Mxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1OisrrN&md5=8603b68f0f6496fdaa743941f8d5454e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0116683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0116683%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChe%26aufirst%3DD.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DJ.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DPan%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DY.%26atitle%3DFibroblast%2520activation%2520protein%2520overexpression%2520and%2520clinical%2520implications%2520in%2520solid%2520tumors%253A%2520a%2520meta-analysis%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0116683%26doi%3D10.1371%2Fjournal.pone.0116683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Acharya, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zukas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenstein, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pure, E.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis</span> <span class="citation_source-journal">Hum. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1016/j.humpath.2005.11.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2Fj.humpath.2005.11.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=16613331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVWgs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2006&pages=352-360&author=P.+S.+Acharyaauthor=A.+Zukasauthor=V.+Chandanauthor=A.+L.+Katzensteinauthor=E.+Pure&title=Fibroblast+activation+protein%3A+a+serine+protease+expressed+at+the+remodeling+interface+in+idiopathic+pulmonary+fibrosis&doi=10.1016%2Fj.humpath.2005.11.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Acharya, Pinak S.; Zukas, Alicia; Chandan, Vishal; Katzenstein, Anna-Luise A.; Pure, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Human Pathology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">352-360</span>CODEN:
                <span class="NLM_cas:coden">HPCQA4</span>;
        ISSN:<span class="NLM_cas:issn">0046-8177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Fibroblast activation protein (FAPα) is a member of the cell surface dipeptidyl peptidase (DPP) family of serine proteases.  In its dimer form, FAPα exhibits gelatinase, collagenase, and DPP activity in vitro.  Reactive fibroblasts in healing wounds and stromal fibroblasts assocd. with epithelial tumors express FAPα.  Idiopathic pulmonary fibrosis (IPF) is a disease of the lung characterized by progressive fibrosis with no clear etiol. or mol. marker for disease activity.  Recently, it has been shown that fibroblast FAPα expression is induced in liver cirrhosis, with an expression pattern distinct from alpha-smooth muscle actin (α-SMA).  In this study, we det. whether FAPα expression is selectively induced in areas of ongoing tissue remodeling characterized by fibroblast foci in IPF.  Human lung tissue was obtained from patients with IPF, centrilobular emphysema, and normal lung.  Immunohistochem. studies were performed using anti-FAPα antibody and antibodies against α-SMA and CD26 (DPPIV), another member of the DPP family.  We found that FAPα was not expressed in normal human lung tissue or tissue with evidence of centriacinar emphysema, but was induced in all patients with IPF and with a pattern distinct from that of CD26 found primarily on hyperplastic alveolar epithelium.  Specifically, FAPα was detected in fibroblast foci and in fibrotic interstitium and not in the interstitium of adjacent architecturally normal lung.  Alveolar/airway epithelium and vascular smooth muscle did not express FAPα.  This is the first report of FAPα expression in IPF and our results suggest that FAPα is selectively induced in fibrotic foci, but not in normal or emphysematous lung.  Future studies will address whether FAPα may be used as a marker for disease activity in IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAUc6hzUMix7Vg90H21EOLACvtfcHk0lgnWmijTc9Mxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVWgs7Y%253D&md5=ba036bf957422a280e73e40081daae30</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.humpath.2005.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.humpath.2005.11.020%26sid%3Dliteratum%253Aachs%26aulast%3DAcharya%26aufirst%3DP.%2BS.%26aulast%3DZukas%26aufirst%3DA.%26aulast%3DChandan%26aufirst%3DV.%26aulast%3DKatzenstein%26aufirst%3DA.%2BL.%26aulast%3DPure%26aufirst%3DE.%26atitle%3DFibroblast%2520activation%2520protein%253A%2520a%2520serine%2520protease%2520expressed%2520at%2520the%2520remodeling%2520interface%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DHum.%2520Pathol.%26date%3D2006%26volume%3D37%26spage%3D352%26epage%3D360%26doi%3D10.1016%2Fj.humpath.2005.11.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Levy, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1768</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span><span class="refDoi"> DOI: 10.1002/hep.510290631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1002%2Fhep.510290631" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1999&pages=1768-1778&author=M.+T.+Levyauthor=G.+W.+McCaughanauthor=C.+A.+Abbottauthor=J.+E.+Parkauthor=A.+M.+Cunninghamauthor=E.+Mullerauthor=W.+J.+Rettigauthor=M.+D.+Gorrell&title=Fibroblast+activation+protein%3A+a+cell+surface+dipeptidyl+peptidase+and+gelatinase+expressed+by+stellate+cells+at+the+tissue+remodelling+interface+in+human+cirrhosis&doi=10.1002%2Fhep.510290631"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fhep.510290631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.510290631%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DM.%2BT.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26aulast%3DAbbott%26aufirst%3DC.%2BA.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DCunningham%26aufirst%3DA.%2BM.%26aulast%3DMuller%26aufirst%3DE.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DFibroblast%2520activation%2520protein%253A%2520a%2520cell%2520surface%2520dipeptidyl%2520peptidase%2520and%2520gelatinase%2520expressed%2520by%2520stellate%2520cells%2520at%2520the%2520tissue%2520remodelling%2520interface%2520in%2520human%2520cirrhosis%26jtitle%3DHepatology%26date%3D1999%26volume%3D29%26spage%3D1768%26epage%3D1778%26doi%3D10.1002%2Fhep.510290631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Bauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jendro, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faccin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinges, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Ladner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">R171</span><span class="refDoi"> DOI: 10.1186/ar2080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1186%2Far2080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=17105646" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=R171&author=S.+Bauerauthor=M.+C.+Jendroauthor=A.+Wadleauthor=S.+Kleberauthor=F.+Stennerauthor=R.+Dinserauthor=A.+Reichauthor=E.+Faccinauthor=S.+Goddeauthor=H.+Dingesauthor=U.+Muller-Ladnerauthor=C.+Renner&title=Fibroblast+activation+protein+is+expressed+by+rheumatoid+myofibroblast-like+synoviocytes&doi=10.1186%2Far2080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2Far2080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far2080%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DJendro%26aufirst%3DM.%2BC.%26aulast%3DWadle%26aufirst%3DA.%26aulast%3DKleber%26aufirst%3DS.%26aulast%3DStenner%26aufirst%3DF.%26aulast%3DDinser%26aufirst%3DR.%26aulast%3DReich%26aufirst%3DA.%26aulast%3DFaccin%26aufirst%3DE.%26aulast%3DGodde%26aufirst%3DS.%26aulast%3DDinges%26aufirst%3DH.%26aulast%3DMuller-Ladner%26aufirst%3DU.%26aulast%3DRenner%26aufirst%3DC.%26atitle%3DFibroblast%2520activation%2520protein%2520is%2520expressed%2520by%2520rheumatoid%2520myofibroblast-like%2520synoviocytes%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2006%26volume%3D8%26spage%3DR171%26doi%3D10.1186%2Far2080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Tillmanns, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habbaba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitto, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraccarollo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galuppo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauersachs, J.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span><span class="refDoi"> DOI: 10.1016/j.yjmcc.2015.08.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2Fj.yjmcc.2015.08.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=26319660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeht7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2015&pages=194-203&author=J.+Tillmannsauthor=D.+Hoffmannauthor=Y.+Habbabaauthor=J.+D.+Schmittoauthor=D.+Seddingauthor=D.+Fraccarolloauthor=P.+Galuppoauthor=J.+Bauersachs&title=Fibroblast+activation+protein+alpha+expression+identifies+activated+fibroblasts+after+myocardial+infarction&doi=10.1016%2Fj.yjmcc.2015.08.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction</span></div><div class="casAuthors">Tillmanns, Jochen; Hoffmann, Daniel; Habbaba, Yasmin; Schmitto, Jan D.; Sedding, Daniel; Fraccarollo, Daniela; Galuppo, Paolo; Bauersachs, Johann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">194-203</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fibroblast activation protein α (FAP) is a membrane-bound serine protease expressed by activated fibroblasts during wound healing in the skin.  Expression of FAP after myocardial infarction (MI) and potential effects on cardiac wound healing are largely unknown.  MI was induced in rats and FAP expression was analyzed at 3, 7 and 28 days post-MI by microarray, Western blot and immunohistochem.  In human hearts after MI, a FAP+ fibroblast population was identified, and characterized by immunohistochem. for prolyl-4-hydroxylase β, α-smooth muscle actin, Thy-1 and vimentin.  Signaling pathways leading to FAP expression were studied in human cardiac fibroblasts by Western blot and ELISA using TGFβ1, TGF-beta type I-receptor (TGFbR1)-inhibitor SB431542 or the MAPK-inhibitor U0126 as well as siRNA targeting SMAD2 and SMAD3.  Finally, fibroblasts were assayed for FAP-dependent migration (modified Boyden-chamber), proliferation (BrdU-assay) and gelatinolytic activity by gelatin zymog.  In rats, FAP expression was increased after MI esp. in the peri-infarct area peaking at 7 days post-MI.  Co-localization anal. identified the majority of FAP+ cells as activated proto-myofibroblasts and myofibroblasts.  Concordantly, FAP+ fibroblasts were abundant in ischemic tissue of human hearts after MI, but not in healthy control hearts.  In vitro, FAP was induced by TGFβ1 via the canonical SMAD2/SMAD3 pathway.  Depletion of FAP in fibroblasts reduced migratory capacity, while proliferation was not affected.  Gelatin zymog. revealed gelatinase activity by fibroblast-derived FAP.  In this study, we show for the first time the expression of FAP in activated fibroblasts after MI and its activation by TGFβ1.  Effects of FAP on fibroblast migration and gelatinolytic activity indicate a potential role in cardiac wound healing and remodeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkduzibIcGTLVg90H21EOLACvtfcHk0lgMbp2unRCPrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeht7zP&md5=979deaf019af45915ad8192b352a7b88</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2015.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2015.08.016%26sid%3Dliteratum%253Aachs%26aulast%3DTillmanns%26aufirst%3DJ.%26aulast%3DHoffmann%26aufirst%3DD.%26aulast%3DHabbaba%26aufirst%3DY.%26aulast%3DSchmitto%26aufirst%3DJ.%2BD.%26aulast%3DSedding%26aufirst%3DD.%26aulast%3DFraccarollo%26aufirst%3DD.%26aulast%3DGaluppo%26aufirst%3DP.%26aulast%3DBauersachs%26aufirst%3DJ.%26atitle%3DFibroblast%2520activation%2520protein%2520alpha%2520expression%2520identifies%2520activated%2520fibroblasts%2520after%2520myocardial%2520infarction%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2015%26volume%3D87%26spage%3D194%26epage%3D203%26doi%3D10.1016%2Fj.yjmcc.2015.08.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Brokopp, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmert, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winnik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aikawa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luscher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoerstrup, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, C. M.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2713</span><span class="NLM_x">–</span> <span class="NLM_lpage">2722</span><span class="refDoi"> DOI: 10.1093/eurheartj/ehq519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1093%2Feurheartj%2Fehq519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=21292680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGnu7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=2713-2722&author=C.+E.+Brokoppauthor=R.+Schoenauerauthor=P.+Richardsauthor=S.+Bauerauthor=C.+Lohmannauthor=M.+Y.+Emmertauthor=B.+Weberauthor=S.+Winnikauthor=E.+Aikawaauthor=K.+Gravesauthor=M.+Genoniauthor=P.+Vogtauthor=T.+F.+Luscherauthor=C.+Rennerauthor=S.+P.+Hoerstrupauthor=C.+M.+Matter&title=Fibroblast+activation+protein+is+induced+by+inflammation+and+degrades+type+I+collagen+in+thin-cap+fibroatheromata&doi=10.1093%2Feurheartj%2Fehq519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata</span></div><div class="casAuthors">Brokopp, Chad E.; Schoenauer, Roman; Richards, Peter; Bauer, Stefan; Lohmann, Christine; Emmert, Maximilian Y.; Weber, Benedikt; Winnik, Stephan; Aikawa, Elena; Graves, Kirk; Genoni, Michele; Vogt, Peter; Luescher, Thomas F.; Renner, Christoph; Hoerstrup, Simon P.; Matter, Christian M.</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2713-2722</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aims Collagen degrdn. in atherosclerotic plaques with thin fibrous caps renders them more prone to rupture.  Fibroblast activation protein (FAP) plays a role in arthritis and tumor formation through its collagenase activity.  However, the significance of FAP in thin-cap human fibroatheromata remains unknown.  Methods and results We detected enhanced FAP expression in type IV-V human aortic atheromata (n = 12), compared with type II-III lesions (n = 9; P < 0.01) and healthy aortae (n = 8; P < 0.01) by immunostaining and western blot analyses.  Fibroblast activation protein was also increased in thin-cap (<65 μm) vs. thick-cap (≥65 μm) human coronary fibroatheromata (n = 12; P < 0.01).  Fibroblast activation protein was expressed by human aortic smooth muscle cells (HASMC) as shown by colocalization on immunofluorescent aortic plaque stainings (n = 10; P < 0.01) and by flow cytometry in cell culture.  Although macrophages did not express FAP, macrophage burden in human aortic plaques correlated with FAP expression (n = 12; R2= 0.763; P < 0.05).  Enzyme-linked immunosorbent assays showed a time- and dose-dependent up-regulation of FAP in response to human tumor necrosis factor α (TNFα) in HASMC (n = 6; P < 0.01).  Moreover, supernatants from peripheral blood-derived macrophages induced FAP expression in cultured HASMC (n = 6; P < 0.01), an effect abolished by blocking TNFα (n = 6; P < 0.01).  Fibroblast activation protein assocd. with collagen-poor regions in human coronary fibrous caps and digested type I collagen and gelatin in vitro (n = 6; P < 0.01).  Zymog. revealed that FAP-mediated collagenase activity was neutralized by an antibody directed against the FAP catalytic domain both in HASMC (n = 6; P < 0.01) and in fibrous caps of atherosclerotic plaques (n = 10; P < 0.01).  Conclusion Fibroblast activation protein expression in HASMC is induced by macrophage-derived TNFα.  Fibroblast activation protein assocs. with thin-cap human coronary fibroatheromata and contributes to type I collagen breakdown in fibrous caps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4eDr7Cnj1c7Vg90H21EOLACvtfcHk0lgMbp2unRCPrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGnu7nO&md5=585eb7eb395d15ac6c5bb83f625da5b6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehq519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehq519%26sid%3Dliteratum%253Aachs%26aulast%3DBrokopp%26aufirst%3DC.%2BE.%26aulast%3DSchoenauer%26aufirst%3DR.%26aulast%3DRichards%26aufirst%3DP.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DLohmann%26aufirst%3DC.%26aulast%3DEmmert%26aufirst%3DM.%2BY.%26aulast%3DWeber%26aufirst%3DB.%26aulast%3DWinnik%26aufirst%3DS.%26aulast%3DAikawa%26aufirst%3DE.%26aulast%3DGraves%26aufirst%3DK.%26aulast%3DGenoni%26aufirst%3DM.%26aulast%3DVogt%26aufirst%3DP.%26aulast%3DLuscher%26aufirst%3DT.%2BF.%26aulast%3DRenner%26aufirst%3DC.%26aulast%3DHoerstrup%26aufirst%3DS.%2BP.%26aulast%3DMatter%26aufirst%3DC.%2BM.%26atitle%3DFibroblast%2520activation%2520protein%2520is%2520induced%2520by%2520inflammation%2520and%2520degrades%2520type%2520I%2520collagen%2520in%2520thin-cap%2520fibroatheromata%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2011%26volume%3D32%26spage%3D2713%26epage%3D2722%26doi%3D10.1093%2Feurheartj%2Fehq519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Busek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrabal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fric, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedo, A.</span><span> </span><span class="NLM_article-title">Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets</span> <span class="citation_source-journal">Histochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1007/s00418-014-1292-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1007%2Fs00418-014-1292-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=25361590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVOltbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2015&pages=497-504&author=P.+Busekauthor=P.+Hrabalauthor=P.+Fricauthor=A.+Sedo&title=Co-expression+of+the+homologous+proteases+fibroblast+activation+protein+and+dipeptidyl+peptidase-IV+in+the+adult+human+Langerhans+islets&doi=10.1007%2Fs00418-014-1292-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets</span></div><div class="casAuthors">Busek, Petr; Hrabal, Petr; Fric, Premysl; Sedo, Aleksi</div><div class="citationInfo"><span class="NLM_cas:title">Histochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-504</span>CODEN:
                <span class="NLM_cas:coden">HCBIFP</span>;
        ISSN:<span class="NLM_cas:issn">0948-6143</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Fibroblast activation protein (FAP, seprase, EC 3.4.21.B28) and dipeptidyl peptidase-IV (DPP-IV, CD26, EC 3.4.14.5) are homologous serine proteases implicated in the modulation of the bioavailability and thus the function of a no. of biol. active peptides.  In spite of their generally nonoverlapping expression patterns, DPP-IV and FAP are co-expressed and probably co-regulated in certain cell types suggesting that for some biol. processes their functional synergy is essential.  By an in situ enzymic activity assay, we show an abundant DPP-IV-like enzymic activity sensitive to a highly specific DPP-IV inhibitor sitagliptin and corresponding DPP-IV immunoreactivity in the adult human islets of Langerhans.  Moreover, the homologous protease FAP was present in the human endocrine pancreas and was co-expressed with DPP-IV.  DPP-IV and FAP were found in the pancreatic alpha cells as detd. by the co-localization with glucagon immunoreactivity.  In summary, we show abundant enzymic activity of the canonical DPP-IV (CD26) in Langerhans islets in the natural tissue context and demonstrate for the first time the coexpression of FAP and DPP-IV in pancreatic alpha cells in adult humans.  Given their ability to proteolytically modify several biol. active peptides, both proteases have the potential to modulate the paracrine signaling in the human Langerhans islets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri_2GWz_Jng7Vg90H21EOLACvtfcHk0lhCZqfEhO2klA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVOltbnI&md5=f4e1a8e778f296a3af103a9e8594ea1b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs00418-014-1292-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00418-014-1292-0%26sid%3Dliteratum%253Aachs%26aulast%3DBusek%26aufirst%3DP.%26aulast%3DHrabal%26aufirst%3DP.%26aulast%3DFric%26aufirst%3DP.%26aulast%3DSedo%26aufirst%3DA.%26atitle%3DCo-expression%2520of%2520the%2520homologous%2520proteases%2520fibroblast%2520activation%2520protein%2520and%2520dipeptidyl%2520peptidase-IV%2520in%2520the%2520adult%2520human%2520Langerhans%2520islets%26jtitle%3DHistochem.%2520Cell%2520Biol.%26date%3D2015%26volume%3D143%26spage%3D497%26epage%3D504%26doi%3D10.1007%2Fs00418-014-1292-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bae, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeon, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span><span class="refDoi"> DOI: 10.1111/j.1365-2141.2008.07241.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1111%2Fj.1365-2141.2008.07241.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=18510677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWntrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2008&pages=827-830&author=S.+Baeauthor=C.+W.+Parkauthor=H.+K.+Sonauthor=H.+K.+Juauthor=D.+Paikauthor=C.+J.+Jeonauthor=G.+Y.+Kohauthor=J.+Kimauthor=H.+Kim&title=Fibroblast+activation+protein+alpha+identifies+mesenchymal+stromal+cells+from+human+bone+marrow&doi=10.1111%2Fj.1365-2141.2008.07241.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein α identifies mesenchymal stromal cells from human bone marrow</span></div><div class="casAuthors">Bae, Sohyun; Park, Chae Woon; Son, Hye Kyung; Ju, Hye Kyung; Paik, Donggi; Jeon, Choon-Ju; Koh, Gou Young; Kim, Jaeseob; Kim, Hoeon</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">827-830</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Mesenchymal stromal cells (MSCs) have gained widespread popularity in cell therapy, but their development into clin. products has been impeded by the scarcity of cell-specific markers.  We previously explored transcriptome and membrane proteome of MSCs, from which fibroblast activation protein α (FAP) was recognized as a prime surface marker candidate.  The present study showed that FAP was constitutively expressed on MSCs, but not on other cells.  FAP immunoselection yielded homogeneous MSCs from cryopreserved bone marrow (BM).  These results suggest that FAP serves as a surface protein marker that can singly define MSCs from BM and possibly from other sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomL8KTuYNoSrVg90H21EOLACvtfcHk0lhCZqfEhO2klA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWntrvK&md5=9df43578ca2dba65fe288a3e48c2e5ba</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2008.07241.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2008.07241.x%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DC.%2BW.%26aulast%3DSon%26aufirst%3DH.%2BK.%26aulast%3DJu%26aufirst%3DH.%2BK.%26aulast%3DPaik%26aufirst%3DD.%26aulast%3DJeon%26aufirst%3DC.%2BJ.%26aulast%3DKoh%26aufirst%3DG.%2BY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26atitle%3DFibroblast%2520activation%2520protein%2520alpha%2520identifies%2520mesenchymal%2520stromal%2520cells%2520from%2520human%2520bone%2520marrow%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2008%26volume%3D142%26spage%3D827%26epage%3D830%26doi%3D10.1111%2Fj.1365-2141.2008.07241.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Dolznig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweifer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraut, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerjaschki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span> </span><span class="NLM_article-title">Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin</span> <span class="citation_source-journal">Cancer Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=16076089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A280%3ADC%252BD2Mvht1KnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=10&author=H.+Dolznigauthor=N.+Schweiferauthor=C.+Puriauthor=N.+Krautauthor=W.+J.+Rettigauthor=D.+Kerjaschkiauthor=P.+Garin-Chesa&title=Characterization+of+cancer+stroma+markers%3A+in+silico+analysis+of+an+mRNA+expression+database+for+fibroblast+activation+protein+and+endosialin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin</span></div><div class="casAuthors">Dolznig Helmut; Schweifer Norbert; Puri Christina; Kraut Norbert; Rettig Wolfgang J; Kerjaschki Dontscho; Garin-Chesa Pilar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer immunity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Standardized, high-throughput RNA detection with microarray chips allows for the construction of genome-wide databases for tissue specimens suitable for in silico electronic Northern blot (eNorthern) analysis of marker genes.  We used the BioExpress database, which contains transcriptional profiles of normal and cancer samples, to examine two putative markers of cancer stroma: fibroblast activation protein-alpha (FAP-alpha) and endosialin.  Analyses for FAP-alpha showed that normal tissues generally lack RNA signals, with the exception of endometrium.  Typing of tumors revealed prominent FAP-alpha signals in cancer types marked by desmoplasia, and localization of FAP-alpha in reactive cancer stroma was confirmed by immunohistochemistry.  A subset of sarcomas displayed prominent FAP-alpha signals localizing to the malignant cells.  For endosialin, eNorthern analyses showed low to moderate RNA signals in many normal organs, whereas immunohistochemistry revealed endosialin in only some tissues, such as endometrium.  Endosialin was detected at the RNA and protein level in sarcomas, notably malignant fibrous histiocytomas.  Low to moderate endosialin RNA signals were found in epithelial cancer types for which immunostaining identifies expression in subsets of tumor capillaries or fibroblasts.  These findings extend the FAP-alpha and endosialin profiling in silico to an unbiased tumor database and place both molecules in a novel context of endometrial biology and sarcoma subtyping.  Our findings suggest that BioExpress can be searched directly for tumor stroma markers but may need prior enrichment for markers with narrow cellular representation, such as endosialin.  Constructing databases from microdissected cancer tissues may be an essential step for tumor stroma-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTflWDAUWKV8m52AMpI4GK2fW6udTcc2eaQSrK7YNn2h7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mvht1KnsQ%253D%253D&md5=2577befe63148736651a743bcddc9425</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDolznig%26aufirst%3DH.%26aulast%3DSchweifer%26aufirst%3DN.%26aulast%3DPuri%26aufirst%3DC.%26aulast%3DKraut%26aufirst%3DN.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DKerjaschki%26aufirst%3DD.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26atitle%3DCharacterization%2520of%2520cancer%2520stroma%2520markers%253A%2520in%2520silico%2520analysis%2520of%2520an%2520mRNA%2520expression%2520database%2520for%2520fibroblast%2520activation%2520protein%2520and%2520endosialin%26jtitle%3DCancer%2520Immun.%26date%3D2005%26volume%3D5%26spage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Monsky, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. T.</span><span> </span><span class="NLM_article-title">A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5702</span><span class="NLM_x">–</span> <span class="NLM_lpage">5710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=7923219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFyit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=5702-5710&author=W.+L.+Monskyauthor=C.+Y.+Linauthor=A.+Aoyamaauthor=T.+Kellyauthor=S.+K.+Akiyamaauthor=S.+C.+Muellerauthor=W.+T.+Chen&title=A+potential+marker+protease+of+invasiveness%2C+seprase%2C+is+localized+on+invadopodia+of+human+malignant+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells</span></div><div class="casAuthors">Monsky, Wayne L.; Lin, Chen-Yong; Aoyama, Atsuko; Kelly, Thomas; Akiyama, Steven K.; Mueller, Susette C.; Chen, Wen-Tien</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5702-10</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Seprase, a large, gelatin-degrading membrane-protease complex, is expressed at the invasive front of malignant melanoma cells on invadopodia, and its surface expression contributes to the invasive phenotype.  An in vitro assay was used to det. the matrix-degrading activity of four malignant human melanoma cell lines.  The lines differ in matrix-degrading activity with LOX > RPMI7951 > A375 > SKMEL28 cells.  Expts. using anti-seprase monoclonal antibodies in conjunction with a cell fractionation technique indicate that seprase consists of Mr 97,000 polypeptides and is enriched on the ventral membrane of LOX in contact with planar extracellular matrix substratum.  Confocal microscopy further substantiates the authors biochem. findings that seprase, as well as gelatinase A, is localized on invadopodia membranes with a 6-fold increase of seprase and 4-fold increase of gelatinase A intensity over the level expressed on dorsal membranes.  In addn., LOX cells expressing higher levels of seprase at the cell surface, as selected by fluorescence-activated cell sorting, are significantly more degradative than LOX cells with lower seprase expression.  Taken together, the data show a concordance between seprase and gelatinase A expression on the cell surface at invadopodia and the matrix-degrading activity of human malignant melanoma cells.  Seprase and major secretion proteases may act in concert to degrade components of the extracellular matrix during invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJlUaNTR27E7Vg90H21EOLACvtfcHk0lh9I3U9Cv7lpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFyit7g%253D&md5=a7e3297dd1ce3332f025dda66e55e749</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonsky%26aufirst%3DW.%2BL.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DAoyama%26aufirst%3DA.%26aulast%3DKelly%26aufirst%3DT.%26aulast%3DAkiyama%26aufirst%3DS.%2BK.%26aulast%3DMueller%26aufirst%3DS.%2BC.%26aulast%3DChen%26aufirst%3DW.%2BT.%26atitle%3DA%2520potential%2520marker%2520protease%2520of%2520invasiveness%252C%2520seprase%252C%2520is%2520localized%2520on%2520invadopodia%2520of%2520human%2520malignant%2520melanoma%2520cells%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D5702%26epage%3D5710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oettgen, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melamed, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span> </span><span class="NLM_article-title">Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">3110</span><span class="NLM_x">–</span> <span class="NLM_lpage">3114</span><span class="refDoi"> DOI: 10.1073/pnas.85.9.3110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1073%2Fpnas.85.9.3110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=2896356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADyaL1cXit1SjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=3110-3114&author=W.+J.+Rettigauthor=P.+Garin-Chesaauthor=H.+R.+Beresfordauthor=H.+F.+Oettgenauthor=M.+R.+Melamedauthor=L.+J.+Old&title=Cell-surface+glycoproteins+of+human+sarcomas%3A+differential+expression+in+normal+and+malignant+tissues+and+cultured+cells&doi=10.1073%2Fpnas.85.9.3110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-surface glycoproteins of human sarcomas:  differential expression in normal and malignant tissues and cultured cells</span></div><div class="casAuthors">Rettig, Wolfgang J.; Garin-Chesa, Pilar; Beresford, H. Richard; Oettgen, Herbert F.; Melamed, Myron R.; Old, Lloyd J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3110-14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Normal differentiation and malignant transformation of human cells are characterized by specific changes in surface antigen phenotype.  Six cell-surface antigens of human sarcomas and normal mesenchymal cells were defined by using mixed hemadsorption assays and immunochem. methods for the anal. of cultured cells and immunohistochem. staining for the anal. of normal tissues and >200 tumor specimens.  Differential patterns of F19 (mol. wt., Mr, 120,000/95,000 glycoprotein), F24 (Mr, 95,000 glycoprotein), G171 (Mr, 75,000 glycoprotein), G253 (Mr, 90,000 glycoprotein), S5 (Mr, 120,000 glycoprotein), and Thy-1 (Mr, 25,000 glycoprotein) antigen expression were found to characterize (i) subsets of cultured sarcoma cell lines, (ii) cultured fibroblasts derived from various organs, (iii) normal resting and activated mesenchymal tissues, and (i.v.) sarcoma and nonmesenchymal tumor tissues.  These results provide a basic surface antigenic map for cultured mesenchymal cells and mesenchymal tissues and permit the classification of human sarcomas according to their antigenic phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWS0L15oPgE7Vg90H21EOLACvtfcHk0lh9I3U9Cv7lpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXit1SjsLw%253D&md5=8d8df4a9ca9253321afa52b44bc040c8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.85.9.3110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.85.9.3110%26sid%3Dliteratum%253Aachs%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DBeresford%26aufirst%3DH.%2BR.%26aulast%3DOettgen%26aufirst%3DH.%2BF.%26aulast%3DMelamed%26aufirst%3DM.%2BR.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26atitle%3DCell-surface%2520glycoproteins%2520of%2520human%2520sarcomas%253A%2520differential%2520expression%2520in%2520normal%2520and%2520malignant%2520tissues%2520and%2520cultured%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1988%26volume%3D85%26spage%3D3110%26epage%3D3114%26doi%3D10.1073%2Fpnas.85.9.3110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span><span class="refDoi"> DOI: 10.1182/blood-2005-08-3452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1182%2Fblood-2005-08-3452" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=1397-1404&author=K.+N.+Leeauthor=K.+W.+Jacksonauthor=V.+J.+Christiansenauthor=C.+S.+Leeauthor=J.+G.+Chunauthor=P.+A.+McKee&title=Antiplasmin-cleaving+enzyme+is+a+soluble+form+of+fibroblast+activation+protein&doi=10.1182%2Fblood-2005-08-3452"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-08-3452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-08-3452%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DChun%26aufirst%3DJ.%2BG.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DAntiplasmin-cleaving%2520enzyme%2520is%2520a%2520soluble%2520form%2520of%2520fibroblast%2520activation%2520protein%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D1397%26epage%3D1404%26doi%3D10.1182%2Fblood-2005-08-3452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Goldstein, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghersi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineiro-Sanchez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salamone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flessate, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. T.</span><span> </span><span class="NLM_article-title">Molecular cloning of seprase: a serine integral membrane protease from human melanoma</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1361</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1016/S0925-4439(97)00032-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2FS0925-4439%2897%2900032-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=9247085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtVKmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1361&publication_year=1997&pages=11-19&author=L.+A.+Goldsteinauthor=G.+Ghersiauthor=M.+L.+Pineiro-Sanchezauthor=M.+Salamoneauthor=Y.+Y.+Yehauthor=D.+Flessateauthor=W.+T.+Chen&title=Molecular+cloning+of+seprase%3A+a+serine+integral+membrane+protease+from+human+melanoma&doi=10.1016%2FS0925-4439%2897%2900032-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of seprase: a serine integral membrane protease from human melanoma</span></div><div class="casAuthors">Goldstein, Leslie A.; Ghersi, Giulio; Pineiro-Sanchez, Mayra L.; Salamone, Monica; Yeh, Yunyun; Flessate, Denise; Chen, Wen-Tien</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1361</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-19</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Seprase is a homodimeric 170 kDa integral membrane gelatinase whose expression correlates with the invasiveness of the human melanoma cell line LOX.  Here, we report the mol. cloning of a cDNA that encodes the 97 kDa subunit of seprase.  Its deduced amino acid sequence predicts a type II integral membrane protein with a cytoplasmic tail of 6 amino acids, followed by a transmembrane domain of 20 amino acids and an extracellular domain of 734 amino acids.  The carboxyl terminus contains a putative catalytic region (∼200 amino acids) which is homologous (68% identity) to that of the nonclassical serine protease dipeptidyl peptidase IV (DPPIV).  The conserved serine protease motif G-X-S-X-G is present as G-W-S-Y-G.  However, sequence anal. of seprase cDNA from LOX and other cell lines strongly suggests that seprase and human fibroblast activation protein α (FAPα) are products of the same gene.  We propose that seprase/FAPα and DPPIV represent a new subfamily of serine integral membrane proteases (SIMP).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh5KoilQf7-LVg90H21EOLACvtfcHk0lh9I3U9Cv7lpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtVKmurc%253D&md5=f91d14e03f2a7265c8733bb6bd1dab98</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0925-4439%2897%2900032-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0925-4439%252897%252900032-X%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DL.%2BA.%26aulast%3DGhersi%26aufirst%3DG.%26aulast%3DPineiro-Sanchez%26aufirst%3DM.%2BL.%26aulast%3DSalamone%26aufirst%3DM.%26aulast%3DYeh%26aufirst%3DY.%2BY.%26aulast%3DFlessate%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%2BT.%26atitle%3DMolecular%2520cloning%2520of%2520seprase%253A%2520a%2520serine%2520integral%2520membrane%2520protease%2520from%2520human%2520melanoma%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D1997%26volume%3D1361%26spage%3D11%26epage%3D19%26doi%3D10.1016%2FS0925-4439%2897%2900032-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Pineiro-Sanchez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. T.</span><span> </span><span class="NLM_article-title">Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">7595</span><span class="NLM_x">–</span> <span class="NLM_lpage">7601</span><span class="refDoi"> DOI: 10.1074/jbc.272.12.7595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1074%2Fjbc.272.12.7595" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=7595-7601&author=M.+L.+Pineiro-Sanchezauthor=L.+A.+Goldsteinauthor=J.+Dodtauthor=L.+Howardauthor=Y.+Yehauthor=W.+T.+Chen&title=Identification+of+the+170-kDa+melanoma+membrane-bound+gelatinase+%28seprase%29+as+a+serine+integral+membrane+protease&doi=10.1074%2Fjbc.272.12.7595"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.12.7595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.12.7595%26sid%3Dliteratum%253Aachs%26aulast%3DPineiro-Sanchez%26aufirst%3DM.%2BL.%26aulast%3DGoldstein%26aufirst%3DL.%2BA.%26aulast%3DDodt%26aufirst%3DJ.%26aulast%3DHoward%26aufirst%3DL.%26aulast%3DYeh%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%2BT.%26atitle%3DIdentification%2520of%2520the%2520170-kDa%2520melanoma%2520membrane-bound%2520gelatinase%2520%2528seprase%2529%2520as%2520a%2520serine%2520integral%2520membrane%2520protease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D7595%26epage%3D7601%26doi%3D10.1074%2Fjbc.272.12.7595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Edosada, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, B. B.</span><span> </span><span class="NLM_article-title">Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">7437</span><span class="NLM_x">–</span> <span class="NLM_lpage">7444</span><span class="refDoi"> DOI: 10.1074/jbc.M511112200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1074%2Fjbc.M511112200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7437-7444&author=C.+Y.+Edosadaauthor=C.+Quanauthor=C.+Wiesmannauthor=T.+Tranauthor=D.+Sutherlinauthor=M.+Reynoldsauthor=J.+M.+Elliottauthor=H.+Raabauthor=W.+Fairbrotherauthor=B.+B.+Wolf&title=Selective+inhibition+of+fibroblast+activation+protein+protease+based+on+dipeptide+substrate+specificity&doi=10.1074%2Fjbc.M511112200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M511112200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M511112200%26sid%3Dliteratum%253Aachs%26aulast%3DEdosada%26aufirst%3DC.%2BY.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%26aulast%3DReynolds%26aufirst%3DM.%26aulast%3DElliott%26aufirst%3DJ.%2BM.%26aulast%3DRaab%26aufirst%3DH.%26aulast%3DFairbrother%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DB.%2BB.%26atitle%3DSelective%2520inhibition%2520of%2520fibroblast%2520activation%2520protein%2520protease%2520based%2520on%2520dipeptide%2520substrate%2520specificity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7437%26epage%3D7444%26doi%3D10.1074%2Fjbc.M511112200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Lee, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco-Barraza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valianou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cukierman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span> </span><span class="NLM_article-title">FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="refDoi"> DOI: 10.1186/1471-2407-11-245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1186%2F1471-2407-11-245" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=245&author=H.+O.+Leeauthor=S.+R.+Mullinsauthor=J.+Franco-Barrazaauthor=M.+Valianouauthor=E.+Cukiermanauthor=J.+D.+Cheng&title=FAP-overexpressing+fibroblasts+produce+an+extracellular+matrix+that+enhances+invasive+velocity+and+directionality+of+pancreatic+cancer+cells&doi=10.1186%2F1471-2407-11-245"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-11-245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-11-245%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BO.%26aulast%3DMullins%26aufirst%3DS.%2BR.%26aulast%3DFranco-Barraza%26aufirst%3DJ.%26aulast%3DValianou%26aufirst%3DM.%26aulast%3DCukierman%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26atitle%3DFAP-overexpressing%2520fibroblasts%2520produce%2520an%2520extracellular%2520matrix%2520that%2520enhances%2520invasive%2520velocity%2520and%2520directionality%2520of%2520pancreatic%2520cancer%2520cells%26jtitle%3DBMC%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D245%26doi%3D10.1186%2F1471-2407-11-245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Yang, X. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span> </span><span class="NLM_article-title">FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">4124</span><span class="NLM_x">–</span> <span class="NLM_lpage">4135</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-2973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1158%2F0008-5472.CAN-15-2973" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4124-4135&author=X.+G.+Yangauthor=Y.+L.+Linauthor=Y.+H.+Shiauthor=B.+J.+Liauthor=W.+R.+Liuauthor=W.+Yinauthor=Y.+J.+Dangauthor=Y.+W.+Chuauthor=J.+Fanauthor=R.+He&title=FAP+promotes+immunosuppression+by+cancer-associated+fibroblasts+in+the+tumor+microenvironment+via+STAT3-CCL2+signaling&doi=10.1158%2F0008-5472.CAN-15-2973"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-2973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-2973%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%2BG.%26aulast%3DLin%26aufirst%3DY.%2BL.%26aulast%3DShi%26aufirst%3DY.%2BH.%26aulast%3DLi%26aufirst%3DB.%2BJ.%26aulast%3DLiu%26aufirst%3DW.%2BR.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DDang%26aufirst%3DY.%2BJ.%26aulast%3DChu%26aufirst%3DY.%2BW.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DR.%26atitle%3DFAP%2520promotes%2520immunosuppression%2520by%2520cancer-associated%2520fibroblasts%2520in%2520the%2520tumor%2520microenvironment%2520via%2520STAT3-CCL2%2520signaling%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4124%26epage%3D4135%26doi%3D10.1158%2F0008-5472.CAN-15-2973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Narra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strzemkowski-Brun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magalong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mckee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egleston, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meropol, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span> </span><span class="NLM_article-title">Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1691</span><span class="NLM_x">–</span> <span class="NLM_lpage">1699</span><span class="refDoi"> DOI: 10.4161/cbt.6.11.4874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.4161%2Fcbt.6.11.4874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=18032930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1Whsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1691-1699&author=K.+Narraauthor=S.+R.+Mullinsauthor=H.+O.+Leeauthor=B.+Strzemkowski-Brunauthor=K.+Magalongauthor=V.+J.+Christiansenauthor=P.+A.+Mckeeauthor=B.+Eglestonauthor=S.+J.+Cohenauthor=L.+M.+Weinerauthor=N.+J.+Meropolauthor=J.+D.+Cheng&title=Phase+II+trial+of+single+agent+Val-boroPro+%28Talabostat%29+inhibiting+fibroblast+activation+protein+in+patients+with+metastatic+colorectal+cancer&doi=10.4161%2Fcbt.6.11.4874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer</span></div><div class="casAuthors">Narra, Kalyani; Mullins, Stefanie R.; Lee, Hyung-Ok; Strzemkowski-Brun, Brenda; Magalong, Kimberly; Christiansen, Victoria J.; McKee, Patrick A.; Egleston, Brian; Cohen, Steven J.; Weiner, Louis M.; Meropol, Neal J.; Cheng, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1691-1699</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Purpose: Fibroblost Activation Protein (FAP) is a tumor fibroblast protease that has been shown to potentiate colorectal cancer growth.  The clin. impact of FAP inhibition was tested using Val-boroPro (Talabostat), the first clin. inhibitor of FAP enzymic activity, in a phase II study of patients with metastatic colorectal cancer.  Methods: Patients with metastatic colorectal cancer who had previously received systemic chemotherapies were treated with single agent Val-boroPro 200 μg p.o. BID continuously.  Eligibility included measurable disease, performance status of 0 to 2, and adequate organ function.  Lab. correlates evaluated the pharmacodynamic effects of Val-boroPro on FAP enzymic function in the peripheral blood.  Results: Twenty-eight patients (median age 62; 12 males, 16 females) were enrolled in this study.  There were no objective responses.  Six of 28 (21%) patients had stable disease for a median of 25 wk (range 11-38 wk).  Lab. anal. demonstrated significant, although incomplete inhibition of FAP enzymic activity in the peripheral blood.  Conclusion: This phase II trial of Val-boroPro demonstrated minimal clin. activity in patients with previously treated metastatic colorectal cancer.  However it provides the initial proof-of-concept that physiol. inhibition of FAP activity can be accomplished in patients with colorectal cancer, and lays the groundwork for future studies targeting the tumor stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_1F424osEbVg90H21EOLACvtfcHk0li7swUlClXYBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1Whsb8%253D&md5=7e69e1187b364d4c1ed43fef5d717c48</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.4161%2Fcbt.6.11.4874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.6.11.4874%26sid%3Dliteratum%253Aachs%26aulast%3DNarra%26aufirst%3DK.%26aulast%3DMullins%26aufirst%3DS.%2BR.%26aulast%3DLee%26aufirst%3DH.%2BO.%26aulast%3DStrzemkowski-Brun%26aufirst%3DB.%26aulast%3DMagalong%26aufirst%3DK.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DMckee%26aufirst%3DP.%2BA.%26aulast%3DEgleston%26aufirst%3DB.%26aulast%3DCohen%26aufirst%3DS.%2BJ.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DMeropol%26aufirst%3DN.%2BJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26atitle%3DPhase%2520II%2520trial%2520of%2520single%2520agent%2520Val-boroPro%2520%2528Talabostat%2529%2520inhibiting%2520fibroblast%2520activation%2520protein%2520in%2520patients%2520with%2520metastatic%2520colorectal%2520cancer%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1691%26epage%3D1699%26doi%3D10.4161%2Fcbt.6.11.4874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Hofheinz, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">al-Batran, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jager, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanswell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunz, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amelsberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuthan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, G.</span><span> </span><span class="NLM_article-title">Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer</span> <span class="citation_source-journal">Oncol. Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span><span class="refDoi"> DOI: 10.1159/000069863</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1159%2F000069863" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=44-48&author=R.+D.+Hofheinzauthor=S.+E.+al-Batranauthor=F.+Hartmannauthor=G.+Hartungauthor=D.+Jagerauthor=C.+Rennerauthor=P.+Tanswellauthor=U.+Kunzauthor=A.+Amelsbergauthor=H.+Kuthanauthor=G.+Stehle&title=Stromal+antigen+targeting+by+a+humanised+monoclonal+antibody%3A+an+early+phase+II+trial+of+sibrotuzumab+in+patients+with+metastatic+colorectal+cancer&doi=10.1159%2F000069863"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1159%2F000069863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000069863%26sid%3Dliteratum%253Aachs%26aulast%3DHofheinz%26aufirst%3DR.%2BD.%26aulast%3Dal-Batran%26aufirst%3DS.%2BE.%26aulast%3DHartmann%26aufirst%3DF.%26aulast%3DHartung%26aufirst%3DG.%26aulast%3DJager%26aufirst%3DD.%26aulast%3DRenner%26aufirst%3DC.%26aulast%3DTanswell%26aufirst%3DP.%26aulast%3DKunz%26aufirst%3DU.%26aulast%3DAmelsberg%26aufirst%3DA.%26aulast%3DKuthan%26aufirst%3DH.%26aulast%3DStehle%26aufirst%3DG.%26atitle%3DStromal%2520antigen%2520targeting%2520by%2520a%2520humanised%2520monoclonal%2520antibody%253A%2520an%2520early%2520phase%2520II%2520trial%2520of%2520sibrotuzumab%2520in%2520patients%2520with%2520metastatic%2520colorectal%2520cancer%26jtitle%3DOncol.%2520Res.%2520Treat.%26date%3D2003%26volume%3D26%26spage%3D44%26epage%3D48%26doi%3D10.1159%2F000069863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Sacha, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knedlik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tykvart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parolek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navratil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorakova, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedlak, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulbrich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strohalm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subr, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konvalinka, J.</span><span> </span><span class="NLM_article-title">iBodies: modular synthetic antibody mimetics based on hydrophilic polymers decorated with functional moieties</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2356</span><span class="NLM_x">–</span> <span class="NLM_lpage">2360</span><span class="refDoi"> DOI: 10.1002/anie.201508642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1002%2Fanie.201508642" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2356-2360&author=P.+Sachaauthor=T.+Knedlikauthor=J.+Schimerauthor=J.+Tykvartauthor=J.+Parolekauthor=V.+Navratilauthor=P.+Dvorakovaauthor=F.+Sedlakauthor=K.+Ulbrichauthor=J.+Strohalmauthor=P.+Majerauthor=V.+Subrauthor=J.+Konvalinka&title=iBodies%3A+modular+synthetic+antibody+mimetics+based+on+hydrophilic+polymers+decorated+with+functional+moieties&doi=10.1002%2Fanie.201508642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fanie.201508642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201508642%26sid%3Dliteratum%253Aachs%26aulast%3DSacha%26aufirst%3DP.%26aulast%3DKnedlik%26aufirst%3DT.%26aulast%3DSchimer%26aufirst%3DJ.%26aulast%3DTykvart%26aufirst%3DJ.%26aulast%3DParolek%26aufirst%3DJ.%26aulast%3DNavratil%26aufirst%3DV.%26aulast%3DDvorakova%26aufirst%3DP.%26aulast%3DSedlak%26aufirst%3DF.%26aulast%3DUlbrich%26aufirst%3DK.%26aulast%3DStrohalm%26aufirst%3DJ.%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DSubr%26aufirst%3DV.%26aulast%3DKonvalinka%26aufirst%3DJ.%26atitle%3DiBodies%253A%2520modular%2520synthetic%2520antibody%2520mimetics%2520based%2520on%2520hydrophilic%2520polymers%2520decorated%2520with%2520functional%2520moieties%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D2356%26epage%3D2360%26doi%3D10.1002%2Fanie.201508642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Ulbrich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hola, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subr, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakandritsos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zboril, R.</span><span> </span><span class="NLM_article-title">Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">5338</span><span class="NLM_x">–</span> <span class="NLM_lpage">5431</span><span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00589</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFCksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=5338-5431&author=K.+Ulbrichauthor=K.+Holaauthor=V.+Subrauthor=A.+Bakandritsosauthor=J.+Tucekauthor=R.+Zboril&title=Targeted+drug+delivery+with+polymers+and+magnetic+nanoparticles%3A+covalent+and+noncovalent+approaches%2C+release+control%2C+and+clinical+studies&doi=10.1021%2Facs.chemrev.5b00589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies</span></div><div class="casAuthors">Ulbrich, Karel; Hola, Katerina; Subr, Vladimir; Bakandritsos, Aristides; Tucek, Jiri; Zboril, Radek</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5338-5431</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeted delivery combined with controlled drug release has a pivotal role in the future of personalized medicine.  This review covers the principles, advantages, and drawbacks of passive and active targeting based on various polymer and magnetic iron oxide nanoparticle carriers with drug attached by both covalent and noncovalent pathways.  Attention is devoted to the tailored conjugation of targeting ligands (e.g., enzymes, antibodies, peptides) to drug carrier systems.  Similarly, the approaches toward controlled drug release are discussed.  Various polymer-drug conjugates based, for example, on polyethylene glycol (PEG), N-(2-hydroxypropyl)methacrylamide (HPMA), polymeric micelles, and nanoparticle carriers are explored with respect to absorption, distribution, metab., and excretion (ADME scheme) of administrated drug.  Design and structure of superparamagnetic iron oxide nanoparticles (SPION) and condensed magnetic clusters are classified according to the mechanism of noncovalent drug loading involving hydrophobic and electrostatic interactions, coordination chem., and encapsulation in porous materials.  Principles of covalent conjugation of drugs with SPIONs including thermo- and pH-degradable bonds, amide linkage, redox-cleavable bonds, and enzymically-cleavable bonds are also thoroughly described.  Finally, results of clin. trials obtained with polymeric and magnetic carriers are analyzed highlighting the potential advantages and future directions in targeted anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpswKKhXA_xLVg90H21EOLACvtfcHk0ljp0JaAPRxmyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFCksr8%253D&md5=7be43f31bde1e683328259580f9256b7</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00589%26sid%3Dliteratum%253Aachs%26aulast%3DUlbrich%26aufirst%3DK.%26aulast%3DHola%26aufirst%3DK.%26aulast%3DSubr%26aufirst%3DV.%26aulast%3DBakandritsos%26aufirst%3DA.%26aulast%3DTucek%26aufirst%3DJ.%26aulast%3DZboril%26aufirst%3DR.%26atitle%3DTargeted%2520drug%2520delivery%2520with%2520polymers%2520and%2520magnetic%2520nanoparticles%253A%2520covalent%2520and%2520noncovalent%2520approaches%252C%2520release%2520control%252C%2520and%2520clinical%2520studies%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D5338%26epage%3D5431%26doi%3D10.1021%2Facs.chemrev.5b00589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Dozono, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanazume, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etrych, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chytil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulbrich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikoma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, H.</span><span> </span><span class="NLM_article-title">HPMA copolymer-conjugated pirarubicin in multimodal treatment of a patient with stage IV prostate cancer and extensive lung and bone metastases</span> <span class="citation_source-journal">Targeted Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1007/s11523-015-0379-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1007%2Fs11523-015-0379-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=26194363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FkvVCrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=101-106&author=H.+Dozonoauthor=S.+Yanazumeauthor=H.+Nakamuraauthor=T.+Etrychauthor=P.+Chytilauthor=K.+Ulbrichauthor=J.+Fangauthor=T.+Arimuraauthor=T.+Douchiauthor=H.+Kobayashiauthor=M.+Ikomaauthor=H.+Maeda&title=HPMA+copolymer-conjugated+pirarubicin+in+multimodal+treatment+of+a+patient+with+stage+IV+prostate+cancer+and+extensive+lung+and+bone+metastases&doi=10.1007%2Fs11523-015-0379-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases</span></div><div class="casAuthors">Dozono Haruhiko; Yanazume Shintaro; Nakamura Hideaki; Fang Jun; Maeda Hiroshi; Etrych Tomas; Chytil Petr; Ulbrich Karel; Arimura Takeshi; Douchi Tsutomu; Kobayashi Hiroaki; Ikoma Michiaki</div><div class="citationInfo"><span class="NLM_cas:title">Targeted oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nanomedicine allows achievement of tumor-selective drug delivery because of the enhanced permeability and retention (EPR) effect of solid tumors.  We report here the first clinical application of a new agent-HPMA copolymer-conjugated pirarubicin (P-THP)-with a molecular size of about 8 nm, or 38.5 kDa.  A patient had advanced prostate cancer with multiple metastases in the lung, pelvis, femur, and perhaps the sacrum.  In April 2013, this 60-year-old patient started treatment with leuprorelin and estradiol, which continued until July 2014, but the patient became refractory to this treatment.  So the patient underwent proton beam radiotherapy targeted to the primary prostate cancer, and P-THP was administered for numerous metastatic tumor nodules concomitantly with radiotherapy.  This combination therapy had remarkable results, with complete remission of multiple metastases in the lung and bone.  The prostate-specific antigen (PSA) value was decreased from about 1000 ng/mL on April 30, 2013, to about 100 ng/mL on June 24, 2013, with hormone therapy, but rose again to 964.2 ng/mL and then to 1472 ng/mL in July 2013, during leuprorelin administration.  P-THP treatment administered concomitantly with proton beam irradiation was started in August 2013.  The PSA value was decreased to 102 ng/mL on August 26, 2013, and then to 0.971 ng/mL on October 8, 2013, and 0.277 ng/mL on January 15, 2015.  The P-THP doses ranged from 30 to 75 mg of free THP equivalent/patient every 2-3 weeks without signs of serious toxicity, such as cardiovascular side effects or a reduction in quality of life.  No evidence of relapse was found more than 20 months after P-THP administration.  This case demonstrates the value of hydrazone-bonded polymeric drugs in multimodal therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7bCEqB2N4nacY7HFp97qMfW6udTcc2eaEPbFKWv-otrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FkvVCrsw%253D%253D&md5=022391d1fd43275b6a17d981a4cc9d94</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs11523-015-0379-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11523-015-0379-4%26sid%3Dliteratum%253Aachs%26aulast%3DDozono%26aufirst%3DH.%26aulast%3DYanazume%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DEtrych%26aufirst%3DT.%26aulast%3DChytil%26aufirst%3DP.%26aulast%3DUlbrich%26aufirst%3DK.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DArimura%26aufirst%3DT.%26aulast%3DDouchi%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DIkoma%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DH.%26atitle%3DHPMA%2520copolymer-conjugated%2520pirarubicin%2520in%2520multimodal%2520treatment%2520of%2520a%2520patient%2520with%2520stage%2520IV%2520prostate%2520cancer%2520and%2520extensive%2520lung%2520and%2520bone%2520metastases%26jtitle%3DTargeted%2520Oncol.%26date%3D2016%26volume%3D11%26spage%3D101%26epage%3D106%26doi%3D10.1007%2Fs11523-015-0379-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koziolova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chytil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukigawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haratake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulbrich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etrych, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, H.</span><span> </span><span class="NLM_article-title">Pronounced cellular uptake of pirarubicin versus that of other anthracyclines: comparison of HPMA copolymer conjugates of pirarubicin and doxorubicin</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">4106</span><span class="NLM_x">–</span> <span class="NLM_lpage">4115</span><span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.6b00697</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.6b00697" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2isrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=4106-4115&author=H.+Nakamuraauthor=E.+Koziolovaauthor=P.+Chytilauthor=K.+Tsukigawaauthor=J.+Fangauthor=M.+Haratakeauthor=K.+Ulbrichauthor=T.+Etrychauthor=H.+Maeda&title=Pronounced+cellular+uptake+of+pirarubicin+versus+that+of+other+anthracyclines%3A+comparison+of+HPMA+copolymer+conjugates+of+pirarubicin+and+doxorubicin&doi=10.1021%2Facs.molpharmaceut.6b00697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin</span></div><div class="casAuthors">Nakamura, Hideaki; Koziolova, Eva; Chytil, Petr; Tsukigawa, Kenji; Fang, Jun; Haratake, Mamoru; Ulbrich, Karel; Etrych, Tomas; Maeda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4106-4115</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Many conjugates of water-sol. polymers with biol. active mols. were developed during last two decades.  However, therapeutic effects of these conjugates now appear more heavily affected by the integrity, properties and mechanisms of action of the attached drugs (active pharmaceutical ingredients, APIs).  Pirarubicin (THP), a tetrahydropyranyl deriv. of doxorubicin (DOX), demonstrated more rapid cellular internalization and potent cytotoxicity than DOX.  Here, we conjugated the THP or DOX to N-(2-hydroxypropyl)methacrylamide copolymer via a hydrazone bond.  The polymeric prodrugs conjugates, abbr. P-THP and P-DOX, resp., had comparable hydrodynamic sizes and drug loading.  Compared with P-DOX, P-THP showed approx. 10 times greater cellular uptake during a 240-min incubation and a cytotoxicity that was more than 10 times higher during a 72-h incubation.  A marginal difference was seen in P-THP and P-DOX accumulation in the liver and kidney at 6 h after drug administration, but no significant difference occurred in the tumor drug concn. during 6-24 h after drug administration.  Antitumor activity against xenograft human pancreatic tumor (SUIT2) in mice was greater for P-THP than for P-DOX.  To sum up, the present study compared the biol. behavior of two different drugs, each attached to an HPMA copolymer carrier, with regard to their uptake by tumor cells, body distribution, and accumulation in tumors, cytotoxicity, and antitumor activity in vitro and in vivo.  No differences in the tumor cell uptake of the polymer-drug conjugates P-THP and P-DOX were obsd.  In contrast, the intracellular uptake of free THP liberated from the P-THP was 25-30 times higher than that of DOX liberated from P-DOX.  This finding indicates that proper selection of the carrier, and esp. conjugated API are most crit. for anticancer activity of the polymer-drug conjugates.  THP thus appears more preferable API for polymer conjugation and treatment based on EPR effect target to solid tumors, although both polymer conjugates exhibited similar enhanced permeability and retention (or EPR) effects and drug release profiles in acidic pH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogi7xZa7TkBrVg90H21EOLACvtfcHk0li2GSjX_GgInA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2isrbM&md5=13191f071c15f1ca7882bc6eddb21467</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.6b00697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.6b00697%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DKoziolova%26aufirst%3DE.%26aulast%3DChytil%26aufirst%3DP.%26aulast%3DTsukigawa%26aufirst%3DK.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DHaratake%26aufirst%3DM.%26aulast%3DUlbrich%26aufirst%3DK.%26aulast%3DEtrych%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DH.%26atitle%3DPronounced%2520cellular%2520uptake%2520of%2520pirarubicin%2520versus%2520that%2520of%2520other%2520anthracyclines%253A%2520comparison%2520of%2520HPMA%2520copolymer%2520conjugates%2520of%2520pirarubicin%2520and%2520doxorubicin%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2016%26volume%3D13%26spage%3D4106%26epage%3D4115%26doi%3D10.1021%2Facs.molpharmaceut.6b00697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Marguet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baggio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drucker, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagtmann, N.</span><span> </span><span class="NLM_article-title">Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">6874</span><span class="NLM_x">–</span> <span class="NLM_lpage">6879</span><span class="refDoi"> DOI: 10.1073/pnas.120069197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1073%2Fpnas.120069197" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=6874-6879&author=D.+Marguetauthor=L.+Baggioauthor=T.+Kobayashiauthor=A.+M.+Bernardauthor=M.+Pierresauthor=P.+F.+Nielsenauthor=U.+Ribelauthor=T.+Watanabeauthor=D.+J.+Druckerauthor=N.+Wagtmann&title=Enhanced+insulin+secretion+and+improved+glucose+tolerance+in+mice+lacking+CD26&doi=10.1073%2Fpnas.120069197"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.120069197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.120069197%26sid%3Dliteratum%253Aachs%26aulast%3DMarguet%26aufirst%3DD.%26aulast%3DBaggio%26aufirst%3DL.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DBernard%26aufirst%3DA.%2BM.%26aulast%3DPierres%26aufirst%3DM.%26aulast%3DNielsen%26aufirst%3DP.%2BF.%26aulast%3DRibel%26aufirst%3DU.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26aulast%3DWagtmann%26aufirst%3DN.%26atitle%3DEnhanced%2520insulin%2520secretion%2520and%2520improved%2520glucose%2520tolerance%2520in%2520mice%2520lacking%2520CD26%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D6874%26epage%3D6879%26doi%3D10.1073%2Fpnas.120069197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Gorrell, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gysbers, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G. W.</span><span> </span><span class="NLM_article-title">CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes</span> <span class="citation_source-journal">Scand. J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span><span class="refDoi"> DOI: 10.1046/j.1365-3083.2001.00984.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1046%2Fj.1365-3083.2001.00984.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=11555388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1Sru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=249-264&author=M.+D.+Gorrellauthor=V.+Gysbersauthor=G.+W.+McCaughan&title=CD26%3A+a+multifunctional+integral+membrane+and+secreted+protein+of+activated+lymphocytes&doi=10.1046%2Fj.1365-3083.2001.00984.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes</span></div><div class="casAuthors">Gorrell, M. D.; Gysbers, V.; McCaughan, G. W.</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-264</span>CODEN:
                <span class="NLM_cas:coden">SJIMAX</span>;
        ISSN:<span class="NLM_cas:issn">0300-9475</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review.  CD26 has proved interesting in the fields of immunol., endocrinol., cancer biol. and nutrition owing to its ubiquitous and unusual enzyme activity.  This dipeptidyl aminopeptidase (DPP IV) activity generally inactivates but sometimes alters or enhances the biol. activities of its peptide substrates, which include several chemokines.  CD26 costimulates both the CD3 and the CD2 dependent T-cell activation and tyrosine phosphorylation of TCR/CD3 signal transduction pathway proteins.  CD26 in vivo has integral membrane protein and sol. forms.  Sol. CD26 is at significant levels in serum, these levels alter in many diseases and sol. CD26 can modulate in vitro T-cell proliferation.  CD26, being an adenosine deaminase binding protein (ADAbp), functions as a receptor for ADA on lymphocytes.  The focus of this review is the structure and function of CD26 and the influence of its ligand binding activity on T-cell proliferation and the T cell costimulatory activity of CD26.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBV_U3MaLyFbVg90H21EOLACvtfcHk0li2GSjX_GgInA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1Sru7c%253D&md5=caa68f661699756a7cbce01dfe5c76e3</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-3083.2001.00984.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-3083.2001.00984.x%26sid%3Dliteratum%253Aachs%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26aulast%3DGysbers%26aufirst%3DV.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26atitle%3DCD26%253A%2520a%2520multifunctional%2520integral%2520membrane%2520and%2520secreted%2520protein%2520of%2520activated%2520lymphocytes%26jtitle%3DScand.%2520J.%2520Immunol.%26date%3D2001%26volume%3D54%26spage%3D249%26epage%3D264%26doi%3D10.1046%2Fj.1365-3083.2001.00984.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Beckenkamp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willig, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buffon, A.</span><span> </span><span class="NLM_article-title">DPPIV/CD26: a tumor suppressor or a marker of malignancy?</span> <span class="citation_source-journal">Tumor Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">7059</span><span class="NLM_x">–</span> <span class="NLM_lpage">7073</span><span class="refDoi"> DOI: 10.1007/s13277-016-5005-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1007%2Fs13277-016-5005-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=26943912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVOgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=7059-7073&author=A.+Beckenkampauthor=S.+Daviesauthor=J.+B.+Willigauthor=A.+Buffon&title=DPPIV%2FCD26%3A+a+tumor+suppressor+or+a+marker+of+malignancy%3F&doi=10.1007%2Fs13277-016-5005-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">DPPIV/CD26: a tumor suppressor or a marker of malignancy?</span></div><div class="casAuthors">Beckenkamp, Aline; Davies, Samuel; Willig, Julia Biz; Buffon, Andreia</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">7059-7073</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPPIV/CD26) is a multifunctional protein with intrinsic peptidase activity that inactivates or degrades some bioactive peptides.  It is the main cellular binding protein for ecto-adenosine deaminase and interacts with extracellular matrix proteins, besides participating in different signaling pathways.  Due to these multiple functions, DPPIV/CD26 has been shown to be closely related to the tumor process.  It has been reported that the progression of certain types of cancer is accompanied by a decrease in DPPIV/CD26 expression, and studies have shown that the malignant phenotype can be reverted when DPPIV/CD26 expression is induced in these cancer cells, characterizing this protein as a tumor suppressor.  On the other hand, DPPIV/CD26 was described as a protein assocd. with invasion and metastatic spread, characterizing it as a marker of malignancy.  Thus, this review explores the roles of DPPIV/CD26 expression in tumor progression in different types of cancer and demonstrates the importance of this protein as a promising therapeutic target and tumor biomarker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVyW6NKjRBgrVg90H21EOLACvtfcHk0lh8P6gQyhSXCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVOgt74%253D&md5=9cd4e1691d7956b0621967222d71ce4a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs13277-016-5005-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-016-5005-2%26sid%3Dliteratum%253Aachs%26aulast%3DBeckenkamp%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DS.%26aulast%3DWillig%26aufirst%3DJ.%2BB.%26aulast%3DBuffon%26aufirst%3DA.%26atitle%3DDPPIV%252FCD26%253A%2520a%2520tumor%2520suppressor%2520or%2520a%2520marker%2520of%2520malignancy%253F%26jtitle%3DTumor%2520Biol.%26date%3D2016%26volume%3D37%26spage%3D7059%26epage%3D7073%26doi%3D10.1007%2Fs13277-016-5005-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heirbaut, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryabtsova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1021/ml300410d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300410d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=491-496&author=K.+Jansenauthor=L.+Heirbautauthor=J.+D.+Chengauthor=J.+Joossensauthor=O.+Ryabtsovaauthor=P.+Cosauthor=L.+Maesauthor=A.+M.+Lambeirauthor=I.+De+Meesterauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Selective+inhibitors+of+fibroblast+activation+protein+%28FAP%29+with+a+%284-quinolinoyl%29-glycyl-2-cyanopyrrolidine+scaffold&doi=10.1021%2Fml300410d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold</span></div><div class="casAuthors">Jansen, Koen; Heirbaut, Leen; Cheng, Jonathan D.; Joossens, Jurgen; Ryabtsova, Oxana; Cos, Paul; Maes, Louis; Lambeir, Anne-Marie; De Meester, Ingrid; Augustyns, Koen; Van der Veken, Pieter</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-496</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fibroblast activation protein (FAP) is a serine protease that is generally accepted to play an important role in tumor growth and other diseases involving tissue remodeling.  Currently there are no FAP inhibitors with reported selectivity toward both the closely related dipeptidyl peptidases (DPPs) and prolyl oligopeptidase (PREP).  We present the discovery of a new class of FAP inhibitors with a N-(4-quinolinoyl)-Gly-(2-cyanopyrrolidine) scaffold, e.g. I.  We have explored the effects of substituting the quinoline ring and varying the position of its sp2 hybridized nitrogen atom.  The most promising inhibitors combined low nanomolar FAP inhibition and high selectivity indexes (>103) with respect to both the DPPs and PREP.  Preliminary expts. on a representative inhibitor demonstrate that plasma stability, kinetic soly., and log D of this class of compds. can be expected to be satisfactory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7f0rayraCQLVg90H21EOLACvtfcHk0lh8P6gQyhSXCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKnsLs%253D&md5=1836427e531f6e13264ca833613966dc</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fml300410d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300410d%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DHeirbaut%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DRyabtsova%26aufirst%3DO.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DSelective%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%2520with%2520a%2520%25284-quinolinoyl%2529-glycyl-2-cyanopyrrolidine%2520scaffold%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D491%26epage%3D496%26doi%3D10.1021%2Fml300410d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heirbaut, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkerk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Extended structure activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycy1–2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3053</span><span class="NLM_x">–</span> <span class="NLM_lpage">3074</span><span class="refDoi"> DOI: 10.1021/jm500031w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500031w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3053-3074&author=K.+Jansenauthor=L.+Heirbautauthor=R.+Verkerkauthor=J.+D.+Chengauthor=J.+Joossensauthor=P.+Cosauthor=L.+Maesauthor=A.+M.+Lambeirauthor=I.+De+Meesterauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Extended+structure+activity+relationship+and+pharmacokinetic+investigation+of+%284-quinolinoyl%29glycy1%E2%80%932-cyanopyrrolidine+inhibitors+of+fibroblast+activation+protein+%28FAP%29&doi=10.1021%2Fjm500031w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm500031w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500031w%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DHeirbaut%26aufirst%3DL.%26aulast%3DVerkerk%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DExtended%2520structure%2520activity%2520relationship%2520and%2520pharmacokinetic%2520investigation%2520of%2520%25284-quinolinoyl%2529glycy1%25E2%2580%25932-cyanopyrrolidine%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3053%26epage%3D3074%26doi%3D10.1021%2Fjm500031w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Ryabtsova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goethem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3412</span><span class="NLM_x">–</span> <span class="NLM_lpage">3417</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.03.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2Fj.bmcl.2012.03.107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=22525314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFait7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3412-3417&author=O.+Ryabtsovaauthor=K.+Jansenauthor=S.+Van+Goethemauthor=J.+Joossensauthor=J.+D.+Chengauthor=A.+M.+Lambeirauthor=I.+De+Meesterauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Acylated+Gly-%282-cyano%29pyrrolidines+as+inhibitors+of+fibroblast+activation+protein+%28FAP%29+and+the+issue+of+FAP%2Fprolyl+oligopeptidase+%28PREP%29-selectivity&doi=10.1016%2Fj.bmcl.2012.03.107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity</span></div><div class="casAuthors">Ryabtsova, Oxana; Jansen, Koen; Van Goethem, Sebastiaan; Joossens, Jurgen; Cheng, Jonathan D.; Lambeir, Anne-Marie; De Meester, Ingrid; Augustyns, Koen; Van der Veken, Pieter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3412-3417</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of N-acylated glycyl-(2-cyano)pyrrolidines were synthesized with the aim of generating structure-activity relationship (SAR) data for this class of compds. as inhibitors of fibroblast activation protein (FAP).  Specifically, the influence of (1) the choice of the N-acyl group and (2) structural modification of the 2-cyanopyrrolidine residue were investigated.  The inhibitors displayed inhibitory potency in the micromolar to nanomolar range and showed good to excellent selectivity with respect to the proline selective dipeptidyl peptidases (DPPs) DPP IV, DPP9 and DPP II.  Addnl., selectivity for FAP with respect to prolyl oligopeptidase (PREP) is reported.  Not unexpectedly, the latter data suggest significant overlap in the pharmacophoric features that define FAP or PREP-inhibitory activity and underscore the importance of systematically evaluating the FAP/PREP-selectivity index for inhibitors of either of these two enzymes.  Finally, this study forwards several compds. that can serve as leads or prototypic structures for future FAP-selective-inhibitor discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVTMe5wzszb7Vg90H21EOLACvtfcHk0lh8P6gQyhSXCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFait7k%253D&md5=0191b3cbe44c893935a33e13f62e4289</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.03.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.03.107%26sid%3Dliteratum%253Aachs%26aulast%3DRyabtsova%26aufirst%3DO.%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DVan%2BGoethem%26aufirst%3DS.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DAcylated%2520Gly-%25282-cyano%2529pyrrolidines%2520as%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%2520and%2520the%2520issue%2520of%2520FAP%252Fprolyl%2520oligopeptidase%2520%2528PREP%2529-selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3412%26epage%3D3417%26doi%3D10.1016%2Fj.bmcl.2012.03.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polverino, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bready, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMelfi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPietro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neervannan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roveto, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrag, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanon, R.</span><span> </span><span class="NLM_article-title">Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1649</span><span class="NLM_x">–</span> <span class="NLM_lpage">1667</span><span class="refDoi"> DOI: 10.1021/jm701097z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701097z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1649-1667&author=J.+C.+Harmangeauthor=M.+M.+Weissauthor=J.+Germainauthor=A.+J.+Polverinoauthor=G.+Borgauthor=J.+Breadyauthor=D.+Chenauthor=D.+Choquetteauthor=A.+Coxonauthor=T.+DeMelfiauthor=L.+DiPietroauthor=N.+Doerrauthor=J.+Estradaauthor=J.+Flynnauthor=R.+F.+Graceffaauthor=S.+P.+Harrimanauthor=S.+Kaufmanauthor=D.+S.+Laauthor=A.+Longauthor=M.+W.+Martinauthor=S.+Neervannanauthor=V.+F.+Patelauthor=M.+Potashmanauthor=K.+Regalauthor=P.+M.+Rovetoauthor=M.+L.+Schragauthor=C.+Starnesauthor=A.+Taskerauthor=Y.+Tefferaauthor=L.+Wangauthor=R.+D.+Whiteauthor=D.+A.+Whittingtonauthor=R.+Zanon&title=Naphthamides+as+novel+and+potent+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitors%3A+design%2C+synthesis%2C+and+evaluations&doi=10.1021%2Fjm701097z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm701097z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701097z%26sid%3Dliteratum%253Aachs%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DGermain%26aufirst%3DJ.%26aulast%3DPolverino%26aufirst%3DA.%2BJ.%26aulast%3DBorg%26aufirst%3DG.%26aulast%3DBready%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDeMelfi%26aufirst%3DT.%26aulast%3DDiPietro%26aufirst%3DL.%26aulast%3DDoerr%26aufirst%3DN.%26aulast%3DEstrada%26aufirst%3DJ.%26aulast%3DFlynn%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLong%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNeervannan%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPotashman%26aufirst%3DM.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DRoveto%26aufirst%3DP.%2BM.%26aulast%3DSchrag%26aufirst%3DM.%2BL.%26aulast%3DStarnes%26aufirst%3DC.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZanon%26aufirst%3DR.%26atitle%3DNaphthamides%2520as%2520novel%2520and%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%253A%2520design%252C%2520synthesis%252C%2520and%2520evaluations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1649%26epage%3D1667%26doi%3D10.1021%2Fjm701097z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Tykvart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacha, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knedlik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starkova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubkowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konvalinka, J.</span><span> </span><span class="NLM_article-title">Efficient and versatile one-step affinity purification of in vivo biotinylated proteins: expression, characterization and structure analysis of recombinant human glutamate carboxypeptidase II</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span><span class="refDoi"> DOI: 10.1016/j.pep.2011.11.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2Fj.pep.2011.11.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=22178733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFWgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=106-115&author=J.+Tykvartauthor=P.+Sachaauthor=C.+Barinkaauthor=T.+Knedlikauthor=J.+Starkovaauthor=J.+Lubkowskiauthor=J.+Konvalinka&title=Efficient+and+versatile+one-step+affinity+purification+of+in+vivo+biotinylated+proteins%3A+expression%2C+characterization+and+structure+analysis+of+recombinant+human+glutamate+carboxypeptidase+II&doi=10.1016%2Fj.pep.2011.11.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and versatile one-step affinity purification of in vivo biotinylated proteins: Expression, characterization and structure analysis of recombinant human glutamate carboxypeptidase II</span></div><div class="casAuthors">Tykvart, J.; Sacha, P.; Barinka, C.; Knedlik, T.; Starkova, J.; Lubkowski, J.; Konvalinka, J.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-115</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Affinity purifn. is a useful approach for purifn. of recombinant proteins.  Eukaryotic expression systems have become more frequently used at the expense of prokaryotic systems since they afford recombinant eukaryotic proteins with post-translational modifications similar or identical to the native ones.  Here, a one-step affinity purifn. set-up suitable for the purifn. of secreted proteins is presented.  The set-up is based on the interaction between biotin and mutated streptavidin.  Drosophila Schneider 2 cells are chosen as the expression host, and a biotin acceptor peptide is used as an affinity tag.  This tag is biotinylated by Escherichia coli biotin-protein ligase in vivo.  It was detd. that localization of the ligase within the ER led to the most effective in vivo biotinylation of the secreted proteins.  A protocol was optimized for large-scale expression and purifn. of AviTEV-tagged recombinant human glutamate carboxypeptidase II (Avi-GCPII) with milligram yields per L of culture.  The 3D structure of Avi-GCPII was also detd. by X-ray crystallog. and the enzymic characteristics of the protein were compared to those of its non-tagged variant.  These expts. confirmed that AviTEV tag does not affect the biophys. properties of its fused partner.  The purifn. approach, developed here, provides not only a sufficient amt. of highly homogeneous protein but also specifically and effectively biotinylates a target protein and thus enables its subsequent visualization or immobilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo57Mui9FOUXbVg90H21EOLACvtfcHk0liOw0dIscSmZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFWgs7c%253D&md5=d731679432bae009c380ace62a6d3893</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2011.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2011.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DTykvart%26aufirst%3DJ.%26aulast%3DSacha%26aufirst%3DP.%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DKnedlik%26aufirst%3DT.%26aulast%3DStarkova%26aufirst%3DJ.%26aulast%3DLubkowski%26aufirst%3DJ.%26aulast%3DKonvalinka%26aufirst%3DJ.%26atitle%3DEfficient%2520and%2520versatile%2520one-step%2520affinity%2520purification%2520of%2520in%2520vivo%2520biotinylated%2520proteins%253A%2520expression%252C%2520characterization%2520and%2520structure%2520analysis%2520of%2520recombinant%2520human%2520glutamate%2520carboxypeptidase%2520II%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2012%26volume%3D82%26spage%3D106%26epage%3D115%26doi%3D10.1016%2Fj.pep.2011.11.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptacek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novakova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morath, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerra, A.</span><span> </span><span class="NLM_article-title">Selection and characterization of anticalins targeting human prostate-specific membrane antigen (PSMA)</span> <span class="citation_source-journal">Protein Eng., Des. Sel.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span><span class="refDoi"> DOI: 10.1093/protein/gzv065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1093%2Fprotein%2Fgzv065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=26802163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWksrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=105-115&author=C.+Barinkaauthor=J.+Ptacekauthor=A.+Richterauthor=Z.+Novakovaauthor=V.+Morathauthor=A.+Skerra&title=Selection+and+characterization+of+anticalins+targeting+human+prostate-specific+membrane+antigen+%28PSMA%29&doi=10.1093%2Fprotein%2Fgzv065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA)</span></div><div class="casAuthors">Barinka, Cyril; Ptacek, Jakub; Richter, Antonia; Novakova, Zora; Morath, Volker; Skerra, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Protein Engineering, Design & Selection</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">105-115</span>CODEN:
                <span class="NLM_cas:coden">PEDSBR</span>;
        ISSN:<span class="NLM_cas:issn">1741-0126</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Although prostate carcinoma (PCa) is by far the most commonly diagnosed neoplasia in men, corresponding diagnostic and therapeutic modalities have limited efficacy at present.  Anticalins comprise a novel class of binding proteins based on a non-Ig scaffold that can be engineered to specifically address mol. targets of interest.  Here we report the selection and characterization of Anticalins that recognize human prostate-specific membrane antigen (PSMA), a membrane-tethered metallopeptidase constituting a disease-related target for imaging and therapy of PCa as well as solid malignancies in general.  We used a randomized lipocalin library based on the human lipocalin 2 (Lcn2) scaffold together with phage display and ELISA screening to select PSMAspecific variants.  Five Anticalin candidates from the original panning were expressed in Escherichia coli as sol. monomeric proteins, revealing affinities toward PSMA down to the low nanomolar range.  Binding characteristics of the most promising candidate were further improved via affinity maturation by applying error-prone PCR followed by selection via phage display as well as bacterial surface display under more stringent conditions.  In BIAcore measurements, the dissocn. const. of the best Anticalin was detd. as ∼500 pM, with a substantially improved dissocn. rate compared with the first-generation candidate.  Finally, immunofluorescence microscopy revealed specific staining of PSMA-pos. tumor cell lines while flowcytometric anal. confirmed the ability of the selected Anticalins to detect PSMA on live cells.  Taken together, Anticalins resulting from this study offer a viable alternative to antibody-based PSMA binders for biomedical applications, including in vivo imaging of PCa or neovasculature of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVLK_TRsl547Vg90H21EOLACvtfcHk0liOw0dIscSmZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWksrjP&md5=48e019568dbfa30dc1d829bf1cc7e8cb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fprotein%2Fgzv065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fprotein%252Fgzv065%26sid%3Dliteratum%253Aachs%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DPtacek%26aufirst%3DJ.%26aulast%3DRichter%26aufirst%3DA.%26aulast%3DNovakova%26aufirst%3DZ.%26aulast%3DMorath%26aufirst%3DV.%26aulast%3DSkerra%26aufirst%3DA.%26atitle%3DSelection%2520and%2520characterization%2520of%2520anticalins%2520targeting%2520human%2520prostate-specific%2520membrane%2520antigen%2520%2528PSMA%2529%26jtitle%3DProtein%2520Eng.%252C%2520Des.%2520Sel.%26date%3D2016%26volume%3D29%26spage%3D105%26epage%3D115%26doi%3D10.1093%2Fprotein%2Fgzv065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Balaziova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stremenova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sromova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krepela, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lizcova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedo, A.</span><span> </span><span class="NLM_article-title">Coupled expression of dipeptidyl peptidase-IV and fibroblast activation protein-alpha in transformed astrocytic cells</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span><span class="refDoi"> DOI: 10.1007/s11010-011-0828-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1007%2Fs11010-011-0828-z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2011&pages=283-289&author=E.+Balaziovaauthor=P.+Busekauthor=J.+Stremenovaauthor=L.+Sromovaauthor=E.+Krepelaauthor=L.+Lizcovaauthor=A.+Sedo&title=Coupled+expression+of+dipeptidyl+peptidase-IV+and+fibroblast+activation+protein-alpha+in+transformed+astrocytic+cells&doi=10.1007%2Fs11010-011-0828-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs11010-011-0828-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-011-0828-z%26sid%3Dliteratum%253Aachs%26aulast%3DBalaziova%26aufirst%3DE.%26aulast%3DBusek%26aufirst%3DP.%26aulast%3DStremenova%26aufirst%3DJ.%26aulast%3DSromova%26aufirst%3DL.%26aulast%3DKrepela%26aufirst%3DE.%26aulast%3DLizcova%26aufirst%3DL.%26aulast%3DSedo%26aufirst%3DA.%26atitle%3DCoupled%2520expression%2520of%2520dipeptidyl%2520peptidase-IV%2520and%2520fibroblast%2520activation%2520protein-alpha%2520in%2520transformed%2520astrocytic%2520cells%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2011%26volume%3D354%26spage%3D283%26epage%3D289%26doi%3D10.1007%2Fs11010-011-0828-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Kelly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazur, A.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein-alpha: a key modulator of the microenvironment in multiple pathologies</span> <span class="citation_source-journal">Int. Rev. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span><span class="refDoi"> DOI: 10.1016/B978-0-12-394308-8.00003-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2FB978-0-12-394308-8.00003-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=22608558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKgtbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2012&pages=83-116&author=T.+Kellyauthor=Y.+Huangauthor=A.+E.+Simmsauthor=A.+Mazur&title=Fibroblast+activation+protein-alpha%3A+a+key+modulator+of+the+microenvironment+in+multiple+pathologies&doi=10.1016%2FB978-0-12-394308-8.00003-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies</span></div><div class="casAuthors">Kelly, Thomas; Huang, Yan; Simms, Avis E.; Mazur, Anna</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-116</span>CODEN:
                <span class="NLM_cas:coden">IRCMAH</span>;
        ISSN:<span class="NLM_cas:issn">1937-6448</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Fibroblast activation protein-α (FAP) is a serine protease that can provide target specificity to therapeutic agents because in adults its expression is restricted to pathol. sites, including cancer, fibrosis, arthritis, wounding, or inflammation.  It is not expressed in most normal tissues.  The majority of FAP is expressed by activated fibroblasts responding to the pathol. situations.  FAP is typically found as a type II transmembrane protein phys. attached to cells and with the bulk of the protein, including the catalytic domain, exposed to the extracellular space and accessible to small mols.  In this chapter, we review the structure, substrate specificities, signaling functions, and current design of FAP inhibitors.  Evidence indicating the presence of FAP in multiple cancers, arthritis, fibrosis, keloids, and other pathologies is described and indicates possible roles for FAP in facilitating cell invasion and growth.  Sep. sections are devoted to the role of FAP in coordinating the stromal response to cancer, including a role in angiogenesis and a potential role in modulation of the antitumor immune response.  Finally studies attempting to demonstrate the clin. potential of FAP are discussed, as well as some novel applications employing FAP in therapy or diagnosis.  Throughout this review, effort is made to highlight areas where information is lacking and to highlight important questions that require further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl6m1rj-1CzLVg90H21EOLACvtfcHk0lh2E9xrHjmCzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKgtbjL&md5=e21de80d77e6b473d8c6fc3d17156a36</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-394308-8.00003-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-394308-8.00003-0%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DSimms%26aufirst%3DA.%2BE.%26aulast%3DMazur%26aufirst%3DA.%26atitle%3DFibroblast%2520activation%2520protein-alpha%253A%2520a%2520key%2520modulator%2520of%2520the%2520microenvironment%2520in%2520multiple%2520pathologies%26jtitle%3DInt.%2520Rev.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D297%26spage%3D83%26epage%3D116%26doi%3D10.1016%2FB978-0-12-394308-8.00003-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders</span> <span class="citation_source-journal">Clin. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span><span class="refDoi"> DOI: 10.1042/CS20040302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1042%2FCS20040302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=15584901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisV2jtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2005&pages=277-292&author=M.+D.+Gorrell&title=Dipeptidyl+peptidase+IV+and+related+enzymes+in+cell+biology+and+liver+disorders&doi=10.1042%2FCS20040302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders</span></div><div class="casAuthors">Gorrell, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">277-292</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  DP (dipeptidyl peptidase) IV is the archetypal member of its six-member gene family.  Four members of this family, DPIV, FAP (fibroblast activation protein), DP8 and DP9, have a rare substrate specificity, hydrolysis of a prolyl bond two residues from the N-terminus.  The ubiquitous DPIV glycoprotein has proved interesting in the fields of immunol., endocrinol., haematol. and endothelial cell and cancer biol. and DPIV has become a novel target for Type II diabetes therapy.  The crystal structure shows that the sol. form of DPIV comprises two domains, an α/β-hydrolase domain and an eight-blade β-propeller domain.  The propeller domain contains the ADA (adenosine deaminase) binding site, a dimerization site, antibody epitopes and two openings for substrate access to the internal active site.  FAP is structurally very similar to DPIV, but FAP protein expression is largely confined to diseased and damaged tissue, notably the tissue remodelling interface in chronically injured liver.  DPIV has a variety of peptide substrates, the best studied being GLP-1 (glucagon-like peptide-1), NPY (neuropeptide Y) and CXCL12.  The DPIV family has roles in bone marrow mobilization.  The functional interactions of DPIV and FAP with extracellular matrix confer roles for these proteins in cancer biol.  DP8 and DP9 are widely distributed and indirectly implicated in immune function.  The DPL (DP-like) glycoproteins that lack peptidase activity, DPL1 and DPL2, are brain-expressed potassium channel modulators.  Thus the six members of the DPIV gene family exhibit diverse biol. roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJupx2RWQPHbVg90H21EOLACvtfcHk0lh2E9xrHjmCzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisV2jtrY%253D&md5=64bbb7dbec2fa9c0c49a2e54c0be908e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1042%2FCS20040302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20040302%26sid%3Dliteratum%253Aachs%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520and%2520related%2520enzymes%2520in%2520cell%2520biology%2520and%2520liver%2520disorders%26jtitle%3DClin.%2520Sci.%26date%3D2005%26volume%3D108%26spage%3D277%26epage%3D292%26doi%3D10.1042%2FCS20040302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">An De Decker, Gwendolyn Vliegen, Dries Van Rompaey, Anke Peeraer, An Bracke, Line Verckist, Koen Jansen, Ruth Geiss-Friedlander, Koen Augustyns, Hans De Winter, Ingrid De Meester, Anne-Marie Lambeir, <span class="NLM_string-name hlFld-ContribAuthor">Pieter Van der Veken</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (8)
                                     , 1173-1179. <a href="https://doi.org/10.1021/acsmedchemlett.9b00191" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00191%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252BSmall%252BMolecule-Derived%25252C%252BHighly%252BSelective%252BSubstrates%252Bfor%252BFibroblast%252BActivation%252BProtein%252B%252528FAP%252529%26aulast%3DDe%2BDecker%26aufirst%3DAn%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D25042019%26date%3D09072019%26date%3D10072019%26date%3D09072019%26volume%3D10%26issue%3D8%26spage%3D1173%26epage%3D1179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Klára Pospíšilová, Tomáš Knedlík, Pavel Šácha, Libor Kostka, Jiří Schimer, Jiří Brynda, Vlastimil Král, Petr Cígler, Václav Navrátil, Tomáš Etrych, Vladimír Šubr, Michael Kugler, Milan Fábry, Pavlína Řezáčová, <span class="NLM_string-name hlFld-ContribAuthor">Jan Konvalinka</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor–Polymer Conjugates as a Versatile Tool for Detection and Visualization of Cancer-Associated Carbonic Anhydrase Isoforms. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (4)
                                     , 6746-6756. <a href="https://doi.org/10.1021/acsomega.9b00596" title="DOI URL">https://doi.org/10.1021/acsomega.9b00596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b00596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b00596%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DInhibitor%2525E2%252580%252593Polymer%252BConjugates%252Bas%252Ba%252BVersatile%252BTool%252Bfor%252BDetection%252Band%252BVisualization%252Bof%252BCancer-Associated%252BCarbonic%252BAnhydrase%252BIsoforms%26aulast%3DPosp%25C3%25AD%25C5%25A1ilov%25C3%25A1%26aufirst%3DKl%25C3%25A1ra%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D03032019%26date%3D26032019%26volume%3D4%26issue%3D4%26spage%3D6746%26epage%3D6756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Petr Šimon, Tomáš Knedlík, Kristýna Blažková, Petra Dvořáková, Anna Březinová, Libor Kostka, Vladimír Šubr, Jan Konvalinka, <span class="NLM_string-name hlFld-ContribAuthor">Pavel Šácha</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Protein Targets of Bioactive Small Molecules Using Randomly Photomodified Probes. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2018,</strong> <em>13 </em>
                                    (12)
                                     , 3333-3342. <a href="https://doi.org/10.1021/acschembio.8b00791" title="DOI URL">https://doi.org/10.1021/acschembio.8b00791</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.8b00791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.8b00791%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DIdentification%252Bof%252BProtein%252BTargets%252Bof%252BBioactive%252BSmall%252BMolecules%252BUsing%252BRandomly%252BPhotomodified%252BProbes%26aulast%3D%25C5%25A0imon%26aufirst%3DPetr%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D24082018%26date%3D29112018%26date%3D07122018%26date%3D29112018%26volume%3D13%26issue%3D12%26spage%3D3333%26epage%3D3342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fan Feng, Xi Chen, Guojie Li, Song Liang, Zhangyong Hong, <span class="NLM_string-name hlFld-ContribAuthor">He-Fang Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Afterglow Resonance Energy Transfer Inhibition for Fibroblast Activation Protein-α Assay. </span><span class="cited-content_cbyCitation_journal-name">ACS Sensors</span><span> <strong>2018,</strong> <em>3 </em>
                                    (9)
                                     , 1846-1854. <a href="https://doi.org/10.1021/acssensors.8b00680" title="DOI URL">https://doi.org/10.1021/acssensors.8b00680</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssensors.8b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssensors.8b00680%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sensors%26atitle%3DAfterglow%252BResonance%252BEnergy%252BTransfer%252BInhibition%252Bfor%252BFibroblast%252BActivation%252BProtein-%2525CE%2525B1%252BAssay%26aulast%3DFeng%26aufirst%3DFan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D20072018%26date%3D06092018%26date%3D18092018%26date%3D06092018%26volume%3D3%26issue%3D9%26spage%3D1846%26epage%3D1854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adéla  Šimková</span>, <span class="hlFld-ContribAuthor ">Tereza  Ormsby</span>, <span class="hlFld-ContribAuthor ">Natan  Sidej</span>, <span class="hlFld-ContribAuthor ">Lenka Poštová  Slavětínská</span>, <span class="hlFld-ContribAuthor ">Jiří  Brynda</span>, <span class="hlFld-ContribAuthor ">Jana  Beranová</span>, <span class="hlFld-ContribAuthor ">Pavel  Šácha</span>, <span class="hlFld-ContribAuthor ">Pavel  Majer</span>, <span class="hlFld-ContribAuthor ">Jan  Konvalinka</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship and biochemical evaluation of novel fibroblast activation protein and prolyl endopeptidase inhibitors with α-ketoamide warheads. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>23 </em>, 113717. <a href="https://doi.org/10.1016/j.ejmech.2021.113717" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113717</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113717%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Band%252Bbiochemical%252Bevaluation%252Bof%252Bnovel%252Bfibroblast%252Bactivation%252Bprotein%252Band%252Bprolyl%252Bendopeptidase%252Binhibitors%252Bwith%252B%2525CE%2525B1-ketoamide%252Bwarheads%26aulast%3D%25C5%25A0imkov%25C3%25A1%26aufirst%3DAd%25C3%25A9la%26date%3D2021%26volume%3D23%26spage%3D113717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yentl  Van Rymenant</span>, <span class="hlFld-ContribAuthor ">Muhammet  Tanc</span>, <span class="hlFld-ContribAuthor ">Roos  Van Elzen</span>, <span class="hlFld-ContribAuthor ">An  Bracke</span>, <span class="hlFld-ContribAuthor ">Olivier  De Wever</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Lambeir</span>, <span class="hlFld-ContribAuthor ">Mark  Kockx</span>, <span class="hlFld-ContribAuthor ">Ingrid  De Meester</span>, <span class="hlFld-ContribAuthor ">Pieter  Van Der Veken</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fchem.2021.640566" title="DOI URL">https://doi.org/10.3389/fchem.2021.640566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2021.640566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2021.640566%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DIn%252BVitro%252Band%252BIn%252BSitu%252BActivity-Based%252BLabeling%252Bof%252BFibroblast%252BActivation%252BProtein%252Bwith%252BUAMC1110-Derived%252BProbes%26aulast%3DVan%2BRymenant%26aufirst%3DYentl%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James M.  Kelly</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Jeitner</span>, <span class="hlFld-ContribAuthor ">Shashikanth  Ponnala</span>, <span class="hlFld-ContribAuthor ">Clarence  Williams</span>, <span class="hlFld-ContribAuthor ">Anastasia  Nikolopoulou</span>, <span class="hlFld-ContribAuthor ">Stephen G.  DiMagno</span>, <span class="hlFld-ContribAuthor ">John W.  Babich</span>. </span><span class="cited-content_cbyCitation_article-title">A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα). </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2021,</strong> <em>7 </em><a href="https://doi.org/10.1007/s11307-021-01593-1" title="DOI URL">https://doi.org/10.1007/s11307-021-01593-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-021-01593-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-021-01593-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DA%252BTrifunctional%252BTheranostic%252BLigand%252BTargeting%252BFibroblast%252BActivation%252BProtein-%2525CE%2525B1%252B%252528FAP%2525CE%2525B1%252529%26aulast%3DKelly%26aufirst%3DJames%2BM.%26date%3D2021%26date%3D2021%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Evzen  Krepela</span>, <span class="hlFld-ContribAuthor ">Zdislava  Vanickova</span>, <span class="hlFld-ContribAuthor ">Petr  Hrabal</span>, <span class="hlFld-ContribAuthor ">Michal  Zubal</span>, <span class="hlFld-ContribAuthor ">Barbora  Chmielova</span>, <span class="hlFld-ContribAuthor ">Eva  Balaziova</span>, <span class="hlFld-ContribAuthor ">Petr  Vymola</span>, <span class="hlFld-ContribAuthor ">Ivana  Matrasova</span>, <span class="hlFld-ContribAuthor ">Petr  Busek</span>, <span class="hlFld-ContribAuthor ">Aleksi  Sedo</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (3)
                                     , 1046. <a href="https://doi.org/10.3390/ijms22031046" title="DOI URL">https://doi.org/10.3390/ijms22031046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22031046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22031046%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DRegulation%252Bof%252BFibroblast%252BActivation%252BProtein%252Bby%252BTransforming%252BGrowth%252BFactor%252BBeta-1%252Bin%252BGlioblastoma%252BMicroenvironment%26aulast%3DKrepela%26aufirst%3DEvzen%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D3%26spage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Euy Sung  Moon</span>, <span class="hlFld-ContribAuthor ">Filipe  Elvas</span>, <span class="hlFld-ContribAuthor ">Gwendolyn  Vliegen</span>, <span class="hlFld-ContribAuthor ">Stef  De Lombaerde</span>, <span class="hlFld-ContribAuthor ">Christel  Vangestel</span>, <span class="hlFld-ContribAuthor ">Sven  De Bruycker</span>, <span class="hlFld-ContribAuthor ">An  Bracke</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Eppard</span>, <span class="hlFld-ContribAuthor ">Lukas  Greifenstein</span>, <span class="hlFld-ContribAuthor ">Benedikt  Klasen</span>, <span class="hlFld-ContribAuthor ">Vasko  Kramer</span>, <span class="hlFld-ContribAuthor ">Steven  Staelens</span>, <span class="hlFld-ContribAuthor ">Ingrid  De Meester</span>, <span class="hlFld-ContribAuthor ">Pieter  Van der Veken</span>, <span class="hlFld-ContribAuthor ">Frank  Rösch</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Radiopharmacy and Chemistry</span><span> <strong>2020,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s41181-020-00102-z" title="DOI URL">https://doi.org/10.1186/s41181-020-00102-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s41181-020-00102-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs41181-020-00102-z%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Radiopharmacy%2520and%2520Chemistry%26atitle%3DTargeting%252Bfibroblast%252Bactivation%252Bprotein%252B%252528FAP%252529%25253A%252Bnext%252Bgeneration%252BPET%252Bradiotracers%252Busing%252Bsquaramide%252Bcoupled%252Bbifunctional%252BDOTA%252Band%252BDATA5m%252Bchelators%26aulast%3DMoon%26aufirst%3DEuy%2BSung%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Brábek</span>, <span class="hlFld-ContribAuthor ">Milan  Jakubek</span>, <span class="hlFld-ContribAuthor ">Fréderic  Vellieux</span>, <span class="hlFld-ContribAuthor ">Jiří  Novotný</span>, <span class="hlFld-ContribAuthor ">Michal  Kolář</span>, <span class="hlFld-ContribAuthor ">Lukáš  Lacina</span>, <span class="hlFld-ContribAuthor ">Pavol  Szabo</span>, <span class="hlFld-ContribAuthor ">Karolína  Strnadová</span>, <span class="hlFld-ContribAuthor ">Daniel  Rösel</span>, <span class="hlFld-ContribAuthor ">Barbora  Dvořánková</span>, <span class="hlFld-ContribAuthor ">Karel  Smetana</span>. </span><span class="cited-content_cbyCitation_article-title">Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (21)
                                     , 7937. <a href="https://doi.org/10.3390/ijms21217937" title="DOI URL">https://doi.org/10.3390/ijms21217937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21217937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21217937%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DInterleukin-6%25253A%252BMolecule%252Bin%252Bthe%252BIntersection%252Bof%252BCancer%25252C%252BAgeing%252Band%252BCOVID-19%26aulast%3DBr%25C3%25A1bek%26aufirst%3DJan%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D21%26spage%3D7937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adéla  Šimková</span>, <span class="hlFld-ContribAuthor ">Petr  Bušek</span>, <span class="hlFld-ContribAuthor ">Aleksi  Šedo</span>, <span class="hlFld-ContribAuthor ">Jan  Konvalinka</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2020,</strong> <em>1868 </em>
                                    (7)
                                     , 140409. <a href="https://doi.org/10.1016/j.bbapap.2020.140409" title="DOI URL">https://doi.org/10.1016/j.bbapap.2020.140409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2020.140409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2020.140409%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DMolecular%252Brecognition%252Bof%252Bfibroblast%252Bactivation%252Bprotein%252Bfor%252Bdiagnostic%252Band%252Btherapeutic%252Bapplications%26aulast%3D%25C5%25A0imkov%25C3%25A1%26aufirst%3DAd%25C3%25A9la%26date%3D2020%26volume%3D1868%26issue%3D7%26spage%3D140409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jana  Beranová</span>, <span class="hlFld-ContribAuthor ">Tomáš  Knedlík</span>, <span class="hlFld-ContribAuthor ">Adéla  Šimková</span>, <span class="hlFld-ContribAuthor ">Vladimír  Šubr</span>, <span class="hlFld-ContribAuthor ">Libor  Kostka</span>, <span class="hlFld-ContribAuthor ">Tomáš  Etrych</span>, <span class="hlFld-ContribAuthor ">Pavel  Šácha</span>, <span class="hlFld-ContribAuthor ">Jan  Konvalinka</span>. </span><span class="cited-content_cbyCitation_article-title">Tris-(Nitrilotriacetic Acid)-Decorated Polymer Conjugates as Tools for Immobilization and Visualization of His-Tagged Proteins. </span><span class="cited-content_cbyCitation_journal-name">Catalysts</span><span> <strong>2019,</strong> <em>9 </em>
                                    (12)
                                     , 1011. <a href="https://doi.org/10.3390/catal9121011" title="DOI URL">https://doi.org/10.3390/catal9121011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/catal9121011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcatal9121011%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysts%26atitle%3DTris-%252528Nitrilotriacetic%252BAcid%252529-Decorated%252BPolymer%252BConjugates%252Bas%252BTools%252Bfor%252BImmobilization%252Band%252BVisualization%252Bof%252BHis-Tagged%252BProteins%26aulast%3DBeranov%25C3%25A1%26aufirst%3DJana%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D12%26spage%3D1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raphaël  De Matos</span>, <span class="hlFld-ContribAuthor ">Jérémy  Vuilleumier</span>, <span class="hlFld-ContribAuthor ">Christophe  Mas</span>, <span class="hlFld-ContribAuthor ">Samuel  Constant</span>, <span class="hlFld-ContribAuthor ">Davide  Staedler</span>, <span class="hlFld-ContribAuthor ">Sandrine  Gerber-Lemaire</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor-conjugated harmonic nanoparticles targeting fibroblast activation protein. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (54)
                                     , 31659-31669. <a href="https://doi.org/10.1039/C9RA05299B" title="DOI URL">https://doi.org/10.1039/C9RA05299B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA05299B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA05299B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DInhibitor-conjugated%252Bharmonic%252Bnanoparticles%252Btargeting%252Bfibroblast%252Bactivation%252Bprotein%26aulast%3DDe%2BMatos%26aufirst%3DRapha%25C3%25ABl%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D54%26spage%3D31659%26epage%3D31669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/medium/jm-2017-007675_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00767&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/medium/jm-2017-007675_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0001.jpeg" id="rightTab-GRAPHIC-d7e511-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design and purification of recombinant FAP and DPP-IV. (a) Schematic structures of the recombinant human and mouse FAP and DPP-IV proteins expressed in <i>Drosophila</i><i>S2</i> cells. The extracellular parts of human and mouse FAP containing Strep-tag II and Flag-tag were purified via Strep-Tactin affinity chromatography. The extracellular parts of human and mouse DPP-IV containing Avi-tag were purified via streptavidin mutein affinity purification. (b) A silver-stained SDS-PAGE gel showing a typical two-round affinity purification of recombinant SF-hFAP protein expressed in <i>Drosophila</i><i>S2</i> cells. Load, concentrated medium; FT, flow-through; W1–W2, wash fractions; E1–E3, elution fractions. Ten microliters were loaded onto the gel, except for Load, FT-1, and FT-2 (0.5 μL).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00767&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/medium/jm-2017-007675_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0005.jpeg" id="rightTab-GRAPHIC-d7e576-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b>–<b>4</b>, Specific Inhibitors of FAP Modified with PEG Linkers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00767&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a*) described in ref <a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">47</a>; (a) SOCl<sub>2</sub>, MeOH, reflux; (b) NaH, <i>t</i>-butyl 2-bromoacetate, DMF, −80 °C to RT; (c) TFA; (d) TBTU, DIEA, NH<sub>2</sub>-PEG<sub>n</sub>-NH-BOC (n = 5, or n = 15), DMF; (e) 5 M NaOH/H<sub>2</sub>O, THF/MeOH; (f) (1) TSTU, DIEA, DMF, (2) (<i>S</i>)-2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethanaminium chloride or (<i>S</i>)-2-(2-cyanopyrrolidin-1-yl)-2-oxoethanaminium chloride; (g) Ts-OH, ACN.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/medium/jm-2017-007675_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of FAP inhibitors and anti-FAP polymer conjugate iBody <b>1</b> and their kinetic characterization. (a) The effect of prolyl moiety modification of the (4-quinolinoyl)glycyl-2-cyanopyrrolidine scaffold and PEG linker length on the kinetic properties of the tested inhibitors. The IC<sub>50</sub> values for modified inhibitors with or without fluorine substitution and PEG linkers of various lengths are presented as mean ± standard deviation. Measurements were performed in duplicate. (b) Schematic structure of anti-FAP polymer conjugate (iBody <b>1</b>) containing an ATTO488 fluorophore, an affinity anchor (biotin), and compound <b>1</b>, the FAP-specific inhibitor. (c) Comparison of IC<sub>50</sub> values of the FAP inhibitor and the anti-FAP iBody toward recombinant FAP, DPP-IV, DPP9, and PREP (IC<sub>50</sub> values are presented as mean ± standard deviation).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00767&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/medium/jm-2017-007675_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Application of anti-FAP iBody <b>1</b> in biochemical methods. (a) SPR analysis of SF-hFAP binding to immobilized iBody <b>1</b> (<i>K</i><sub>D</sub> < 6 nM). (b) Affinity isolation of FAP from FAP-transfected U251 (U251_FAP+) cell lysate using iBody <b>1</b>. iBody <b>2</b> (lacking FAP inhibitor) and blank streptavidin agarose (NC-SA) were used as negative controls. Load = U251_FAP+ cell lysate. (c) Sandwich ELISA for quantification of FAP using iBody <b>1</b> and anti-FAP F-19 antibody as a detection “agent” and a capture antibody, respectively. Each sample was measured in triplicate; values are presented as the mean ± standard deviation. (d) Western blot visualization of FAP using iBody <b>1</b> followed by an IRDye 800CW streptavidin conjugate. Purified recombinant human FAP (SF-hFAP) and a lysate of U251_FAP+ cells were used. The right section refers to the membrane probed with IRDye 800CW streptavidin conjugate only.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00767&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/medium/jm-2017-007675_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Detection and visualization of FAP on cells using anti-FAP iBody <b>1</b>. (a) Confocal microscopy analysis of cells expressing and not expressing FAP. Cells with inducible FAP expression were incubated with 200 nM iBody <b>1</b> (at 37 °C for 1 h), which was then visualized by confocal microscopy; the cell nuclei were stained with Hoechst H34580 dye. (b) Flow cytometry detection of FAP expression in GL261 cells transfected with mouse FAP but not in cells transfected with the closely related mouse DPP-IV. Nontransfected GL261 cells stained with iBody <b>1</b> and streptavidin–PE conjugate, and FAP-GL261 transfectants stained with streptavidin–PE conjugate only were used as negative controls. (c) Flow cytometry detection of endogenous FAP expression in human fibroblasts and U87 glioma cells using anti-FAP iBody <b>1</b>. GL261 cells incubated with iBody <b>1</b> and streptavidin–PE conjugate and human fibroblasts incubated with streptavidin–PE conjugate only were used as negative controls. (d) Immunohistochemistry on frozen sections of a tumor (delineated by a dashed line) generated by xenotransplantation of FAP-transfected glioma cells into mouse brain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00767/20171020/images/large/jm-2017-007675_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00767&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53557" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53557" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Sevenich, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. A.</span><span> </span><span class="NLM_article-title">Pericellular proteolysis in cancer</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2331</span><span class="NLM_x">–</span> <span class="NLM_lpage">2347</span><span class="refDoi"> DOI: 10.1101/gad.250647.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1101%2Fgad.250647.114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=2331-2347&author=L.+Sevenichauthor=J.+A.+Joyce&title=Pericellular+proteolysis+in+cancer&doi=10.1101%2Fgad.250647.114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1101%2Fgad.250647.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.250647.114%26sid%3Dliteratum%253Aachs%26aulast%3DSevenich%26aufirst%3DL.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26atitle%3DPericellular%2520proteolysis%2520in%2520cancer%26jtitle%3DGenes%2520Dev.%26date%3D2014%26volume%3D28%26spage%3D2331%26epage%3D2347%26doi%3D10.1101%2Fgad.250647.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Bonnans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werb, Z.</span><span> </span><span class="NLM_article-title">Remodelling the extracellular matrix in development and disease</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">786</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span><span class="refDoi"> DOI: 10.1038/nrm3904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1038%2Fnrm3904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=25415508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKmtbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=786-801&author=C.+Bonnansauthor=J.+Chouauthor=Z.+Werb&title=Remodelling+the+extracellular+matrix+in+development+and+disease&doi=10.1038%2Fnrm3904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Remodelling the extracellular matrix in development and disease</span></div><div class="casAuthors">Bonnans, Caroline; Chou, Jonathan; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">786-801</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The extracellular matrix (ECM) is a highly dynamic structure that is present in all tissues and continuously undergoes controlled remodelling.  This process involves quant. and qual. changes in the ECM, mediated by specific enzymes that are responsible for ECM degrdn., such as metalloproteinases.  The ECM interacts with cells to regulate diverse functions, including proliferation, migration and differentiation.  ECM remodelling is crucial for regulating the morphogenesis of the intestine and lungs, as well as of the mammary and submandibular glands.  Dysregulation of ECM compn., structure, stiffness and abundance contributes to several pathol. conditions, such as fibrosis and invasive cancer.  A better understanding of how the ECM regulates organ structure and function and of how ECM remodelling affects disease progression will contribute to the development of new therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgvNjm5IvLgLVg90H21EOLACvtfcHk0lhpziaPKqBf-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKmtbbF&md5=623492080876fee0ffa62b9f0dc1937c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm3904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3904%26sid%3Dliteratum%253Aachs%26aulast%3DBonnans%26aufirst%3DC.%26aulast%3DChou%26aufirst%3DJ.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DRemodelling%2520the%2520extracellular%2520matrix%2520in%2520development%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D786%26epage%3D801%26doi%3D10.1038%2Fnrm3904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Basset, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellocq, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limacher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podhajcer, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rio, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambon, P.</span><span> </span><span class="NLM_article-title">A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">704</span><span class="refDoi"> DOI: 10.1038/348699a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1038%2F348699a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1990&pages=699-704&author=P.+Bassetauthor=J.+P.+Bellocqauthor=C.+Wolfauthor=I.+Stollauthor=P.+Hutinauthor=J.+M.+Limacherauthor=O.+L.+Podhajcerauthor=M.+P.+Chenardauthor=M.+C.+Rioauthor=P.+Chambon&title=A+novel+metalloproteinase+gene+specifically+expressed+in+stromal+cells+of+breast+carcinomas&doi=10.1038%2F348699a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F348699a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F348699a0%26sid%3Dliteratum%253Aachs%26aulast%3DBasset%26aufirst%3DP.%26aulast%3DBellocq%26aufirst%3DJ.%2BP.%26aulast%3DWolf%26aufirst%3DC.%26aulast%3DStoll%26aufirst%3DI.%26aulast%3DHutin%26aufirst%3DP.%26aulast%3DLimacher%26aufirst%3DJ.%2BM.%26aulast%3DPodhajcer%26aufirst%3DO.%2BL.%26aulast%3DChenard%26aufirst%3DM.%2BP.%26aulast%3DRio%26aufirst%3DM.%2BC.%26aulast%3DChambon%26aufirst%3DP.%26atitle%3DA%2520novel%2520metalloproteinase%2520gene%2520specifically%2520expressed%2520in%2520stromal%2520cells%2520of%2520breast%2520carcinomas%26jtitle%3DNature%26date%3D1990%26volume%3D348%26spage%3D699%26epage%3D704%26doi%3D10.1038%2F348699a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Cathcart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulkoski-Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span> </span><span class="NLM_article-title">Targeting matrix metalloproteinases in cancer: bringing new life to old ideas</span> <span class="citation_source-journal">Genes Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1016/j.gendis.2014.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2Fj.gendis.2014.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=26097889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A280%3ADC%252BC2srotlKmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=26-34&author=J.+Cathcartauthor=A.+Pulkoski-Grossauthor=J.+Cao&title=Targeting+matrix+metalloproteinases+in+cancer%3A+bringing+new+life+to+old+ideas&doi=10.1016%2Fj.gendis.2014.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas</span></div><div class="casAuthors">Cathcart Jillian; Pulkoski-Gross Ashleigh; Cao Jian</div><div class="citationInfo"><span class="NLM_cas:title">Genes & diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-34</span>
        ISSN:<span class="NLM_cas:issn">2352-4820</span>.
    </div><div class="casAbstract">Since the identification of matrix metalloproteinases (MMPs), a family of zinc-dependent endopeptidases, as being a driving factor for cancer progression and patient prognosis, MMPs have been studied extensively.  Although early programs targeting MMPs were largely unsuccessful in clinical trials, they remain a viable and highly desirable therapeutic target based on preclinical studies and their role in disease progression.  As information regarding the structure and function of these proteinases is compiled and biotechnology evolves, tools to develop better inhibitors is within our grasp.  Improved methods for high throughput screening and in silico drug design programs have identified compounds which are highly potent, have high binding affinities, and exhibit favorable pharmacokinetic profiles.  More recently, advances in drug delivery methods or compounds which bind outside the active site have brought new light to the field.  In this review, we highlight the role of MMPs in cancer, clinical trials for MMP inhibitors, and novel approaches to targeting MMPs in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEJ37PEUcnpYxhnOQkIHOxfW6udTcc2eZClPVwYiXe_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srotlKmtw%253D%253D&md5=195802fe3f5c6881cdc9202d2ea3d957</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.gendis.2014.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gendis.2014.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DCathcart%26aufirst%3DJ.%26aulast%3DPulkoski-Gross%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DJ.%26atitle%3DTargeting%2520matrix%2520metalloproteinases%2520in%2520cancer%253A%2520bringing%2520new%2520life%2520to%2520old%2520ideas%26jtitle%3DGenes%2520Dis.%26date%3D2015%26volume%3D2%26spage%3D26%26epage%3D34%26doi%3D10.1016%2Fj.gendis.2014.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Zucker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. T.</span><span> </span><span class="NLM_article-title">Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6642</span><span class="NLM_x">–</span> <span class="NLM_lpage">6650</span><span class="refDoi"> DOI: 10.1038/sj.onc.1204097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1038%2Fsj.onc.1204097" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=6642-6650&author=S.+Zuckerauthor=J.+Caoauthor=W.+T.+Chen&title=Critical+appraisal+of+the+use+of+matrix+metalloproteinase+inhibitors+in+cancer+treatment&doi=10.1038%2Fsj.onc.1204097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1204097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1204097%26sid%3Dliteratum%253Aachs%26aulast%3DZucker%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DW.%2BT.%26atitle%3DCritical%2520appraisal%2520of%2520the%2520use%2520of%2520matrix%2520metalloproteinase%2520inhibitors%2520in%2520cancer%2520treatment%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D6642%26epage%3D6650%26doi%3D10.1038%2Fsj.onc.1204097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">7235</span><span class="NLM_x">–</span> <span class="NLM_lpage">7239</span><span class="refDoi"> DOI: 10.1073/pnas.87.18.7235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1073%2Fpnas.87.18.7235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=2402505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADyaK3cXmtV2isbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=7235-7239&author=P.+Garin-Chesaauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Cell+surface+glycoprotein+of+reactive+stromal+fibroblasts+as+a+potential+antibody+target+in+human+epithelial+cancers&doi=10.1073%2Fpnas.87.18.7235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers</span></div><div class="casAuthors">Garin-Chesa, Pilar; Old, Lloyd J.; Rettig, Wolfgang J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7235-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The F19 antigen is a cell surface glycoprotein (mol. wt. 95,000) of human sarcomas and proliferating cultured fibroblasts that is absent from resting fibroblasts in normal adult tissues.  Normal and malignant epithelial cells are also F19-.  The present immunohistochem. study describes induction of F19 in the reactive mesenchyme of epithelial tumors.  F19+ fibroblasts were found in primary and metastatic carcinomas, including colorectal, breast, ovarian, bladder, and lung carcinomas.  The stroma of benign colorectal adenomas, fibrocystic disease, and fibroadenomas of breast, benign prostate hyperplasia, bladder carcinomas, and benign ovarian tumors showed no or only moderate nos. of F19+ fibroblasts.  Anal. of dermal incision wounds revealed that F19 was strongly induced during scar formation.  Comparison of F19 with the extracellular matrix protein tenascin, a putative marker of tumor mesenchyme, showed a cellular staining pattern for F19 vs. the extracellular matrix pattern for tenascin and widespread expression of tenascin in F19- normal tissues and benign tumors.  The F19+ phenotype may correlate with specialized fibroblast functions in wound healing and malignant tumor growth.  Because of its abundance in tumor mesenchyme, F19 may serve as a target for antibodies labeled with radioisotopes or toxic agents, or inflammatogenic antibodies, in carcinoma patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9_KYVTgRj8LVg90H21EOLACvtfcHk0li4rdtlJYpAFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtV2isbw%253D&md5=957bd13237f20c4f1e95a7a1b2204081</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.87.18.7235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.87.18.7235%26sid%3Dliteratum%253Aachs%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DCell%2520surface%2520glycoprotein%2520of%2520reactive%2520stromal%2520fibroblasts%2520as%2520a%2520potential%2520antibody%2520target%2520in%2520human%2520epithelial%2520cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1990%26volume%3D87%26spage%3D7235%26epage%3D7239%26doi%3D10.1073%2Fpnas.87.18.7235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlogie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaughnessy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaccoby, S.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1111/j.1365-2141.2006.05976.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1111%2Fj.1365-2141.2006.05976.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=16512833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFaktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2006&pages=83-92&author=Y.+Geauthor=F.+G.+Zhanauthor=B.+Barlogieauthor=J.+Epsteinauthor=J.+Shaughnessyauthor=S.+Yaccoby&title=Fibroblast+activation+protein+%28FAP%29+is+upregulated+in+myelomatous+bone+and+supports+myeloma+cell+survival&doi=10.1111%2Fj.1365-2141.2006.05976.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival</span></div><div class="casAuthors">Ge, Yun; Zhan, Fenghuang; Barlogie, Bart; Epstein, Joshua; Shaughnessy, John, Jr.; Yaccoby, Shmuel</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-92</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The microenvironment plays a crit. role in facilitating cancer progression and metastasis.  We previously demonstrated the ability of osteoclasts to support primary myeloma plasma cell (MM PC) growth.  Our study on the role of the bone marrow (BM) microenvironment in myeloma, using global gene expression profiling, has identified fibroblast activation protein (FAP) as one of 28 genes significantly overexpressed in cocultured osteoclasts.  Because FAP has been previously implicated in tumorigenesis and shown to be selectively expressed by the reactive stroma of epithelial tumors, we focused our study on the role of this serine protease in myeloma.  Using quant. polymerase chain reaction amplification, we demonstrated upregulation of FAP by cocultured osteoclasts and mesenchymal stem cells, and in whole myelomatous human bone in SCID-hu mice.  Immunohistochem. anal. of myelomatous bone sections revealed FAP expression by osteoclasts, osteogenic cells, fibrotic stroma and certain adipocytes and vascular endothelial cells.  FAP was not expressed in PCs by all these methods.  Inhibition of FAP expression with the use of small-interference RNA reduced MM PC survival in cocultures.  Our results indicate that FAP is crit. for the interaction of MM cells with the BM microenvironment - a potential therapeutic target in myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRKLTZGv4ItLVg90H21EOLACvtfcHk0li4rdtlJYpAFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFaktbg%253D&md5=154862801f747c44fa47df2980eb9d75</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2006.05976.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2006.05976.x%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DF.%2BG.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DEpstein%26aufirst%3DJ.%26aulast%3DShaughnessy%26aufirst%3DJ.%26aulast%3DYaccoby%26aufirst%3DS.%26atitle%3DFibroblast%2520activation%2520protein%2520%2528FAP%2529%2520is%2520upregulated%2520in%2520myelomatous%2520bone%2520and%2520supports%2520myeloma%2520cell%2520survival%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2006%26volume%3D133%26spage%3D83%26epage%3D92%26doi%3D10.1111%2Fj.1365-2141.2006.05976.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Busek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaziova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matrasova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syrucek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zemanova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krepela, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belacek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedo, A.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma</span> <span class="citation_source-journal">Tumor Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">13961</span><span class="NLM_x">–</span> <span class="NLM_lpage">13971</span><span class="refDoi"> DOI: 10.1007/s13277-016-5274-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1007%2Fs13277-016-5274-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=27492457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlejtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=13961-13971&author=P.+Busekauthor=E.+Balaziovaauthor=I.+Matrasovaauthor=M.+Hilserauthor=R.+Tomasauthor=M.+Syrucekauthor=Z.+Zemanovaauthor=E.+Krepelaauthor=J.+Belacekauthor=A.+Sedo&title=Fibroblast+activation+protein+alpha+is+expressed+by+transformed+and+stromal+cells+and+is+associated+with+mesenchymal+features+in+glioblastoma&doi=10.1007%2Fs13277-016-5274-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma</span></div><div class="casAuthors">Busek, Petr; Balaziova, Eva; Matrasova, Ivana; Hilser, Marek; Tomas, Robert; Syrucek, Martin; Zemanova, Zuzana; Krepela, Evzen; Belacek, Jaromir; Sedo, Aleksi</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">13961-13971</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Glioblastomas are deadly neoplasms resistant to current treatment modalities.  Fibroblast activation protein (FAP) is a protease which is not expressed in most of the normal adult tissues but is characteristically present in the stroma of extracranial malignancies.  FAP is considered a potential therapeutic target and is assocd. with a worse patient outcome in some cancers.  The FAP localization in the glioma microenvironment and its relation to patient survival are unknown.  By analyzing 56 gliomas and 15 non-tumorous brain samples, we demonstrate increased FAP expression in a subgroup of high-grade gliomas, in particular on the protein level.  FAP expression was most elevated in the mesenchymal subtype of glioblastoma.  It was neither assocd. with glioblastoma patient survival in our patient cohort nor in publicly available datasets.  FAP was expressed in both transformed and stromal cells; the latter were frequently localized around dysplastic blood vessels and commonly expressed mesenchymal markers.  In a mouse xenotransplantation model, FAP was expressed in glioma cells in a subgroup of tumors that typically did not express the astrocytic marker GFAP.  Endogenous FAP was frequently upregulated and part of the FAP+ host cells coexpressed the CXCR4 chemokine receptor.  In summary, FAP is expressed by several constituents of the glioblastoma microenvironment, including stromal non-malignant mesenchymal cells recruited to and/or activated in response to glioma growth.  The limited expression of FAP in healthy tissues together with its presence in both transformed and stromal cells suggests that FAP may be a candidate target for specific delivery of therapeutic agents in glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6zANoeaouHLVg90H21EOLACvtfcHk0lhSRIXSfdfZ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlejtLfO&md5=87c12c033d2ac230da4b7e7d94928398</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs13277-016-5274-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-016-5274-9%26sid%3Dliteratum%253Aachs%26aulast%3DBusek%26aufirst%3DP.%26aulast%3DBalaziova%26aufirst%3DE.%26aulast%3DMatrasova%26aufirst%3DI.%26aulast%3DHilser%26aufirst%3DM.%26aulast%3DTomas%26aufirst%3DR.%26aulast%3DSyrucek%26aufirst%3DM.%26aulast%3DZemanova%26aufirst%3DZ.%26aulast%3DKrepela%26aufirst%3DE.%26aulast%3DBelacek%26aufirst%3DJ.%26aulast%3DSedo%26aufirst%3DA.%26atitle%3DFibroblast%2520activation%2520protein%2520alpha%2520is%2520expressed%2520by%2520transformed%2520and%2520stromal%2520cells%2520and%2520is%2520associated%2520with%2520mesenchymal%2520features%2520in%2520glioblastoma%26jtitle%3DTumor%2520Biol.%26date%3D2016%26volume%3D37%26spage%3D13961%26epage%3D13971%26doi%3D10.1007%2Fs13277-016-5274-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Shi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, M. H.</span><span> </span><span class="NLM_article-title">Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">840</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span><span class="refDoi"> DOI: 10.3748/wjg.v18.i8.840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.3748%2Fwjg.v18.i8.840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=22371645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC38XjslOlsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=840-846&author=M.+Shiauthor=D.+H.+Yuauthor=Y.+Chenauthor=C.+Y.+Zhaoauthor=J.+Zhangauthor=Q.+H.+Liuauthor=C.+R.+Niauthor=M.+H.+Zhu&title=Expression+of+fibroblast+activation+protein+in+human+pancreatic+adenocarcinoma+and+its+clinicopathological+significance&doi=10.3748%2Fwjg.v18.i8.840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance</span></div><div class="casAuthors">Shi, Min; Yu, Dang-Hui; Chen, Ying; Zhao, Chen-Yan; Zhang, Jing; Liu, Qing-Hua; Ni, Can-Rong; Zhu, Ming-Hua</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">840-846</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Co., Ltd.</span>)
        </div><div class="casAbstract">Aim: To examine fibroblast activation protein (FAP) expression in pancreatic ductal adenocarcinoma (PDAC) and to analyze its relationship with the clinicopathol. of PDAC.  Methods: FAP expression was examd. in 134 PDAC specimens by immunohistochem. and in four pancreatic cancer cell lines (SW1990, Miapaca-2, AsPC-1 and BxPC-3) by Western blotting assay.  We also analyzed the assocn. between FAP expression in PDAC cells and the clinicopathol. of PDAC patients.  Results: The results showed that the FAP was expressed in both stromal fibroblast cells (98/134, 73.1%) and carcinoma cells (102/134, 76.1 %).  All 4 pancreatic cancer cell lines expressed FAP protein at different levels.  Protein bands corresponding to the proteolytically active 170-kDa seprase dimer and its 88-kDa seprase subunit were identified.  Higher FAP expression in carcinoma cells was assocd. with tumor size (P < 0.001), fibrotic focus (P = 0.003), perineural invasion (P = 0.009) and worse clin. outcome (P = 0.0085).  Conclusion: FAP is highly expressed in carcinoma cells and fibroblasts in PDAC tissues and its expression is assocd. with desmoplasia and worse prognosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxNJB6yGpISbVg90H21EOLACvtfcHk0lhSRIXSfdfZ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjslOlsr4%253D&md5=3e73023ef7a37f9d8eba9decdf4b72e6</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v18.i8.840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v18.i8.840%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DD.%2BH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DC.%2BY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DQ.%2BH.%26aulast%3DNi%26aufirst%3DC.%2BR.%26aulast%3DZhu%26aufirst%3DM.%2BH.%26atitle%3DExpression%2520of%2520fibroblast%2520activation%2520protein%2520in%2520human%2520pancreatic%2520adenocarcinoma%2520and%2520its%2520clinicopathological%2520significance%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2012%26volume%3D18%26spage%3D840%26epage%3D846%26doi%3D10.3748%2Fwjg.v18.i8.840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Busek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanickova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrabal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brabec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fric, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavoral, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kmochova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laclav, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunganic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedo, A.</span><span> </span><span class="NLM_article-title">Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma</span> <span class="citation_source-journal">Pancreatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">838</span><span class="refDoi"> DOI: 10.1016/j.pan.2016.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2Fj.pan.2016.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=829-838&author=P.+Busekauthor=Z.+Vanickovaauthor=P.+Hrabalauthor=M.+Brabecauthor=P.+Fricauthor=M.+Zavoralauthor=J.+Skrhaauthor=K.+Kmochovaauthor=M.+Laclavauthor=B.+Bunganicauthor=K.+Augustynsauthor=P.+Van+der+Vekenauthor=A.+Sedo&title=Increased+tissue+and+circulating+levels+of+dipeptidyl+peptidase-IV+enzymatic+activity+in+patients+with+pancreatic+ductal+adenocarcinoma&doi=10.1016%2Fj.pan.2016.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.pan.2016.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pan.2016.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DBusek%26aufirst%3DP.%26aulast%3DVanickova%26aufirst%3DZ.%26aulast%3DHrabal%26aufirst%3DP.%26aulast%3DBrabec%26aufirst%3DM.%26aulast%3DFric%26aufirst%3DP.%26aulast%3DZavoral%26aufirst%3DM.%26aulast%3DSkrha%26aufirst%3DJ.%26aulast%3DKmochova%26aufirst%3DK.%26aulast%3DLaclav%26aufirst%3DM.%26aulast%3DBunganic%26aufirst%3DB.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DSedo%26aufirst%3DA.%26atitle%3DIncreased%2520tissue%2520and%2520circulating%2520levels%2520of%2520dipeptidyl%2520peptidase-IV%2520enzymatic%2520activity%2520in%2520patients%2520with%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DPancreatology%26date%3D2016%26volume%3D16%26spage%3D829%26epage%3D838%26doi%3D10.1016%2Fj.pan.2016.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kelly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kechelava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozypal, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korourian, S.</span><span> </span><span class="NLM_article-title">Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers</span> <span class="citation_source-journal">Mod. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=9758365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A280%3ADyaK1cvivFegsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1998&pages=855-863&author=T.+Kellyauthor=S.+Kechelavaauthor=T.+L.+Rozypalauthor=K.+W.+Westauthor=S.+Korourian&title=Seprase%2C+a+membrane-bound+protease%2C+is+overexpressed+by+invasive+ductal+carcinoma+cells+of+human+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers</span></div><div class="casAuthors">Kelly T; Kechelava S; Rozypal T L; West K W; Korourian S</div><div class="citationInfo"><span class="NLM_cas:title">Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">855-63</span>
        ISSN:<span class="NLM_cas:issn">0893-3952</span>.
    </div><div class="casAbstract">The increased cell surface expression of the serine integral membrane protease, seprase, has been associated with the invasive behavior of human melanoma cell lines in vitro.  The present study investigates the expression of seprase in malignant, premalignant, benign, and normal human breast tissues.  The 170-kDa gelatinase activity of seprase was identified in extracts of infiltrating ductal carcinomas (IDC).  Protein bands corresponding to the proteolytically active 170-kDa seprase dimer and its 97-kDa seprase subunit protein were identified by immunoblot analysis of IDC extracts using an antiserum elicited against immunoaffinity-purified seprase.  Immunohistochemical analysis of seprase expression in 41 formalin-fixed and paraffin-embedded specimens of human breast tissue revealed preferential immunoreactivity with the malignant cells of IDC (27 cases).  Within individual IDC specimens, the stromal cells or morphologically normal epithelium revealed low labeling that was always significantly less than the labeling of neoplastic cells.  Lymph node metastases of IDC cells were also strongly positive, but the lymphoid tissue in affected nodes was not stained.  Neoplastic cells in DC in situ (5 cases) exhibited variable levels of staining.  Epithelial cells of benign fibroadenoma specimens (2 cases) and benign proliferative breast disease (5 cases) exhibited little or no immunoreactivity.  Epithelial cells of normal breast tissue (1 case) were not stained.  The overexpression of seprase by DC cells is consistent with seprase having a role in facilitating invasion and metastasis of IDC of the breast.  The cell surface localization of seprase could be used to target therapeutic agents to malignant breast cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXFZ5CzApM6g8IxFYvehhofW6udTcc2ebqZKjr_DnrELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvivFegsA%253D%253D&md5=b348b49ed7e1645600038f4abfbcb410</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DT.%26aulast%3DKechelava%26aufirst%3DS.%26aulast%3DRozypal%26aufirst%3DT.%2BL.%26aulast%3DWest%26aufirst%3DK.%2BW.%26aulast%3DKorourian%26aufirst%3DS.%26atitle%3DSeprase%252C%2520a%2520membrane-bound%2520protease%252C%2520is%2520overexpressed%2520by%2520invasive%2520ductal%2520carcinoma%2520cells%2520of%2520human%2520breast%2520cancers%26jtitle%3DMod.%2520Pathol.%26date%3D1998%26volume%3D11%26spage%3D855%26epage%3D863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Iwasa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsumata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooi, A.</span><span> </span><span class="NLM_article-title">Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">199</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/S0304-3835(03)00315-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2FS0304-3835%2803%2900315-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=12963128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVylsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2003&pages=91-98&author=S.+Iwasaauthor=X.+Jinauthor=K.+Okadaauthor=M.+Mitsumataauthor=A.+Ooi&title=Increased+expression+of+seprase%2C+a+membrane-type+serine+protease%2C+is+associated+with+lymph+node+metastasis+in+human+colorectal+cancer&doi=10.1016%2FS0304-3835%2803%2900315-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer</span></div><div class="casAuthors">Iwasa, Satoshi; Jin, Xin; Okada, Kyoko; Mitsumata, Masako; Ooi, Akishi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">199</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Seprase is a membrane-bound serine proteinase with gelatinase activity, which may be involved in cancer invasion and metastasis.  We examd. seprase expression in colorectal cancer specimens obtained from 109 patients.  Seprase immunoreactivity was found in cancer cells and adjacent stromal cells.  Immunoblotting showed higher levels of seprase protein in colorectal cancer tissue than in normal colorectal tissue.  A semiquant. assessment of the immunohistochem. results revealed a significant correlation between seprase expression and lymph node metastasis.  These results suggested that an abundant expression of seprase in colorectal cancer tissue is assocd. with lymph node metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowKXBr8wGFDLVg90H21EOLACvtfcHk0lj4mjbHoy6rsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVylsLs%253D&md5=884618a04d7df606b0733369880811c1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0304-3835%2803%2900315-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3835%252803%252900315-X%26sid%3Dliteratum%253Aachs%26aulast%3DIwasa%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DMitsumata%26aufirst%3DM.%26aulast%3DOoi%26aufirst%3DA.%26atitle%3DIncreased%2520expression%2520of%2520seprase%252C%2520a%2520membrane-type%2520serine%2520protease%252C%2520is%2520associated%2520with%2520lymph%2520node%2520metastasis%2520in%2520human%2520colorectal%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2003%26volume%3D199%26spage%3D91%26epage%3D98%26doi%3D10.1016%2FS0304-3835%2803%2900315-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsumata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooi, A.</span><span> </span><span class="NLM_article-title">Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3195</span><span class="NLM_x">–</span> <span class="NLM_lpage">3198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=12926053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVChur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=3195-3198&author=X.+Jinauthor=S.+Iwasaauthor=K.+Okadaauthor=M.+Mitsumataauthor=A.+Ooi&title=Expression+patterns+of+seprase%2C+a+membrane+serine+protease%2C+in+cervical+carcinoma+and+cervical+intraepithelial+neoplasm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm</span></div><div class="casAuthors">Jin, Xin; Iwasa, Satoshi; Okada, Kyoko; Mitsumata, Masako; Ooi, Akishi</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">3195-3198</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Seprase is a membrane-bound serine proteinase with gelatinase activity, which may be involved in cancer invasion and metastasis.  Patients and Methods: The authors examd. the seprase expression patterns in invasive or preinvasive squamous epithelial lesions.  Results and Conclusion: No seprase immunoreactivity was found in the atypical epithelial cells and subepithelial stromal cells of CIN1 and 2 lesions.  No seprase expression could be detected even in CIN3 lesions.  However, in contrast to CIN1 and 2, seprase immunoreactivity was occasionally obsd. in the subepithelial stromal cells that were assocd. with moderate or severe inflammatory infiltrates.  Some microinvasive carcinomas and all invasive carcinomas showed seprase immunoreactivity in the cancer cells with various degrees of seprase pos. stromal cells.  Seprase may be an early marker of tumor invasion in squamous lesions of the uterine cervix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLpiTHhlVCnrVg90H21EOLACvtfcHk0lj4mjbHoy6rsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVChur4%253D&md5=c822bb883328ad846cd5b0ccc05c9c4d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DX.%26aulast%3DIwasa%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DMitsumata%26aufirst%3DM.%26aulast%3DOoi%26aufirst%3DA.%26atitle%3DExpression%2520patterns%2520of%2520seprase%252C%2520a%2520membrane%2520serine%2520protease%252C%2520in%2520cervical%2520carcinoma%2520and%2520cervical%2520intraepithelial%2520neoplasm%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26spage%3D3195%26epage%3D3198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, X.</span><span> </span><span class="NLM_article-title">Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1155</span><span class="refDoi"> DOI: 10.1038/cddis.2014.122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1038%2Fcddis.2014.122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=24722280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmslWrt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1155&author=H.+Wangauthor=Q.+Wuauthor=Z.+Liuauthor=X.+Luoauthor=Y.+Fanauthor=Y.+Liuauthor=Y.+Zhangauthor=S.+Huaauthor=Q.+Fuauthor=M.+Zhaoauthor=Y.+Chenauthor=W.+Fangauthor=X.+Lv&title=Downregulation+of+FAP+suppresses+cell+proliferation+and+metastasis+through+PTEN%2FPI3K%2FAKT+and+Ras-ERK+signaling+in+oral+squamous+cell+carcinoma&doi=10.1038%2Fcddis.2014.122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma</span></div><div class="casAuthors">Wang, H.; Wu, Q.; Liu, Z.; Luo, X.; Fan, Y.; Liu, Y.; Zhang, Y.; Hua, S.; Fu, Q.; Zhao, M.; Chen, Y.; Fang, W.; Lv, X.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1155</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">It is largely recognized that fibroblast activation protein (FAP) is expressed in cancer-assocd. fibroblasts (CAFs) of many human carcinomas.  Furthermore, FAP was recently also reported to be expressed in carcinoma cells of the breast, stomach, pancreatic ductal adenocarcinoma, colorectum, and uterine cervix.  The carcinoma cell expression pattern of FAP has been described in several types of cancers, but the role of FAP in oral squamous cell carcinoma (OSCC) is unknown.  The role of endogenous FAP in epithelium-derived tumors and mol. mechanisms has also not been reported.  In this study, FAP was found to be expressed in carcinoma cells of OSCC and was upregulated in OSCC tissue samples compared with benign tissue samples using immunohistochem.  In addn., its expression level was closely correlated with overall survival of patients with OSCC.  Silencing FAP inhibited the growth and metastasis of OSCC cells in vitro and in vivo.  Mechanistically, knockdown of FAP inactivated PTEN/PI3K/AKT and Ras-ERK and its downstream signaling regulating proliferation, migration, and invasion in OSCC cells, as the inhibitory effects of FAP on the proliferation and metastasis could be rescued by PTEN silencing.  Our study suggests that FAP acts as an oncogene and may be a potential therapeutic target for patients with OSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs6rCzKYMH07Vg90H21EOLACvtfcHk0lj4mjbHoy6rsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmslWrt74%253D&md5=a707a92b74ab7b3396051cee1442b9ed</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.122%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DFu%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DW.%26aulast%3DLv%26aufirst%3DX.%26atitle%3DDownregulation%2520of%2520FAP%2520suppresses%2520cell%2520proliferation%2520and%2520metastasis%2520through%2520PTEN%252FPI3K%252FAKT%2520and%2520Ras-ERK%2520signaling%2520in%2520oral%2520squamous%2520cell%2520carcinoma%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1155%26doi%3D10.1038%2Fcddis.2014.122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ramirez-Montagut, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blachere, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sviderskaya, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, A. N.</span><span> </span><span class="NLM_article-title">FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5435</span><span class="NLM_x">–</span> <span class="NLM_lpage">5446</span><span class="refDoi"> DOI: 10.1038/sj.onc.1207730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1038%2Fsj.onc.1207730" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=5435-5446&author=T.+Ramirez-Montagutauthor=N.+E.+Blachereauthor=E.+V.+Sviderskayaauthor=D.+C.+Bennettauthor=W.+J.+Rettigauthor=P.+Garin-Chesaauthor=A.+N.+Houghton&title=FAPalpha%2C+a+surface+peptidase+expressed+during+wound+healing%2C+is+a+tumor+suppressor&doi=10.1038%2Fsj.onc.1207730"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207730%26sid%3Dliteratum%253Aachs%26aulast%3DRamirez-Montagut%26aufirst%3DT.%26aulast%3DBlachere%26aufirst%3DN.%2BE.%26aulast%3DSviderskaya%26aufirst%3DE.%2BV.%26aulast%3DBennett%26aufirst%3DD.%2BC.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DHoughton%26aufirst%3DA.%2BN.%26atitle%3DFAPalpha%252C%2520a%2520surface%2520peptidase%2520expressed%2520during%2520wound%2520healing%252C%2520is%2520a%2520tumor%2520suppressor%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D5435%26epage%3D5446%26doi%3D10.1038%2Fsj.onc.1207730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span> </span><span class="NLM_article-title">Ultrasensitive fluorescent probes reveal an adverse action of dipeptide peptidase IV and fibroblast activation protein during proliferation of cancer cells</span> <span class="citation_source-journal">Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">8309</span><span class="NLM_x">–</span> <span class="NLM_lpage">8314</span><span class="refDoi"> DOI: 10.1021/acs.analchem.6b02231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.analchem.6b02231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1WntLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2016&pages=8309-8314&author=Q.+Gongauthor=W.+Shiauthor=L.+Liauthor=X.+Wuauthor=H.+Ma&title=Ultrasensitive+fluorescent+probes+reveal+an+adverse+action+of+dipeptide+peptidase+IV+and+fibroblast+activation+protein+during+proliferation+of+cancer+cells&doi=10.1021%2Facs.analchem.6b02231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Ultrasensitive Fluorescent Probes Reveal an Adverse Action of Dipeptide Peptidase IV and Fibroblast Activation Protein during Proliferation of Cancer Cells</span></div><div class="casAuthors">Gong, Qiuyu; Shi, Wen; Li, Lihong; Wu, Xiaofeng; Ma, Huimin</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8309-8314</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dipeptide peptidase IV (DPPIV) and fibroblast activation protein (FAP) are isoenzymes.  Evidence shows that DPPIV is related to antitumor immunity, and FAP may be a drug target in cancer therapy, making it seem that the two enzymes might have a synergistic role during the proliferation of cancer cells.  Surprisingly, herein, the authors find an adverse action of DPPIV and FAP in the proliferation process by analyzing their changes with two tailor-made ultrasensitive fluorescent probes.  First, the up-regulation of DPPIV and down-regulation of FAP in cancer cells under the stimulation of genistein are detected.  Then, the authors find that MGC803 cells with a higher FAP but lower DPPIV level than SGC7901 cells exhibit a faster proliferation rate.  Importantly, inhibiting the DPPIV expression with siRNA increases the proliferation rate of MGC803 cells, whereas the FAP inhibition decreases the rate.  These findings suggest that the two enzymes play an adverse role during the proliferation of cancer cells, which provides the authors a new viewpoint for cancer studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUcJ3nvdooBbVg90H21EOLACvtfcHk0li88YBXjnnsLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1WntLjM&md5=a2384c3586884532b9d36364b3dd40ca</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.analchem.6b02231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.analchem.6b02231%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DH.%26atitle%3DUltrasensitive%2520fluorescent%2520probes%2520reveal%2520an%2520adverse%2520action%2520of%2520dipeptide%2520peptidase%2520IV%2520and%2520fibroblast%2520activation%2520protein%2520during%2520proliferation%2520of%2520cancer%2520cells%26jtitle%3DAnal.%2520Chem.%26date%3D2016%26volume%3D88%26spage%3D8309%26epage%3D8314%26doi%3D10.1021%2Facs.analchem.6b02231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Tulley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. T.</span><span> </span><span class="NLM_article-title">Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-beta signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">15280</span><span class="NLM_x">–</span> <span class="NLM_lpage">15296</span><span class="refDoi"> DOI: 10.1074/jbc.M114.568501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1074%2Fjbc.M114.568501" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=15280-15296&author=S.+Tulleyauthor=W.+T.+Chen&title=Transcriptional+regulation+of+seprase+in+invasive+melanoma+cells+by+transforming+growth+factor-beta+signaling&doi=10.1074%2Fjbc.M114.568501"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.568501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.568501%26sid%3Dliteratum%253Aachs%26aulast%3DTulley%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DW.%2BT.%26atitle%3DTranscriptional%2520regulation%2520of%2520seprase%2520in%2520invasive%2520melanoma%2520cells%2520by%2520transforming%2520growth%2520factor-beta%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D15280%26epage%3D15296%26doi%3D10.1074%2Fjbc.M114.568501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0116683</span><span class="refDoi"> DOI: 10.1371/journal.pone.0116683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1371%2Fjournal.pone.0116683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=25775399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1OisrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0116683&author=F.+Liuauthor=L.+Qiauthor=B.+Liuauthor=J.+Liuauthor=H.+Zhangauthor=D.+Cheauthor=J.+Caoauthor=J.+Shenauthor=J.+Gengauthor=Y.+Biauthor=L.+Yeauthor=B.+Panauthor=Y.+Yu&title=Fibroblast+activation+protein+overexpression+and+clinical+implications+in+solid+tumors%3A+a+meta-analysis&doi=10.1371%2Fjournal.pone.0116683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis</span></div><div class="casAuthors">Liu, Fang; Qi, Li; Liu, Bao; Liu, Jie; Zhang, Hua; Che, De Hai; Cao, Jing Yan; Shen, Jing; Geng, Jian Xiong; Bi, Yi; Ye, Lie Guang; Pan, Bo; Yu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e0116683/1-e0116683/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Objective: Fibroblast activation protein (FAP) plays a vital role in tumor invasion and metastasis.  Previous studies have reported its prognostic value in different tumors.  However, the results of these reports remain controversial.  In this study, a meta-anal. was performed to clarify this issue.  Methods: A search of the PubMed, Embase and CNKI databases was conducted to analyze relevant articles.  The outcomes included the relations between FAP expression and histol. differentiation, tumor invasion, lymph node metastasis, distant metastasis and overall survival (OS).  Sensitivity anal. by FAP expression in different cells and tumor types were further subjected to sensitivity analyses as subgroups.  Pooled odds ratios (ORs) and hazard ratios (HRs) were evaluated using the random-effects model.  Results: The global anal. included 15 studies concerning various solid tumors.  For global anal., FAP overexpression in tumor tissue displayed significant assocns. with poor OS and tumor progression (OS: HR = 2.18, P = 0.004; tumor invasion: OR = 4.48, P = 0.007; and lymph node metastasis: OR = 3.80, P = 0.004).  The subgroup analyses yielded two no-table results.  First, the relation between FAP overexpression and poor OS and tumor lymph node metastasis was closer in the patients with FAP expression in tumor cells.  Second, the pooled analyses of colorectal cancers or pancreatic cancers all indicated that FAP overexpression was assocd. with a detrimental OS (HR: 1.72, P = 0.009; HR: 3.18, P = 0.005, resp.).  The magnitude of this effect was not statistically significant compared with that in patients with non-colorectal cancers or non-pancreatic cancers.  These analyses did not display a statistically significant correlation between FAP expression and histol. differentiation and distant metastasis in all of the groups.  Conclusions: FAP expression is assocd. with worse prognosis in solid tumors, and this assocn. is particularly pronounced if FAP overexpression is found in the tumor cells rather than the stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBfoME4lxADLVg90H21EOLACvtfcHk0li88YBXjnnsLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1OisrrN&md5=8603b68f0f6496fdaa743941f8d5454e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0116683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0116683%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChe%26aufirst%3DD.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DJ.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DPan%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DY.%26atitle%3DFibroblast%2520activation%2520protein%2520overexpression%2520and%2520clinical%2520implications%2520in%2520solid%2520tumors%253A%2520a%2520meta-analysis%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0116683%26doi%3D10.1371%2Fjournal.pone.0116683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Acharya, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zukas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenstein, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pure, E.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis</span> <span class="citation_source-journal">Hum. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1016/j.humpath.2005.11.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2Fj.humpath.2005.11.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=16613331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVWgs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2006&pages=352-360&author=P.+S.+Acharyaauthor=A.+Zukasauthor=V.+Chandanauthor=A.+L.+Katzensteinauthor=E.+Pure&title=Fibroblast+activation+protein%3A+a+serine+protease+expressed+at+the+remodeling+interface+in+idiopathic+pulmonary+fibrosis&doi=10.1016%2Fj.humpath.2005.11.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Acharya, Pinak S.; Zukas, Alicia; Chandan, Vishal; Katzenstein, Anna-Luise A.; Pure, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Human Pathology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">352-360</span>CODEN:
                <span class="NLM_cas:coden">HPCQA4</span>;
        ISSN:<span class="NLM_cas:issn">0046-8177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Fibroblast activation protein (FAPα) is a member of the cell surface dipeptidyl peptidase (DPP) family of serine proteases.  In its dimer form, FAPα exhibits gelatinase, collagenase, and DPP activity in vitro.  Reactive fibroblasts in healing wounds and stromal fibroblasts assocd. with epithelial tumors express FAPα.  Idiopathic pulmonary fibrosis (IPF) is a disease of the lung characterized by progressive fibrosis with no clear etiol. or mol. marker for disease activity.  Recently, it has been shown that fibroblast FAPα expression is induced in liver cirrhosis, with an expression pattern distinct from alpha-smooth muscle actin (α-SMA).  In this study, we det. whether FAPα expression is selectively induced in areas of ongoing tissue remodeling characterized by fibroblast foci in IPF.  Human lung tissue was obtained from patients with IPF, centrilobular emphysema, and normal lung.  Immunohistochem. studies were performed using anti-FAPα antibody and antibodies against α-SMA and CD26 (DPPIV), another member of the DPP family.  We found that FAPα was not expressed in normal human lung tissue or tissue with evidence of centriacinar emphysema, but was induced in all patients with IPF and with a pattern distinct from that of CD26 found primarily on hyperplastic alveolar epithelium.  Specifically, FAPα was detected in fibroblast foci and in fibrotic interstitium and not in the interstitium of adjacent architecturally normal lung.  Alveolar/airway epithelium and vascular smooth muscle did not express FAPα.  This is the first report of FAPα expression in IPF and our results suggest that FAPα is selectively induced in fibrotic foci, but not in normal or emphysematous lung.  Future studies will address whether FAPα may be used as a marker for disease activity in IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAUc6hzUMix7Vg90H21EOLACvtfcHk0lhROyJOek6dwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVWgs7Y%253D&md5=ba036bf957422a280e73e40081daae30</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.humpath.2005.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.humpath.2005.11.020%26sid%3Dliteratum%253Aachs%26aulast%3DAcharya%26aufirst%3DP.%2BS.%26aulast%3DZukas%26aufirst%3DA.%26aulast%3DChandan%26aufirst%3DV.%26aulast%3DKatzenstein%26aufirst%3DA.%2BL.%26aulast%3DPure%26aufirst%3DE.%26atitle%3DFibroblast%2520activation%2520protein%253A%2520a%2520serine%2520protease%2520expressed%2520at%2520the%2520remodeling%2520interface%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DHum.%2520Pathol.%26date%3D2006%26volume%3D37%26spage%3D352%26epage%3D360%26doi%3D10.1016%2Fj.humpath.2005.11.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Levy, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1768</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span><span class="refDoi"> DOI: 10.1002/hep.510290631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1002%2Fhep.510290631" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1999&pages=1768-1778&author=M.+T.+Levyauthor=G.+W.+McCaughanauthor=C.+A.+Abbottauthor=J.+E.+Parkauthor=A.+M.+Cunninghamauthor=E.+Mullerauthor=W.+J.+Rettigauthor=M.+D.+Gorrell&title=Fibroblast+activation+protein%3A+a+cell+surface+dipeptidyl+peptidase+and+gelatinase+expressed+by+stellate+cells+at+the+tissue+remodelling+interface+in+human+cirrhosis&doi=10.1002%2Fhep.510290631"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fhep.510290631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.510290631%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DM.%2BT.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26aulast%3DAbbott%26aufirst%3DC.%2BA.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DCunningham%26aufirst%3DA.%2BM.%26aulast%3DMuller%26aufirst%3DE.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DFibroblast%2520activation%2520protein%253A%2520a%2520cell%2520surface%2520dipeptidyl%2520peptidase%2520and%2520gelatinase%2520expressed%2520by%2520stellate%2520cells%2520at%2520the%2520tissue%2520remodelling%2520interface%2520in%2520human%2520cirrhosis%26jtitle%3DHepatology%26date%3D1999%26volume%3D29%26spage%3D1768%26epage%3D1778%26doi%3D10.1002%2Fhep.510290631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Bauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jendro, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faccin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinges, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Ladner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">R171</span><span class="refDoi"> DOI: 10.1186/ar2080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1186%2Far2080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=17105646" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=R171&author=S.+Bauerauthor=M.+C.+Jendroauthor=A.+Wadleauthor=S.+Kleberauthor=F.+Stennerauthor=R.+Dinserauthor=A.+Reichauthor=E.+Faccinauthor=S.+Goddeauthor=H.+Dingesauthor=U.+Muller-Ladnerauthor=C.+Renner&title=Fibroblast+activation+protein+is+expressed+by+rheumatoid+myofibroblast-like+synoviocytes&doi=10.1186%2Far2080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2Far2080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far2080%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DJendro%26aufirst%3DM.%2BC.%26aulast%3DWadle%26aufirst%3DA.%26aulast%3DKleber%26aufirst%3DS.%26aulast%3DStenner%26aufirst%3DF.%26aulast%3DDinser%26aufirst%3DR.%26aulast%3DReich%26aufirst%3DA.%26aulast%3DFaccin%26aufirst%3DE.%26aulast%3DGodde%26aufirst%3DS.%26aulast%3DDinges%26aufirst%3DH.%26aulast%3DMuller-Ladner%26aufirst%3DU.%26aulast%3DRenner%26aufirst%3DC.%26atitle%3DFibroblast%2520activation%2520protein%2520is%2520expressed%2520by%2520rheumatoid%2520myofibroblast-like%2520synoviocytes%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2006%26volume%3D8%26spage%3DR171%26doi%3D10.1186%2Far2080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Tillmanns, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habbaba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitto, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraccarollo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galuppo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauersachs, J.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span><span class="refDoi"> DOI: 10.1016/j.yjmcc.2015.08.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2Fj.yjmcc.2015.08.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=26319660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeht7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2015&pages=194-203&author=J.+Tillmannsauthor=D.+Hoffmannauthor=Y.+Habbabaauthor=J.+D.+Schmittoauthor=D.+Seddingauthor=D.+Fraccarolloauthor=P.+Galuppoauthor=J.+Bauersachs&title=Fibroblast+activation+protein+alpha+expression+identifies+activated+fibroblasts+after+myocardial+infarction&doi=10.1016%2Fj.yjmcc.2015.08.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction</span></div><div class="casAuthors">Tillmanns, Jochen; Hoffmann, Daniel; Habbaba, Yasmin; Schmitto, Jan D.; Sedding, Daniel; Fraccarollo, Daniela; Galuppo, Paolo; Bauersachs, Johann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">194-203</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fibroblast activation protein α (FAP) is a membrane-bound serine protease expressed by activated fibroblasts during wound healing in the skin.  Expression of FAP after myocardial infarction (MI) and potential effects on cardiac wound healing are largely unknown.  MI was induced in rats and FAP expression was analyzed at 3, 7 and 28 days post-MI by microarray, Western blot and immunohistochem.  In human hearts after MI, a FAP+ fibroblast population was identified, and characterized by immunohistochem. for prolyl-4-hydroxylase β, α-smooth muscle actin, Thy-1 and vimentin.  Signaling pathways leading to FAP expression were studied in human cardiac fibroblasts by Western blot and ELISA using TGFβ1, TGF-beta type I-receptor (TGFbR1)-inhibitor SB431542 or the MAPK-inhibitor U0126 as well as siRNA targeting SMAD2 and SMAD3.  Finally, fibroblasts were assayed for FAP-dependent migration (modified Boyden-chamber), proliferation (BrdU-assay) and gelatinolytic activity by gelatin zymog.  In rats, FAP expression was increased after MI esp. in the peri-infarct area peaking at 7 days post-MI.  Co-localization anal. identified the majority of FAP+ cells as activated proto-myofibroblasts and myofibroblasts.  Concordantly, FAP+ fibroblasts were abundant in ischemic tissue of human hearts after MI, but not in healthy control hearts.  In vitro, FAP was induced by TGFβ1 via the canonical SMAD2/SMAD3 pathway.  Depletion of FAP in fibroblasts reduced migratory capacity, while proliferation was not affected.  Gelatin zymog. revealed gelatinase activity by fibroblast-derived FAP.  In this study, we show for the first time the expression of FAP in activated fibroblasts after MI and its activation by TGFβ1.  Effects of FAP on fibroblast migration and gelatinolytic activity indicate a potential role in cardiac wound healing and remodeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkduzibIcGTLVg90H21EOLACvtfcHk0lhROyJOek6dwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeht7zP&md5=979deaf019af45915ad8192b352a7b88</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2015.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2015.08.016%26sid%3Dliteratum%253Aachs%26aulast%3DTillmanns%26aufirst%3DJ.%26aulast%3DHoffmann%26aufirst%3DD.%26aulast%3DHabbaba%26aufirst%3DY.%26aulast%3DSchmitto%26aufirst%3DJ.%2BD.%26aulast%3DSedding%26aufirst%3DD.%26aulast%3DFraccarollo%26aufirst%3DD.%26aulast%3DGaluppo%26aufirst%3DP.%26aulast%3DBauersachs%26aufirst%3DJ.%26atitle%3DFibroblast%2520activation%2520protein%2520alpha%2520expression%2520identifies%2520activated%2520fibroblasts%2520after%2520myocardial%2520infarction%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2015%26volume%3D87%26spage%3D194%26epage%3D203%26doi%3D10.1016%2Fj.yjmcc.2015.08.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Brokopp, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmert, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winnik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aikawa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luscher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoerstrup, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, C. M.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2713</span><span class="NLM_x">–</span> <span class="NLM_lpage">2722</span><span class="refDoi"> DOI: 10.1093/eurheartj/ehq519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1093%2Feurheartj%2Fehq519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=21292680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGnu7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=2713-2722&author=C.+E.+Brokoppauthor=R.+Schoenauerauthor=P.+Richardsauthor=S.+Bauerauthor=C.+Lohmannauthor=M.+Y.+Emmertauthor=B.+Weberauthor=S.+Winnikauthor=E.+Aikawaauthor=K.+Gravesauthor=M.+Genoniauthor=P.+Vogtauthor=T.+F.+Luscherauthor=C.+Rennerauthor=S.+P.+Hoerstrupauthor=C.+M.+Matter&title=Fibroblast+activation+protein+is+induced+by+inflammation+and+degrades+type+I+collagen+in+thin-cap+fibroatheromata&doi=10.1093%2Feurheartj%2Fehq519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata</span></div><div class="casAuthors">Brokopp, Chad E.; Schoenauer, Roman; Richards, Peter; Bauer, Stefan; Lohmann, Christine; Emmert, Maximilian Y.; Weber, Benedikt; Winnik, Stephan; Aikawa, Elena; Graves, Kirk; Genoni, Michele; Vogt, Peter; Luescher, Thomas F.; Renner, Christoph; Hoerstrup, Simon P.; Matter, Christian M.</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2713-2722</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aims Collagen degrdn. in atherosclerotic plaques with thin fibrous caps renders them more prone to rupture.  Fibroblast activation protein (FAP) plays a role in arthritis and tumor formation through its collagenase activity.  However, the significance of FAP in thin-cap human fibroatheromata remains unknown.  Methods and results We detected enhanced FAP expression in type IV-V human aortic atheromata (n = 12), compared with type II-III lesions (n = 9; P < 0.01) and healthy aortae (n = 8; P < 0.01) by immunostaining and western blot analyses.  Fibroblast activation protein was also increased in thin-cap (<65 μm) vs. thick-cap (≥65 μm) human coronary fibroatheromata (n = 12; P < 0.01).  Fibroblast activation protein was expressed by human aortic smooth muscle cells (HASMC) as shown by colocalization on immunofluorescent aortic plaque stainings (n = 10; P < 0.01) and by flow cytometry in cell culture.  Although macrophages did not express FAP, macrophage burden in human aortic plaques correlated with FAP expression (n = 12; R2= 0.763; P < 0.05).  Enzyme-linked immunosorbent assays showed a time- and dose-dependent up-regulation of FAP in response to human tumor necrosis factor α (TNFα) in HASMC (n = 6; P < 0.01).  Moreover, supernatants from peripheral blood-derived macrophages induced FAP expression in cultured HASMC (n = 6; P < 0.01), an effect abolished by blocking TNFα (n = 6; P < 0.01).  Fibroblast activation protein assocd. with collagen-poor regions in human coronary fibrous caps and digested type I collagen and gelatin in vitro (n = 6; P < 0.01).  Zymog. revealed that FAP-mediated collagenase activity was neutralized by an antibody directed against the FAP catalytic domain both in HASMC (n = 6; P < 0.01) and in fibrous caps of atherosclerotic plaques (n = 10; P < 0.01).  Conclusion Fibroblast activation protein expression in HASMC is induced by macrophage-derived TNFα.  Fibroblast activation protein assocs. with thin-cap human coronary fibroatheromata and contributes to type I collagen breakdown in fibrous caps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4eDr7Cnj1c7Vg90H21EOLACvtfcHk0lhrEmnaXH9bwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGnu7nO&md5=585eb7eb395d15ac6c5bb83f625da5b6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehq519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehq519%26sid%3Dliteratum%253Aachs%26aulast%3DBrokopp%26aufirst%3DC.%2BE.%26aulast%3DSchoenauer%26aufirst%3DR.%26aulast%3DRichards%26aufirst%3DP.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DLohmann%26aufirst%3DC.%26aulast%3DEmmert%26aufirst%3DM.%2BY.%26aulast%3DWeber%26aufirst%3DB.%26aulast%3DWinnik%26aufirst%3DS.%26aulast%3DAikawa%26aufirst%3DE.%26aulast%3DGraves%26aufirst%3DK.%26aulast%3DGenoni%26aufirst%3DM.%26aulast%3DVogt%26aufirst%3DP.%26aulast%3DLuscher%26aufirst%3DT.%2BF.%26aulast%3DRenner%26aufirst%3DC.%26aulast%3DHoerstrup%26aufirst%3DS.%2BP.%26aulast%3DMatter%26aufirst%3DC.%2BM.%26atitle%3DFibroblast%2520activation%2520protein%2520is%2520induced%2520by%2520inflammation%2520and%2520degrades%2520type%2520I%2520collagen%2520in%2520thin-cap%2520fibroatheromata%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2011%26volume%3D32%26spage%3D2713%26epage%3D2722%26doi%3D10.1093%2Feurheartj%2Fehq519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Busek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrabal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fric, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedo, A.</span><span> </span><span class="NLM_article-title">Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets</span> <span class="citation_source-journal">Histochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1007/s00418-014-1292-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1007%2Fs00418-014-1292-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=25361590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVOltbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2015&pages=497-504&author=P.+Busekauthor=P.+Hrabalauthor=P.+Fricauthor=A.+Sedo&title=Co-expression+of+the+homologous+proteases+fibroblast+activation+protein+and+dipeptidyl+peptidase-IV+in+the+adult+human+Langerhans+islets&doi=10.1007%2Fs00418-014-1292-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets</span></div><div class="casAuthors">Busek, Petr; Hrabal, Petr; Fric, Premysl; Sedo, Aleksi</div><div class="citationInfo"><span class="NLM_cas:title">Histochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-504</span>CODEN:
                <span class="NLM_cas:coden">HCBIFP</span>;
        ISSN:<span class="NLM_cas:issn">0948-6143</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Fibroblast activation protein (FAP, seprase, EC 3.4.21.B28) and dipeptidyl peptidase-IV (DPP-IV, CD26, EC 3.4.14.5) are homologous serine proteases implicated in the modulation of the bioavailability and thus the function of a no. of biol. active peptides.  In spite of their generally nonoverlapping expression patterns, DPP-IV and FAP are co-expressed and probably co-regulated in certain cell types suggesting that for some biol. processes their functional synergy is essential.  By an in situ enzymic activity assay, we show an abundant DPP-IV-like enzymic activity sensitive to a highly specific DPP-IV inhibitor sitagliptin and corresponding DPP-IV immunoreactivity in the adult human islets of Langerhans.  Moreover, the homologous protease FAP was present in the human endocrine pancreas and was co-expressed with DPP-IV.  DPP-IV and FAP were found in the pancreatic alpha cells as detd. by the co-localization with glucagon immunoreactivity.  In summary, we show abundant enzymic activity of the canonical DPP-IV (CD26) in Langerhans islets in the natural tissue context and demonstrate for the first time the coexpression of FAP and DPP-IV in pancreatic alpha cells in adult humans.  Given their ability to proteolytically modify several biol. active peptides, both proteases have the potential to modulate the paracrine signaling in the human Langerhans islets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri_2GWz_Jng7Vg90H21EOLACvtfcHk0lhrEmnaXH9bwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVOltbnI&md5=f4e1a8e778f296a3af103a9e8594ea1b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs00418-014-1292-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00418-014-1292-0%26sid%3Dliteratum%253Aachs%26aulast%3DBusek%26aufirst%3DP.%26aulast%3DHrabal%26aufirst%3DP.%26aulast%3DFric%26aufirst%3DP.%26aulast%3DSedo%26aufirst%3DA.%26atitle%3DCo-expression%2520of%2520the%2520homologous%2520proteases%2520fibroblast%2520activation%2520protein%2520and%2520dipeptidyl%2520peptidase-IV%2520in%2520the%2520adult%2520human%2520Langerhans%2520islets%26jtitle%3DHistochem.%2520Cell%2520Biol.%26date%3D2015%26volume%3D143%26spage%3D497%26epage%3D504%26doi%3D10.1007%2Fs00418-014-1292-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bae, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeon, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span><span class="refDoi"> DOI: 10.1111/j.1365-2141.2008.07241.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1111%2Fj.1365-2141.2008.07241.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=18510677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWntrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2008&pages=827-830&author=S.+Baeauthor=C.+W.+Parkauthor=H.+K.+Sonauthor=H.+K.+Juauthor=D.+Paikauthor=C.+J.+Jeonauthor=G.+Y.+Kohauthor=J.+Kimauthor=H.+Kim&title=Fibroblast+activation+protein+alpha+identifies+mesenchymal+stromal+cells+from+human+bone+marrow&doi=10.1111%2Fj.1365-2141.2008.07241.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein α identifies mesenchymal stromal cells from human bone marrow</span></div><div class="casAuthors">Bae, Sohyun; Park, Chae Woon; Son, Hye Kyung; Ju, Hye Kyung; Paik, Donggi; Jeon, Choon-Ju; Koh, Gou Young; Kim, Jaeseob; Kim, Hoeon</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">827-830</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Mesenchymal stromal cells (MSCs) have gained widespread popularity in cell therapy, but their development into clin. products has been impeded by the scarcity of cell-specific markers.  We previously explored transcriptome and membrane proteome of MSCs, from which fibroblast activation protein α (FAP) was recognized as a prime surface marker candidate.  The present study showed that FAP was constitutively expressed on MSCs, but not on other cells.  FAP immunoselection yielded homogeneous MSCs from cryopreserved bone marrow (BM).  These results suggest that FAP serves as a surface protein marker that can singly define MSCs from BM and possibly from other sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomL8KTuYNoSrVg90H21EOLACvtfcHk0lhrEmnaXH9bwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWntrvK&md5=9df43578ca2dba65fe288a3e48c2e5ba</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2008.07241.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2008.07241.x%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DC.%2BW.%26aulast%3DSon%26aufirst%3DH.%2BK.%26aulast%3DJu%26aufirst%3DH.%2BK.%26aulast%3DPaik%26aufirst%3DD.%26aulast%3DJeon%26aufirst%3DC.%2BJ.%26aulast%3DKoh%26aufirst%3DG.%2BY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26atitle%3DFibroblast%2520activation%2520protein%2520alpha%2520identifies%2520mesenchymal%2520stromal%2520cells%2520from%2520human%2520bone%2520marrow%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2008%26volume%3D142%26spage%3D827%26epage%3D830%26doi%3D10.1111%2Fj.1365-2141.2008.07241.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Dolznig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweifer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraut, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerjaschki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span> </span><span class="NLM_article-title">Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin</span> <span class="citation_source-journal">Cancer Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=16076089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A280%3ADC%252BD2Mvht1KnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=10&author=H.+Dolznigauthor=N.+Schweiferauthor=C.+Puriauthor=N.+Krautauthor=W.+J.+Rettigauthor=D.+Kerjaschkiauthor=P.+Garin-Chesa&title=Characterization+of+cancer+stroma+markers%3A+in+silico+analysis+of+an+mRNA+expression+database+for+fibroblast+activation+protein+and+endosialin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin</span></div><div class="casAuthors">Dolznig Helmut; Schweifer Norbert; Puri Christina; Kraut Norbert; Rettig Wolfgang J; Kerjaschki Dontscho; Garin-Chesa Pilar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer immunity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Standardized, high-throughput RNA detection with microarray chips allows for the construction of genome-wide databases for tissue specimens suitable for in silico electronic Northern blot (eNorthern) analysis of marker genes.  We used the BioExpress database, which contains transcriptional profiles of normal and cancer samples, to examine two putative markers of cancer stroma: fibroblast activation protein-alpha (FAP-alpha) and endosialin.  Analyses for FAP-alpha showed that normal tissues generally lack RNA signals, with the exception of endometrium.  Typing of tumors revealed prominent FAP-alpha signals in cancer types marked by desmoplasia, and localization of FAP-alpha in reactive cancer stroma was confirmed by immunohistochemistry.  A subset of sarcomas displayed prominent FAP-alpha signals localizing to the malignant cells.  For endosialin, eNorthern analyses showed low to moderate RNA signals in many normal organs, whereas immunohistochemistry revealed endosialin in only some tissues, such as endometrium.  Endosialin was detected at the RNA and protein level in sarcomas, notably malignant fibrous histiocytomas.  Low to moderate endosialin RNA signals were found in epithelial cancer types for which immunostaining identifies expression in subsets of tumor capillaries or fibroblasts.  These findings extend the FAP-alpha and endosialin profiling in silico to an unbiased tumor database and place both molecules in a novel context of endometrial biology and sarcoma subtyping.  Our findings suggest that BioExpress can be searched directly for tumor stroma markers but may need prior enrichment for markers with narrow cellular representation, such as endosialin.  Constructing databases from microdissected cancer tissues may be an essential step for tumor stroma-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTflWDAUWKV8m52AMpI4GK2fW6udTcc2eYz8q62cdqjgbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mvht1KnsQ%253D%253D&md5=2577befe63148736651a743bcddc9425</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDolznig%26aufirst%3DH.%26aulast%3DSchweifer%26aufirst%3DN.%26aulast%3DPuri%26aufirst%3DC.%26aulast%3DKraut%26aufirst%3DN.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DKerjaschki%26aufirst%3DD.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26atitle%3DCharacterization%2520of%2520cancer%2520stroma%2520markers%253A%2520in%2520silico%2520analysis%2520of%2520an%2520mRNA%2520expression%2520database%2520for%2520fibroblast%2520activation%2520protein%2520and%2520endosialin%26jtitle%3DCancer%2520Immun.%26date%3D2005%26volume%3D5%26spage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Monsky, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. T.</span><span> </span><span class="NLM_article-title">A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5702</span><span class="NLM_x">–</span> <span class="NLM_lpage">5710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=7923219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFyit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=5702-5710&author=W.+L.+Monskyauthor=C.+Y.+Linauthor=A.+Aoyamaauthor=T.+Kellyauthor=S.+K.+Akiyamaauthor=S.+C.+Muellerauthor=W.+T.+Chen&title=A+potential+marker+protease+of+invasiveness%2C+seprase%2C+is+localized+on+invadopodia+of+human+malignant+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells</span></div><div class="casAuthors">Monsky, Wayne L.; Lin, Chen-Yong; Aoyama, Atsuko; Kelly, Thomas; Akiyama, Steven K.; Mueller, Susette C.; Chen, Wen-Tien</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5702-10</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Seprase, a large, gelatin-degrading membrane-protease complex, is expressed at the invasive front of malignant melanoma cells on invadopodia, and its surface expression contributes to the invasive phenotype.  An in vitro assay was used to det. the matrix-degrading activity of four malignant human melanoma cell lines.  The lines differ in matrix-degrading activity with LOX > RPMI7951 > A375 > SKMEL28 cells.  Expts. using anti-seprase monoclonal antibodies in conjunction with a cell fractionation technique indicate that seprase consists of Mr 97,000 polypeptides and is enriched on the ventral membrane of LOX in contact with planar extracellular matrix substratum.  Confocal microscopy further substantiates the authors biochem. findings that seprase, as well as gelatinase A, is localized on invadopodia membranes with a 6-fold increase of seprase and 4-fold increase of gelatinase A intensity over the level expressed on dorsal membranes.  In addn., LOX cells expressing higher levels of seprase at the cell surface, as selected by fluorescence-activated cell sorting, are significantly more degradative than LOX cells with lower seprase expression.  Taken together, the data show a concordance between seprase and gelatinase A expression on the cell surface at invadopodia and the matrix-degrading activity of human malignant melanoma cells.  Seprase and major secretion proteases may act in concert to degrade components of the extracellular matrix during invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJlUaNTR27E7Vg90H21EOLACvtfcHk0lg2cYUT5IVd3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFyit7g%253D&md5=a7e3297dd1ce3332f025dda66e55e749</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonsky%26aufirst%3DW.%2BL.%26aulast%3DLin%26aufirst%3DC.%2BY.%26aulast%3DAoyama%26aufirst%3DA.%26aulast%3DKelly%26aufirst%3DT.%26aulast%3DAkiyama%26aufirst%3DS.%2BK.%26aulast%3DMueller%26aufirst%3DS.%2BC.%26aulast%3DChen%26aufirst%3DW.%2BT.%26atitle%3DA%2520potential%2520marker%2520protease%2520of%2520invasiveness%252C%2520seprase%252C%2520is%2520localized%2520on%2520invadopodia%2520of%2520human%2520malignant%2520melanoma%2520cells%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D5702%26epage%3D5710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oettgen, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melamed, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span> </span><span class="NLM_article-title">Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">3110</span><span class="NLM_x">–</span> <span class="NLM_lpage">3114</span><span class="refDoi"> DOI: 10.1073/pnas.85.9.3110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1073%2Fpnas.85.9.3110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=2896356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADyaL1cXit1SjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=3110-3114&author=W.+J.+Rettigauthor=P.+Garin-Chesaauthor=H.+R.+Beresfordauthor=H.+F.+Oettgenauthor=M.+R.+Melamedauthor=L.+J.+Old&title=Cell-surface+glycoproteins+of+human+sarcomas%3A+differential+expression+in+normal+and+malignant+tissues+and+cultured+cells&doi=10.1073%2Fpnas.85.9.3110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-surface glycoproteins of human sarcomas:  differential expression in normal and malignant tissues and cultured cells</span></div><div class="casAuthors">Rettig, Wolfgang J.; Garin-Chesa, Pilar; Beresford, H. Richard; Oettgen, Herbert F.; Melamed, Myron R.; Old, Lloyd J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3110-14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Normal differentiation and malignant transformation of human cells are characterized by specific changes in surface antigen phenotype.  Six cell-surface antigens of human sarcomas and normal mesenchymal cells were defined by using mixed hemadsorption assays and immunochem. methods for the anal. of cultured cells and immunohistochem. staining for the anal. of normal tissues and >200 tumor specimens.  Differential patterns of F19 (mol. wt., Mr, 120,000/95,000 glycoprotein), F24 (Mr, 95,000 glycoprotein), G171 (Mr, 75,000 glycoprotein), G253 (Mr, 90,000 glycoprotein), S5 (Mr, 120,000 glycoprotein), and Thy-1 (Mr, 25,000 glycoprotein) antigen expression were found to characterize (i) subsets of cultured sarcoma cell lines, (ii) cultured fibroblasts derived from various organs, (iii) normal resting and activated mesenchymal tissues, and (i.v.) sarcoma and nonmesenchymal tumor tissues.  These results provide a basic surface antigenic map for cultured mesenchymal cells and mesenchymal tissues and permit the classification of human sarcomas according to their antigenic phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWS0L15oPgE7Vg90H21EOLACvtfcHk0lg2cYUT5IVd3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXit1SjsLw%253D&md5=8d8df4a9ca9253321afa52b44bc040c8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.85.9.3110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.85.9.3110%26sid%3Dliteratum%253Aachs%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DBeresford%26aufirst%3DH.%2BR.%26aulast%3DOettgen%26aufirst%3DH.%2BF.%26aulast%3DMelamed%26aufirst%3DM.%2BR.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26atitle%3DCell-surface%2520glycoproteins%2520of%2520human%2520sarcomas%253A%2520differential%2520expression%2520in%2520normal%2520and%2520malignant%2520tissues%2520and%2520cultured%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1988%26volume%3D85%26spage%3D3110%26epage%3D3114%26doi%3D10.1073%2Fpnas.85.9.3110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1397</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span><span class="refDoi"> DOI: 10.1182/blood-2005-08-3452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1182%2Fblood-2005-08-3452" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=1397-1404&author=K.+N.+Leeauthor=K.+W.+Jacksonauthor=V.+J.+Christiansenauthor=C.+S.+Leeauthor=J.+G.+Chunauthor=P.+A.+McKee&title=Antiplasmin-cleaving+enzyme+is+a+soluble+form+of+fibroblast+activation+protein&doi=10.1182%2Fblood-2005-08-3452"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-08-3452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-08-3452%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DChun%26aufirst%3DJ.%2BG.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DAntiplasmin-cleaving%2520enzyme%2520is%2520a%2520soluble%2520form%2520of%2520fibroblast%2520activation%2520protein%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D1397%26epage%3D1404%26doi%3D10.1182%2Fblood-2005-08-3452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Goldstein, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghersi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineiro-Sanchez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salamone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flessate, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. T.</span><span> </span><span class="NLM_article-title">Molecular cloning of seprase: a serine integral membrane protease from human melanoma</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1361</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1016/S0925-4439(97)00032-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2FS0925-4439%2897%2900032-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=9247085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtVKmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1361&publication_year=1997&pages=11-19&author=L.+A.+Goldsteinauthor=G.+Ghersiauthor=M.+L.+Pineiro-Sanchezauthor=M.+Salamoneauthor=Y.+Y.+Yehauthor=D.+Flessateauthor=W.+T.+Chen&title=Molecular+cloning+of+seprase%3A+a+serine+integral+membrane+protease+from+human+melanoma&doi=10.1016%2FS0925-4439%2897%2900032-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of seprase: a serine integral membrane protease from human melanoma</span></div><div class="casAuthors">Goldstein, Leslie A.; Ghersi, Giulio; Pineiro-Sanchez, Mayra L.; Salamone, Monica; Yeh, Yunyun; Flessate, Denise; Chen, Wen-Tien</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1361</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-19</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Seprase is a homodimeric 170 kDa integral membrane gelatinase whose expression correlates with the invasiveness of the human melanoma cell line LOX.  Here, we report the mol. cloning of a cDNA that encodes the 97 kDa subunit of seprase.  Its deduced amino acid sequence predicts a type II integral membrane protein with a cytoplasmic tail of 6 amino acids, followed by a transmembrane domain of 20 amino acids and an extracellular domain of 734 amino acids.  The carboxyl terminus contains a putative catalytic region (∼200 amino acids) which is homologous (68% identity) to that of the nonclassical serine protease dipeptidyl peptidase IV (DPPIV).  The conserved serine protease motif G-X-S-X-G is present as G-W-S-Y-G.  However, sequence anal. of seprase cDNA from LOX and other cell lines strongly suggests that seprase and human fibroblast activation protein α (FAPα) are products of the same gene.  We propose that seprase/FAPα and DPPIV represent a new subfamily of serine integral membrane proteases (SIMP).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh5KoilQf7-LVg90H21EOLACvtfcHk0ljMeF1Vzm2Gow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtVKmurc%253D&md5=f91d14e03f2a7265c8733bb6bd1dab98</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0925-4439%2897%2900032-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0925-4439%252897%252900032-X%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DL.%2BA.%26aulast%3DGhersi%26aufirst%3DG.%26aulast%3DPineiro-Sanchez%26aufirst%3DM.%2BL.%26aulast%3DSalamone%26aufirst%3DM.%26aulast%3DYeh%26aufirst%3DY.%2BY.%26aulast%3DFlessate%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DW.%2BT.%26atitle%3DMolecular%2520cloning%2520of%2520seprase%253A%2520a%2520serine%2520integral%2520membrane%2520protease%2520from%2520human%2520melanoma%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D1997%26volume%3D1361%26spage%3D11%26epage%3D19%26doi%3D10.1016%2FS0925-4439%2897%2900032-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Pineiro-Sanchez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. T.</span><span> </span><span class="NLM_article-title">Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">7595</span><span class="NLM_x">–</span> <span class="NLM_lpage">7601</span><span class="refDoi"> DOI: 10.1074/jbc.272.12.7595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1074%2Fjbc.272.12.7595" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=7595-7601&author=M.+L.+Pineiro-Sanchezauthor=L.+A.+Goldsteinauthor=J.+Dodtauthor=L.+Howardauthor=Y.+Yehauthor=W.+T.+Chen&title=Identification+of+the+170-kDa+melanoma+membrane-bound+gelatinase+%28seprase%29+as+a+serine+integral+membrane+protease&doi=10.1074%2Fjbc.272.12.7595"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.12.7595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.12.7595%26sid%3Dliteratum%253Aachs%26aulast%3DPineiro-Sanchez%26aufirst%3DM.%2BL.%26aulast%3DGoldstein%26aufirst%3DL.%2BA.%26aulast%3DDodt%26aufirst%3DJ.%26aulast%3DHoward%26aufirst%3DL.%26aulast%3DYeh%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%2BT.%26atitle%3DIdentification%2520of%2520the%2520170-kDa%2520melanoma%2520membrane-bound%2520gelatinase%2520%2528seprase%2529%2520as%2520a%2520serine%2520integral%2520membrane%2520protease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D7595%26epage%3D7601%26doi%3D10.1074%2Fjbc.272.12.7595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Edosada, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, B. B.</span><span> </span><span class="NLM_article-title">Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">7437</span><span class="NLM_x">–</span> <span class="NLM_lpage">7444</span><span class="refDoi"> DOI: 10.1074/jbc.M511112200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1074%2Fjbc.M511112200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7437-7444&author=C.+Y.+Edosadaauthor=C.+Quanauthor=C.+Wiesmannauthor=T.+Tranauthor=D.+Sutherlinauthor=M.+Reynoldsauthor=J.+M.+Elliottauthor=H.+Raabauthor=W.+Fairbrotherauthor=B.+B.+Wolf&title=Selective+inhibition+of+fibroblast+activation+protein+protease+based+on+dipeptide+substrate+specificity&doi=10.1074%2Fjbc.M511112200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M511112200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M511112200%26sid%3Dliteratum%253Aachs%26aulast%3DEdosada%26aufirst%3DC.%2BY.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%26aulast%3DReynolds%26aufirst%3DM.%26aulast%3DElliott%26aufirst%3DJ.%2BM.%26aulast%3DRaab%26aufirst%3DH.%26aulast%3DFairbrother%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DB.%2BB.%26atitle%3DSelective%2520inhibition%2520of%2520fibroblast%2520activation%2520protein%2520protease%2520based%2520on%2520dipeptide%2520substrate%2520specificity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7437%26epage%3D7444%26doi%3D10.1074%2Fjbc.M511112200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Lee, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco-Barraza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valianou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cukierman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span> </span><span class="NLM_article-title">FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="refDoi"> DOI: 10.1186/1471-2407-11-245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1186%2F1471-2407-11-245" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=245&author=H.+O.+Leeauthor=S.+R.+Mullinsauthor=J.+Franco-Barrazaauthor=M.+Valianouauthor=E.+Cukiermanauthor=J.+D.+Cheng&title=FAP-overexpressing+fibroblasts+produce+an+extracellular+matrix+that+enhances+invasive+velocity+and+directionality+of+pancreatic+cancer+cells&doi=10.1186%2F1471-2407-11-245"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-11-245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-11-245%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BO.%26aulast%3DMullins%26aufirst%3DS.%2BR.%26aulast%3DFranco-Barraza%26aufirst%3DJ.%26aulast%3DValianou%26aufirst%3DM.%26aulast%3DCukierman%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26atitle%3DFAP-overexpressing%2520fibroblasts%2520produce%2520an%2520extracellular%2520matrix%2520that%2520enhances%2520invasive%2520velocity%2520and%2520directionality%2520of%2520pancreatic%2520cancer%2520cells%26jtitle%3DBMC%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D245%26doi%3D10.1186%2F1471-2407-11-245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Yang, X. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, R.</span><span> </span><span class="NLM_article-title">FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">4124</span><span class="NLM_x">–</span> <span class="NLM_lpage">4135</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-2973</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1158%2F0008-5472.CAN-15-2973" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4124-4135&author=X.+G.+Yangauthor=Y.+L.+Linauthor=Y.+H.+Shiauthor=B.+J.+Liauthor=W.+R.+Liuauthor=W.+Yinauthor=Y.+J.+Dangauthor=Y.+W.+Chuauthor=J.+Fanauthor=R.+He&title=FAP+promotes+immunosuppression+by+cancer-associated+fibroblasts+in+the+tumor+microenvironment+via+STAT3-CCL2+signaling&doi=10.1158%2F0008-5472.CAN-15-2973"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-2973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-2973%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%2BG.%26aulast%3DLin%26aufirst%3DY.%2BL.%26aulast%3DShi%26aufirst%3DY.%2BH.%26aulast%3DLi%26aufirst%3DB.%2BJ.%26aulast%3DLiu%26aufirst%3DW.%2BR.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DDang%26aufirst%3DY.%2BJ.%26aulast%3DChu%26aufirst%3DY.%2BW.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DR.%26atitle%3DFAP%2520promotes%2520immunosuppression%2520by%2520cancer-associated%2520fibroblasts%2520in%2520the%2520tumor%2520microenvironment%2520via%2520STAT3-CCL2%2520signaling%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4124%26epage%3D4135%26doi%3D10.1158%2F0008-5472.CAN-15-2973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Narra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strzemkowski-Brun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magalong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mckee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egleston, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meropol, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span> </span><span class="NLM_article-title">Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1691</span><span class="NLM_x">–</span> <span class="NLM_lpage">1699</span><span class="refDoi"> DOI: 10.4161/cbt.6.11.4874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.4161%2Fcbt.6.11.4874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=18032930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1Whsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1691-1699&author=K.+Narraauthor=S.+R.+Mullinsauthor=H.+O.+Leeauthor=B.+Strzemkowski-Brunauthor=K.+Magalongauthor=V.+J.+Christiansenauthor=P.+A.+Mckeeauthor=B.+Eglestonauthor=S.+J.+Cohenauthor=L.+M.+Weinerauthor=N.+J.+Meropolauthor=J.+D.+Cheng&title=Phase+II+trial+of+single+agent+Val-boroPro+%28Talabostat%29+inhibiting+fibroblast+activation+protein+in+patients+with+metastatic+colorectal+cancer&doi=10.4161%2Fcbt.6.11.4874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer</span></div><div class="casAuthors">Narra, Kalyani; Mullins, Stefanie R.; Lee, Hyung-Ok; Strzemkowski-Brun, Brenda; Magalong, Kimberly; Christiansen, Victoria J.; McKee, Patrick A.; Egleston, Brian; Cohen, Steven J.; Weiner, Louis M.; Meropol, Neal J.; Cheng, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1691-1699</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Purpose: Fibroblost Activation Protein (FAP) is a tumor fibroblast protease that has been shown to potentiate colorectal cancer growth.  The clin. impact of FAP inhibition was tested using Val-boroPro (Talabostat), the first clin. inhibitor of FAP enzymic activity, in a phase II study of patients with metastatic colorectal cancer.  Methods: Patients with metastatic colorectal cancer who had previously received systemic chemotherapies were treated with single agent Val-boroPro 200 μg p.o. BID continuously.  Eligibility included measurable disease, performance status of 0 to 2, and adequate organ function.  Lab. correlates evaluated the pharmacodynamic effects of Val-boroPro on FAP enzymic function in the peripheral blood.  Results: Twenty-eight patients (median age 62; 12 males, 16 females) were enrolled in this study.  There were no objective responses.  Six of 28 (21%) patients had stable disease for a median of 25 wk (range 11-38 wk).  Lab. anal. demonstrated significant, although incomplete inhibition of FAP enzymic activity in the peripheral blood.  Conclusion: This phase II trial of Val-boroPro demonstrated minimal clin. activity in patients with previously treated metastatic colorectal cancer.  However it provides the initial proof-of-concept that physiol. inhibition of FAP activity can be accomplished in patients with colorectal cancer, and lays the groundwork for future studies targeting the tumor stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_1F424osEbVg90H21EOLACvtfcHk0ljnZ73LxfR5TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1Whsb8%253D&md5=7e69e1187b364d4c1ed43fef5d717c48</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.4161%2Fcbt.6.11.4874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.6.11.4874%26sid%3Dliteratum%253Aachs%26aulast%3DNarra%26aufirst%3DK.%26aulast%3DMullins%26aufirst%3DS.%2BR.%26aulast%3DLee%26aufirst%3DH.%2BO.%26aulast%3DStrzemkowski-Brun%26aufirst%3DB.%26aulast%3DMagalong%26aufirst%3DK.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DMckee%26aufirst%3DP.%2BA.%26aulast%3DEgleston%26aufirst%3DB.%26aulast%3DCohen%26aufirst%3DS.%2BJ.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DMeropol%26aufirst%3DN.%2BJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26atitle%3DPhase%2520II%2520trial%2520of%2520single%2520agent%2520Val-boroPro%2520%2528Talabostat%2529%2520inhibiting%2520fibroblast%2520activation%2520protein%2520in%2520patients%2520with%2520metastatic%2520colorectal%2520cancer%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1691%26epage%3D1699%26doi%3D10.4161%2Fcbt.6.11.4874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Hofheinz, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">al-Batran, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jager, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanswell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunz, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amelsberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuthan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, G.</span><span> </span><span class="NLM_article-title">Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer</span> <span class="citation_source-journal">Oncol. Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span><span class="refDoi"> DOI: 10.1159/000069863</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1159%2F000069863" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=44-48&author=R.+D.+Hofheinzauthor=S.+E.+al-Batranauthor=F.+Hartmannauthor=G.+Hartungauthor=D.+Jagerauthor=C.+Rennerauthor=P.+Tanswellauthor=U.+Kunzauthor=A.+Amelsbergauthor=H.+Kuthanauthor=G.+Stehle&title=Stromal+antigen+targeting+by+a+humanised+monoclonal+antibody%3A+an+early+phase+II+trial+of+sibrotuzumab+in+patients+with+metastatic+colorectal+cancer&doi=10.1159%2F000069863"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1159%2F000069863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000069863%26sid%3Dliteratum%253Aachs%26aulast%3DHofheinz%26aufirst%3DR.%2BD.%26aulast%3Dal-Batran%26aufirst%3DS.%2BE.%26aulast%3DHartmann%26aufirst%3DF.%26aulast%3DHartung%26aufirst%3DG.%26aulast%3DJager%26aufirst%3DD.%26aulast%3DRenner%26aufirst%3DC.%26aulast%3DTanswell%26aufirst%3DP.%26aulast%3DKunz%26aufirst%3DU.%26aulast%3DAmelsberg%26aufirst%3DA.%26aulast%3DKuthan%26aufirst%3DH.%26aulast%3DStehle%26aufirst%3DG.%26atitle%3DStromal%2520antigen%2520targeting%2520by%2520a%2520humanised%2520monoclonal%2520antibody%253A%2520an%2520early%2520phase%2520II%2520trial%2520of%2520sibrotuzumab%2520in%2520patients%2520with%2520metastatic%2520colorectal%2520cancer%26jtitle%3DOncol.%2520Res.%2520Treat.%26date%3D2003%26volume%3D26%26spage%3D44%26epage%3D48%26doi%3D10.1159%2F000069863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Sacha, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knedlik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tykvart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parolek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navratil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorakova, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedlak, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulbrich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strohalm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subr, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konvalinka, J.</span><span> </span><span class="NLM_article-title">iBodies: modular synthetic antibody mimetics based on hydrophilic polymers decorated with functional moieties</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2356</span><span class="NLM_x">–</span> <span class="NLM_lpage">2360</span><span class="refDoi"> DOI: 10.1002/anie.201508642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1002%2Fanie.201508642" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2356-2360&author=P.+Sachaauthor=T.+Knedlikauthor=J.+Schimerauthor=J.+Tykvartauthor=J.+Parolekauthor=V.+Navratilauthor=P.+Dvorakovaauthor=F.+Sedlakauthor=K.+Ulbrichauthor=J.+Strohalmauthor=P.+Majerauthor=V.+Subrauthor=J.+Konvalinka&title=iBodies%3A+modular+synthetic+antibody+mimetics+based+on+hydrophilic+polymers+decorated+with+functional+moieties&doi=10.1002%2Fanie.201508642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fanie.201508642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201508642%26sid%3Dliteratum%253Aachs%26aulast%3DSacha%26aufirst%3DP.%26aulast%3DKnedlik%26aufirst%3DT.%26aulast%3DSchimer%26aufirst%3DJ.%26aulast%3DTykvart%26aufirst%3DJ.%26aulast%3DParolek%26aufirst%3DJ.%26aulast%3DNavratil%26aufirst%3DV.%26aulast%3DDvorakova%26aufirst%3DP.%26aulast%3DSedlak%26aufirst%3DF.%26aulast%3DUlbrich%26aufirst%3DK.%26aulast%3DStrohalm%26aufirst%3DJ.%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DSubr%26aufirst%3DV.%26aulast%3DKonvalinka%26aufirst%3DJ.%26atitle%3DiBodies%253A%2520modular%2520synthetic%2520antibody%2520mimetics%2520based%2520on%2520hydrophilic%2520polymers%2520decorated%2520with%2520functional%2520moieties%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D2356%26epage%3D2360%26doi%3D10.1002%2Fanie.201508642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Ulbrich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hola, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subr, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakandritsos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zboril, R.</span><span> </span><span class="NLM_article-title">Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">5338</span><span class="NLM_x">–</span> <span class="NLM_lpage">5431</span><span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00589</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFCksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=5338-5431&author=K.+Ulbrichauthor=K.+Holaauthor=V.+Subrauthor=A.+Bakandritsosauthor=J.+Tucekauthor=R.+Zboril&title=Targeted+drug+delivery+with+polymers+and+magnetic+nanoparticles%3A+covalent+and+noncovalent+approaches%2C+release+control%2C+and+clinical+studies&doi=10.1021%2Facs.chemrev.5b00589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies</span></div><div class="casAuthors">Ulbrich, Karel; Hola, Katerina; Subr, Vladimir; Bakandritsos, Aristides; Tucek, Jiri; Zboril, Radek</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5338-5431</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeted delivery combined with controlled drug release has a pivotal role in the future of personalized medicine.  This review covers the principles, advantages, and drawbacks of passive and active targeting based on various polymer and magnetic iron oxide nanoparticle carriers with drug attached by both covalent and noncovalent pathways.  Attention is devoted to the tailored conjugation of targeting ligands (e.g., enzymes, antibodies, peptides) to drug carrier systems.  Similarly, the approaches toward controlled drug release are discussed.  Various polymer-drug conjugates based, for example, on polyethylene glycol (PEG), N-(2-hydroxypropyl)methacrylamide (HPMA), polymeric micelles, and nanoparticle carriers are explored with respect to absorption, distribution, metab., and excretion (ADME scheme) of administrated drug.  Design and structure of superparamagnetic iron oxide nanoparticles (SPION) and condensed magnetic clusters are classified according to the mechanism of noncovalent drug loading involving hydrophobic and electrostatic interactions, coordination chem., and encapsulation in porous materials.  Principles of covalent conjugation of drugs with SPIONs including thermo- and pH-degradable bonds, amide linkage, redox-cleavable bonds, and enzymically-cleavable bonds are also thoroughly described.  Finally, results of clin. trials obtained with polymeric and magnetic carriers are analyzed highlighting the potential advantages and future directions in targeted anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpswKKhXA_xLVg90H21EOLACvtfcHk0lhDxCsxG9Smgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFCksr8%253D&md5=7be43f31bde1e683328259580f9256b7</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00589%26sid%3Dliteratum%253Aachs%26aulast%3DUlbrich%26aufirst%3DK.%26aulast%3DHola%26aufirst%3DK.%26aulast%3DSubr%26aufirst%3DV.%26aulast%3DBakandritsos%26aufirst%3DA.%26aulast%3DTucek%26aufirst%3DJ.%26aulast%3DZboril%26aufirst%3DR.%26atitle%3DTargeted%2520drug%2520delivery%2520with%2520polymers%2520and%2520magnetic%2520nanoparticles%253A%2520covalent%2520and%2520noncovalent%2520approaches%252C%2520release%2520control%252C%2520and%2520clinical%2520studies%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D5338%26epage%3D5431%26doi%3D10.1021%2Facs.chemrev.5b00589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Dozono, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanazume, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etrych, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chytil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulbrich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikoma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, H.</span><span> </span><span class="NLM_article-title">HPMA copolymer-conjugated pirarubicin in multimodal treatment of a patient with stage IV prostate cancer and extensive lung and bone metastases</span> <span class="citation_source-journal">Targeted Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1007/s11523-015-0379-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1007%2Fs11523-015-0379-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=26194363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FkvVCrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=101-106&author=H.+Dozonoauthor=S.+Yanazumeauthor=H.+Nakamuraauthor=T.+Etrychauthor=P.+Chytilauthor=K.+Ulbrichauthor=J.+Fangauthor=T.+Arimuraauthor=T.+Douchiauthor=H.+Kobayashiauthor=M.+Ikomaauthor=H.+Maeda&title=HPMA+copolymer-conjugated+pirarubicin+in+multimodal+treatment+of+a+patient+with+stage+IV+prostate+cancer+and+extensive+lung+and+bone+metastases&doi=10.1007%2Fs11523-015-0379-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases</span></div><div class="casAuthors">Dozono Haruhiko; Yanazume Shintaro; Nakamura Hideaki; Fang Jun; Maeda Hiroshi; Etrych Tomas; Chytil Petr; Ulbrich Karel; Arimura Takeshi; Douchi Tsutomu; Kobayashi Hiroaki; Ikoma Michiaki</div><div class="citationInfo"><span class="NLM_cas:title">Targeted oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nanomedicine allows achievement of tumor-selective drug delivery because of the enhanced permeability and retention (EPR) effect of solid tumors.  We report here the first clinical application of a new agent-HPMA copolymer-conjugated pirarubicin (P-THP)-with a molecular size of about 8 nm, or 38.5 kDa.  A patient had advanced prostate cancer with multiple metastases in the lung, pelvis, femur, and perhaps the sacrum.  In April 2013, this 60-year-old patient started treatment with leuprorelin and estradiol, which continued until July 2014, but the patient became refractory to this treatment.  So the patient underwent proton beam radiotherapy targeted to the primary prostate cancer, and P-THP was administered for numerous metastatic tumor nodules concomitantly with radiotherapy.  This combination therapy had remarkable results, with complete remission of multiple metastases in the lung and bone.  The prostate-specific antigen (PSA) value was decreased from about 1000 ng/mL on April 30, 2013, to about 100 ng/mL on June 24, 2013, with hormone therapy, but rose again to 964.2 ng/mL and then to 1472 ng/mL in July 2013, during leuprorelin administration.  P-THP treatment administered concomitantly with proton beam irradiation was started in August 2013.  The PSA value was decreased to 102 ng/mL on August 26, 2013, and then to 0.971 ng/mL on October 8, 2013, and 0.277 ng/mL on January 15, 2015.  The P-THP doses ranged from 30 to 75 mg of free THP equivalent/patient every 2-3 weeks without signs of serious toxicity, such as cardiovascular side effects or a reduction in quality of life.  No evidence of relapse was found more than 20 months after P-THP administration.  This case demonstrates the value of hydrazone-bonded polymeric drugs in multimodal therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7bCEqB2N4nacY7HFp97qMfW6udTcc2ea2_zSswKwT_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FkvVCrsw%253D%253D&md5=022391d1fd43275b6a17d981a4cc9d94</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs11523-015-0379-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11523-015-0379-4%26sid%3Dliteratum%253Aachs%26aulast%3DDozono%26aufirst%3DH.%26aulast%3DYanazume%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DEtrych%26aufirst%3DT.%26aulast%3DChytil%26aufirst%3DP.%26aulast%3DUlbrich%26aufirst%3DK.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DArimura%26aufirst%3DT.%26aulast%3DDouchi%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DIkoma%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DH.%26atitle%3DHPMA%2520copolymer-conjugated%2520pirarubicin%2520in%2520multimodal%2520treatment%2520of%2520a%2520patient%2520with%2520stage%2520IV%2520prostate%2520cancer%2520and%2520extensive%2520lung%2520and%2520bone%2520metastases%26jtitle%3DTargeted%2520Oncol.%26date%3D2016%26volume%3D11%26spage%3D101%26epage%3D106%26doi%3D10.1007%2Fs11523-015-0379-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koziolova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chytil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukigawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haratake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulbrich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etrych, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, H.</span><span> </span><span class="NLM_article-title">Pronounced cellular uptake of pirarubicin versus that of other anthracyclines: comparison of HPMA copolymer conjugates of pirarubicin and doxorubicin</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">4106</span><span class="NLM_x">–</span> <span class="NLM_lpage">4115</span><span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.6b00697</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.6b00697" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2isrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=4106-4115&author=H.+Nakamuraauthor=E.+Koziolovaauthor=P.+Chytilauthor=K.+Tsukigawaauthor=J.+Fangauthor=M.+Haratakeauthor=K.+Ulbrichauthor=T.+Etrychauthor=H.+Maeda&title=Pronounced+cellular+uptake+of+pirarubicin+versus+that+of+other+anthracyclines%3A+comparison+of+HPMA+copolymer+conjugates+of+pirarubicin+and+doxorubicin&doi=10.1021%2Facs.molpharmaceut.6b00697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin</span></div><div class="casAuthors">Nakamura, Hideaki; Koziolova, Eva; Chytil, Petr; Tsukigawa, Kenji; Fang, Jun; Haratake, Mamoru; Ulbrich, Karel; Etrych, Tomas; Maeda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4106-4115</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Many conjugates of water-sol. polymers with biol. active mols. were developed during last two decades.  However, therapeutic effects of these conjugates now appear more heavily affected by the integrity, properties and mechanisms of action of the attached drugs (active pharmaceutical ingredients, APIs).  Pirarubicin (THP), a tetrahydropyranyl deriv. of doxorubicin (DOX), demonstrated more rapid cellular internalization and potent cytotoxicity than DOX.  Here, we conjugated the THP or DOX to N-(2-hydroxypropyl)methacrylamide copolymer via a hydrazone bond.  The polymeric prodrugs conjugates, abbr. P-THP and P-DOX, resp., had comparable hydrodynamic sizes and drug loading.  Compared with P-DOX, P-THP showed approx. 10 times greater cellular uptake during a 240-min incubation and a cytotoxicity that was more than 10 times higher during a 72-h incubation.  A marginal difference was seen in P-THP and P-DOX accumulation in the liver and kidney at 6 h after drug administration, but no significant difference occurred in the tumor drug concn. during 6-24 h after drug administration.  Antitumor activity against xenograft human pancreatic tumor (SUIT2) in mice was greater for P-THP than for P-DOX.  To sum up, the present study compared the biol. behavior of two different drugs, each attached to an HPMA copolymer carrier, with regard to their uptake by tumor cells, body distribution, and accumulation in tumors, cytotoxicity, and antitumor activity in vitro and in vivo.  No differences in the tumor cell uptake of the polymer-drug conjugates P-THP and P-DOX were obsd.  In contrast, the intracellular uptake of free THP liberated from the P-THP was 25-30 times higher than that of DOX liberated from P-DOX.  This finding indicates that proper selection of the carrier, and esp. conjugated API are most crit. for anticancer activity of the polymer-drug conjugates.  THP thus appears more preferable API for polymer conjugation and treatment based on EPR effect target to solid tumors, although both polymer conjugates exhibited similar enhanced permeability and retention (or EPR) effects and drug release profiles in acidic pH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogi7xZa7TkBrVg90H21EOLACvtfcHk0lhDxCsxG9Smgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2isrbM&md5=13191f071c15f1ca7882bc6eddb21467</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.6b00697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.6b00697%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DKoziolova%26aufirst%3DE.%26aulast%3DChytil%26aufirst%3DP.%26aulast%3DTsukigawa%26aufirst%3DK.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DHaratake%26aufirst%3DM.%26aulast%3DUlbrich%26aufirst%3DK.%26aulast%3DEtrych%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DH.%26atitle%3DPronounced%2520cellular%2520uptake%2520of%2520pirarubicin%2520versus%2520that%2520of%2520other%2520anthracyclines%253A%2520comparison%2520of%2520HPMA%2520copolymer%2520conjugates%2520of%2520pirarubicin%2520and%2520doxorubicin%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2016%26volume%3D13%26spage%3D4106%26epage%3D4115%26doi%3D10.1021%2Facs.molpharmaceut.6b00697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Marguet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baggio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drucker, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagtmann, N.</span><span> </span><span class="NLM_article-title">Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">6874</span><span class="NLM_x">–</span> <span class="NLM_lpage">6879</span><span class="refDoi"> DOI: 10.1073/pnas.120069197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1073%2Fpnas.120069197" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=6874-6879&author=D.+Marguetauthor=L.+Baggioauthor=T.+Kobayashiauthor=A.+M.+Bernardauthor=M.+Pierresauthor=P.+F.+Nielsenauthor=U.+Ribelauthor=T.+Watanabeauthor=D.+J.+Druckerauthor=N.+Wagtmann&title=Enhanced+insulin+secretion+and+improved+glucose+tolerance+in+mice+lacking+CD26&doi=10.1073%2Fpnas.120069197"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.120069197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.120069197%26sid%3Dliteratum%253Aachs%26aulast%3DMarguet%26aufirst%3DD.%26aulast%3DBaggio%26aufirst%3DL.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DBernard%26aufirst%3DA.%2BM.%26aulast%3DPierres%26aufirst%3DM.%26aulast%3DNielsen%26aufirst%3DP.%2BF.%26aulast%3DRibel%26aufirst%3DU.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26aulast%3DWagtmann%26aufirst%3DN.%26atitle%3DEnhanced%2520insulin%2520secretion%2520and%2520improved%2520glucose%2520tolerance%2520in%2520mice%2520lacking%2520CD26%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D6874%26epage%3D6879%26doi%3D10.1073%2Fpnas.120069197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Gorrell, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gysbers, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G. W.</span><span> </span><span class="NLM_article-title">CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes</span> <span class="citation_source-journal">Scand. J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span><span class="refDoi"> DOI: 10.1046/j.1365-3083.2001.00984.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1046%2Fj.1365-3083.2001.00984.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=11555388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1Sru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=249-264&author=M.+D.+Gorrellauthor=V.+Gysbersauthor=G.+W.+McCaughan&title=CD26%3A+a+multifunctional+integral+membrane+and+secreted+protein+of+activated+lymphocytes&doi=10.1046%2Fj.1365-3083.2001.00984.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes</span></div><div class="casAuthors">Gorrell, M. D.; Gysbers, V.; McCaughan, G. W.</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian Journal of Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-264</span>CODEN:
                <span class="NLM_cas:coden">SJIMAX</span>;
        ISSN:<span class="NLM_cas:issn">0300-9475</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review.  CD26 has proved interesting in the fields of immunol., endocrinol., cancer biol. and nutrition owing to its ubiquitous and unusual enzyme activity.  This dipeptidyl aminopeptidase (DPP IV) activity generally inactivates but sometimes alters or enhances the biol. activities of its peptide substrates, which include several chemokines.  CD26 costimulates both the CD3 and the CD2 dependent T-cell activation and tyrosine phosphorylation of TCR/CD3 signal transduction pathway proteins.  CD26 in vivo has integral membrane protein and sol. forms.  Sol. CD26 is at significant levels in serum, these levels alter in many diseases and sol. CD26 can modulate in vitro T-cell proliferation.  CD26, being an adenosine deaminase binding protein (ADAbp), functions as a receptor for ADA on lymphocytes.  The focus of this review is the structure and function of CD26 and the influence of its ligand binding activity on T-cell proliferation and the T cell costimulatory activity of CD26.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBV_U3MaLyFbVg90H21EOLACvtfcHk0lgkcGuguMbzpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1Sru7c%253D&md5=caa68f661699756a7cbce01dfe5c76e3</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-3083.2001.00984.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-3083.2001.00984.x%26sid%3Dliteratum%253Aachs%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26aulast%3DGysbers%26aufirst%3DV.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26atitle%3DCD26%253A%2520a%2520multifunctional%2520integral%2520membrane%2520and%2520secreted%2520protein%2520of%2520activated%2520lymphocytes%26jtitle%3DScand.%2520J.%2520Immunol.%26date%3D2001%26volume%3D54%26spage%3D249%26epage%3D264%26doi%3D10.1046%2Fj.1365-3083.2001.00984.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Beckenkamp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willig, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buffon, A.</span><span> </span><span class="NLM_article-title">DPPIV/CD26: a tumor suppressor or a marker of malignancy?</span> <span class="citation_source-journal">Tumor Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">7059</span><span class="NLM_x">–</span> <span class="NLM_lpage">7073</span><span class="refDoi"> DOI: 10.1007/s13277-016-5005-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1007%2Fs13277-016-5005-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=26943912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVOgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=7059-7073&author=A.+Beckenkampauthor=S.+Daviesauthor=J.+B.+Willigauthor=A.+Buffon&title=DPPIV%2FCD26%3A+a+tumor+suppressor+or+a+marker+of+malignancy%3F&doi=10.1007%2Fs13277-016-5005-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">DPPIV/CD26: a tumor suppressor or a marker of malignancy?</span></div><div class="casAuthors">Beckenkamp, Aline; Davies, Samuel; Willig, Julia Biz; Buffon, Andreia</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">7059-7073</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPPIV/CD26) is a multifunctional protein with intrinsic peptidase activity that inactivates or degrades some bioactive peptides.  It is the main cellular binding protein for ecto-adenosine deaminase and interacts with extracellular matrix proteins, besides participating in different signaling pathways.  Due to these multiple functions, DPPIV/CD26 has been shown to be closely related to the tumor process.  It has been reported that the progression of certain types of cancer is accompanied by a decrease in DPPIV/CD26 expression, and studies have shown that the malignant phenotype can be reverted when DPPIV/CD26 expression is induced in these cancer cells, characterizing this protein as a tumor suppressor.  On the other hand, DPPIV/CD26 was described as a protein assocd. with invasion and metastatic spread, characterizing it as a marker of malignancy.  Thus, this review explores the roles of DPPIV/CD26 expression in tumor progression in different types of cancer and demonstrates the importance of this protein as a promising therapeutic target and tumor biomarker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVyW6NKjRBgrVg90H21EOLACvtfcHk0lgkcGuguMbzpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVOgt74%253D&md5=9cd4e1691d7956b0621967222d71ce4a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs13277-016-5005-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-016-5005-2%26sid%3Dliteratum%253Aachs%26aulast%3DBeckenkamp%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DS.%26aulast%3DWillig%26aufirst%3DJ.%2BB.%26aulast%3DBuffon%26aufirst%3DA.%26atitle%3DDPPIV%252FCD26%253A%2520a%2520tumor%2520suppressor%2520or%2520a%2520marker%2520of%2520malignancy%253F%26jtitle%3DTumor%2520Biol.%26date%3D2016%26volume%3D37%26spage%3D7059%26epage%3D7073%26doi%3D10.1007%2Fs13277-016-5005-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heirbaut, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryabtsova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1021/ml300410d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300410d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=491-496&author=K.+Jansenauthor=L.+Heirbautauthor=J.+D.+Chengauthor=J.+Joossensauthor=O.+Ryabtsovaauthor=P.+Cosauthor=L.+Maesauthor=A.+M.+Lambeirauthor=I.+De+Meesterauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Selective+inhibitors+of+fibroblast+activation+protein+%28FAP%29+with+a+%284-quinolinoyl%29-glycyl-2-cyanopyrrolidine+scaffold&doi=10.1021%2Fml300410d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold</span></div><div class="casAuthors">Jansen, Koen; Heirbaut, Leen; Cheng, Jonathan D.; Joossens, Jurgen; Ryabtsova, Oxana; Cos, Paul; Maes, Louis; Lambeir, Anne-Marie; De Meester, Ingrid; Augustyns, Koen; Van der Veken, Pieter</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-496</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fibroblast activation protein (FAP) is a serine protease that is generally accepted to play an important role in tumor growth and other diseases involving tissue remodeling.  Currently there are no FAP inhibitors with reported selectivity toward both the closely related dipeptidyl peptidases (DPPs) and prolyl oligopeptidase (PREP).  We present the discovery of a new class of FAP inhibitors with a N-(4-quinolinoyl)-Gly-(2-cyanopyrrolidine) scaffold, e.g. I.  We have explored the effects of substituting the quinoline ring and varying the position of its sp2 hybridized nitrogen atom.  The most promising inhibitors combined low nanomolar FAP inhibition and high selectivity indexes (>103) with respect to both the DPPs and PREP.  Preliminary expts. on a representative inhibitor demonstrate that plasma stability, kinetic soly., and log D of this class of compds. can be expected to be satisfactory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7f0rayraCQLVg90H21EOLACvtfcHk0lgkcGuguMbzpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKnsLs%253D&md5=1836427e531f6e13264ca833613966dc</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fml300410d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300410d%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DHeirbaut%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DRyabtsova%26aufirst%3DO.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DSelective%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%2520with%2520a%2520%25284-quinolinoyl%2529-glycyl-2-cyanopyrrolidine%2520scaffold%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D491%26epage%3D496%26doi%3D10.1021%2Fml300410d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heirbaut, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkerk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Extended structure activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycy1–2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3053</span><span class="NLM_x">–</span> <span class="NLM_lpage">3074</span><span class="refDoi"> DOI: 10.1021/jm500031w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500031w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3053-3074&author=K.+Jansenauthor=L.+Heirbautauthor=R.+Verkerkauthor=J.+D.+Chengauthor=J.+Joossensauthor=P.+Cosauthor=L.+Maesauthor=A.+M.+Lambeirauthor=I.+De+Meesterauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Extended+structure+activity+relationship+and+pharmacokinetic+investigation+of+%284-quinolinoyl%29glycy1%E2%80%932-cyanopyrrolidine+inhibitors+of+fibroblast+activation+protein+%28FAP%29&doi=10.1021%2Fjm500031w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm500031w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500031w%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DHeirbaut%26aufirst%3DL.%26aulast%3DVerkerk%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DExtended%2520structure%2520activity%2520relationship%2520and%2520pharmacokinetic%2520investigation%2520of%2520%25284-quinolinoyl%2529glycy1%25E2%2580%25932-cyanopyrrolidine%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3053%26epage%3D3074%26doi%3D10.1021%2Fjm500031w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Ryabtsova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goethem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3412</span><span class="NLM_x">–</span> <span class="NLM_lpage">3417</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.03.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2Fj.bmcl.2012.03.107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=22525314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFait7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3412-3417&author=O.+Ryabtsovaauthor=K.+Jansenauthor=S.+Van+Goethemauthor=J.+Joossensauthor=J.+D.+Chengauthor=A.+M.+Lambeirauthor=I.+De+Meesterauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Acylated+Gly-%282-cyano%29pyrrolidines+as+inhibitors+of+fibroblast+activation+protein+%28FAP%29+and+the+issue+of+FAP%2Fprolyl+oligopeptidase+%28PREP%29-selectivity&doi=10.1016%2Fj.bmcl.2012.03.107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity</span></div><div class="casAuthors">Ryabtsova, Oxana; Jansen, Koen; Van Goethem, Sebastiaan; Joossens, Jurgen; Cheng, Jonathan D.; Lambeir, Anne-Marie; De Meester, Ingrid; Augustyns, Koen; Van der Veken, Pieter</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3412-3417</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of N-acylated glycyl-(2-cyano)pyrrolidines were synthesized with the aim of generating structure-activity relationship (SAR) data for this class of compds. as inhibitors of fibroblast activation protein (FAP).  Specifically, the influence of (1) the choice of the N-acyl group and (2) structural modification of the 2-cyanopyrrolidine residue were investigated.  The inhibitors displayed inhibitory potency in the micromolar to nanomolar range and showed good to excellent selectivity with respect to the proline selective dipeptidyl peptidases (DPPs) DPP IV, DPP9 and DPP II.  Addnl., selectivity for FAP with respect to prolyl oligopeptidase (PREP) is reported.  Not unexpectedly, the latter data suggest significant overlap in the pharmacophoric features that define FAP or PREP-inhibitory activity and underscore the importance of systematically evaluating the FAP/PREP-selectivity index for inhibitors of either of these two enzymes.  Finally, this study forwards several compds. that can serve as leads or prototypic structures for future FAP-selective-inhibitor discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVTMe5wzszb7Vg90H21EOLACvtfcHk0lioa1dId5dgEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFait7k%253D&md5=0191b3cbe44c893935a33e13f62e4289</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.03.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.03.107%26sid%3Dliteratum%253Aachs%26aulast%3DRyabtsova%26aufirst%3DO.%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DVan%2BGoethem%26aufirst%3DS.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DAcylated%2520Gly-%25282-cyano%2529pyrrolidines%2520as%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%2520and%2520the%2520issue%2520of%2520FAP%252Fprolyl%2520oligopeptidase%2520%2528PREP%2529-selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3412%26epage%3D3417%26doi%3D10.1016%2Fj.bmcl.2012.03.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polverino, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bready, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMelfi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPietro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neervannan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roveto, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrag, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanon, R.</span><span> </span><span class="NLM_article-title">Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1649</span><span class="NLM_x">–</span> <span class="NLM_lpage">1667</span><span class="refDoi"> DOI: 10.1021/jm701097z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701097z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1649-1667&author=J.+C.+Harmangeauthor=M.+M.+Weissauthor=J.+Germainauthor=A.+J.+Polverinoauthor=G.+Borgauthor=J.+Breadyauthor=D.+Chenauthor=D.+Choquetteauthor=A.+Coxonauthor=T.+DeMelfiauthor=L.+DiPietroauthor=N.+Doerrauthor=J.+Estradaauthor=J.+Flynnauthor=R.+F.+Graceffaauthor=S.+P.+Harrimanauthor=S.+Kaufmanauthor=D.+S.+Laauthor=A.+Longauthor=M.+W.+Martinauthor=S.+Neervannanauthor=V.+F.+Patelauthor=M.+Potashmanauthor=K.+Regalauthor=P.+M.+Rovetoauthor=M.+L.+Schragauthor=C.+Starnesauthor=A.+Taskerauthor=Y.+Tefferaauthor=L.+Wangauthor=R.+D.+Whiteauthor=D.+A.+Whittingtonauthor=R.+Zanon&title=Naphthamides+as+novel+and+potent+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitors%3A+design%2C+synthesis%2C+and+evaluations&doi=10.1021%2Fjm701097z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm701097z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701097z%26sid%3Dliteratum%253Aachs%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DGermain%26aufirst%3DJ.%26aulast%3DPolverino%26aufirst%3DA.%2BJ.%26aulast%3DBorg%26aufirst%3DG.%26aulast%3DBready%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDeMelfi%26aufirst%3DT.%26aulast%3DDiPietro%26aufirst%3DL.%26aulast%3DDoerr%26aufirst%3DN.%26aulast%3DEstrada%26aufirst%3DJ.%26aulast%3DFlynn%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLong%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNeervannan%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPotashman%26aufirst%3DM.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DRoveto%26aufirst%3DP.%2BM.%26aulast%3DSchrag%26aufirst%3DM.%2BL.%26aulast%3DStarnes%26aufirst%3DC.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZanon%26aufirst%3DR.%26atitle%3DNaphthamides%2520as%2520novel%2520and%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%253A%2520design%252C%2520synthesis%252C%2520and%2520evaluations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1649%26epage%3D1667%26doi%3D10.1021%2Fjm701097z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Tykvart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacha, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knedlik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starkova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubkowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konvalinka, J.</span><span> </span><span class="NLM_article-title">Efficient and versatile one-step affinity purification of in vivo biotinylated proteins: expression, characterization and structure analysis of recombinant human glutamate carboxypeptidase II</span> <span class="citation_source-journal">Protein Expression Purif.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span><span class="refDoi"> DOI: 10.1016/j.pep.2011.11.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2Fj.pep.2011.11.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=22178733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFWgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=106-115&author=J.+Tykvartauthor=P.+Sachaauthor=C.+Barinkaauthor=T.+Knedlikauthor=J.+Starkovaauthor=J.+Lubkowskiauthor=J.+Konvalinka&title=Efficient+and+versatile+one-step+affinity+purification+of+in+vivo+biotinylated+proteins%3A+expression%2C+characterization+and+structure+analysis+of+recombinant+human+glutamate+carboxypeptidase+II&doi=10.1016%2Fj.pep.2011.11.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and versatile one-step affinity purification of in vivo biotinylated proteins: Expression, characterization and structure analysis of recombinant human glutamate carboxypeptidase II</span></div><div class="casAuthors">Tykvart, J.; Sacha, P.; Barinka, C.; Knedlik, T.; Starkova, J.; Lubkowski, J.; Konvalinka, J.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-115</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Affinity purifn. is a useful approach for purifn. of recombinant proteins.  Eukaryotic expression systems have become more frequently used at the expense of prokaryotic systems since they afford recombinant eukaryotic proteins with post-translational modifications similar or identical to the native ones.  Here, a one-step affinity purifn. set-up suitable for the purifn. of secreted proteins is presented.  The set-up is based on the interaction between biotin and mutated streptavidin.  Drosophila Schneider 2 cells are chosen as the expression host, and a biotin acceptor peptide is used as an affinity tag.  This tag is biotinylated by Escherichia coli biotin-protein ligase in vivo.  It was detd. that localization of the ligase within the ER led to the most effective in vivo biotinylation of the secreted proteins.  A protocol was optimized for large-scale expression and purifn. of AviTEV-tagged recombinant human glutamate carboxypeptidase II (Avi-GCPII) with milligram yields per L of culture.  The 3D structure of Avi-GCPII was also detd. by X-ray crystallog. and the enzymic characteristics of the protein were compared to those of its non-tagged variant.  These expts. confirmed that AviTEV tag does not affect the biophys. properties of its fused partner.  The purifn. approach, developed here, provides not only a sufficient amt. of highly homogeneous protein but also specifically and effectively biotinylates a target protein and thus enables its subsequent visualization or immobilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo57Mui9FOUXbVg90H21EOLACvtfcHk0lioa1dId5dgEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFWgs7c%253D&md5=d731679432bae009c380ace62a6d3893</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2011.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2011.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DTykvart%26aufirst%3DJ.%26aulast%3DSacha%26aufirst%3DP.%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DKnedlik%26aufirst%3DT.%26aulast%3DStarkova%26aufirst%3DJ.%26aulast%3DLubkowski%26aufirst%3DJ.%26aulast%3DKonvalinka%26aufirst%3DJ.%26atitle%3DEfficient%2520and%2520versatile%2520one-step%2520affinity%2520purification%2520of%2520in%2520vivo%2520biotinylated%2520proteins%253A%2520expression%252C%2520characterization%2520and%2520structure%2520analysis%2520of%2520recombinant%2520human%2520glutamate%2520carboxypeptidase%2520II%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2012%26volume%3D82%26spage%3D106%26epage%3D115%26doi%3D10.1016%2Fj.pep.2011.11.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptacek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novakova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morath, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerra, A.</span><span> </span><span class="NLM_article-title">Selection and characterization of anticalins targeting human prostate-specific membrane antigen (PSMA)</span> <span class="citation_source-journal">Protein Eng., Des. Sel.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span><span class="refDoi"> DOI: 10.1093/protein/gzv065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1093%2Fprotein%2Fgzv065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=26802163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWksrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=105-115&author=C.+Barinkaauthor=J.+Ptacekauthor=A.+Richterauthor=Z.+Novakovaauthor=V.+Morathauthor=A.+Skerra&title=Selection+and+characterization+of+anticalins+targeting+human+prostate-specific+membrane+antigen+%28PSMA%29&doi=10.1093%2Fprotein%2Fgzv065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA)</span></div><div class="casAuthors">Barinka, Cyril; Ptacek, Jakub; Richter, Antonia; Novakova, Zora; Morath, Volker; Skerra, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Protein Engineering, Design & Selection</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">105-115</span>CODEN:
                <span class="NLM_cas:coden">PEDSBR</span>;
        ISSN:<span class="NLM_cas:issn">1741-0126</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Although prostate carcinoma (PCa) is by far the most commonly diagnosed neoplasia in men, corresponding diagnostic and therapeutic modalities have limited efficacy at present.  Anticalins comprise a novel class of binding proteins based on a non-Ig scaffold that can be engineered to specifically address mol. targets of interest.  Here we report the selection and characterization of Anticalins that recognize human prostate-specific membrane antigen (PSMA), a membrane-tethered metallopeptidase constituting a disease-related target for imaging and therapy of PCa as well as solid malignancies in general.  We used a randomized lipocalin library based on the human lipocalin 2 (Lcn2) scaffold together with phage display and ELISA screening to select PSMAspecific variants.  Five Anticalin candidates from the original panning were expressed in Escherichia coli as sol. monomeric proteins, revealing affinities toward PSMA down to the low nanomolar range.  Binding characteristics of the most promising candidate were further improved via affinity maturation by applying error-prone PCR followed by selection via phage display as well as bacterial surface display under more stringent conditions.  In BIAcore measurements, the dissocn. const. of the best Anticalin was detd. as ∼500 pM, with a substantially improved dissocn. rate compared with the first-generation candidate.  Finally, immunofluorescence microscopy revealed specific staining of PSMA-pos. tumor cell lines while flowcytometric anal. confirmed the ability of the selected Anticalins to detect PSMA on live cells.  Taken together, Anticalins resulting from this study offer a viable alternative to antibody-based PSMA binders for biomedical applications, including in vivo imaging of PCa or neovasculature of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVLK_TRsl547Vg90H21EOLACvtfcHk0lhLvngdEvzFow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWksrjP&md5=48e019568dbfa30dc1d829bf1cc7e8cb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fprotein%2Fgzv065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fprotein%252Fgzv065%26sid%3Dliteratum%253Aachs%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DPtacek%26aufirst%3DJ.%26aulast%3DRichter%26aufirst%3DA.%26aulast%3DNovakova%26aufirst%3DZ.%26aulast%3DMorath%26aufirst%3DV.%26aulast%3DSkerra%26aufirst%3DA.%26atitle%3DSelection%2520and%2520characterization%2520of%2520anticalins%2520targeting%2520human%2520prostate-specific%2520membrane%2520antigen%2520%2528PSMA%2529%26jtitle%3DProtein%2520Eng.%252C%2520Des.%2520Sel.%26date%3D2016%26volume%3D29%26spage%3D105%26epage%3D115%26doi%3D10.1093%2Fprotein%2Fgzv065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Balaziova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stremenova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sromova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krepela, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lizcova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedo, A.</span><span> </span><span class="NLM_article-title">Coupled expression of dipeptidyl peptidase-IV and fibroblast activation protein-alpha in transformed astrocytic cells</span> <span class="citation_source-journal">Mol. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span><span class="refDoi"> DOI: 10.1007/s11010-011-0828-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1007%2Fs11010-011-0828-z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2011&pages=283-289&author=E.+Balaziovaauthor=P.+Busekauthor=J.+Stremenovaauthor=L.+Sromovaauthor=E.+Krepelaauthor=L.+Lizcovaauthor=A.+Sedo&title=Coupled+expression+of+dipeptidyl+peptidase-IV+and+fibroblast+activation+protein-alpha+in+transformed+astrocytic+cells&doi=10.1007%2Fs11010-011-0828-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs11010-011-0828-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-011-0828-z%26sid%3Dliteratum%253Aachs%26aulast%3DBalaziova%26aufirst%3DE.%26aulast%3DBusek%26aufirst%3DP.%26aulast%3DStremenova%26aufirst%3DJ.%26aulast%3DSromova%26aufirst%3DL.%26aulast%3DKrepela%26aufirst%3DE.%26aulast%3DLizcova%26aufirst%3DL.%26aulast%3DSedo%26aufirst%3DA.%26atitle%3DCoupled%2520expression%2520of%2520dipeptidyl%2520peptidase-IV%2520and%2520fibroblast%2520activation%2520protein-alpha%2520in%2520transformed%2520astrocytic%2520cells%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2011%26volume%3D354%26spage%3D283%26epage%3D289%26doi%3D10.1007%2Fs11010-011-0828-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Kelly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simms, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazur, A.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein-alpha: a key modulator of the microenvironment in multiple pathologies</span> <span class="citation_source-journal">Int. Rev. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span><span class="refDoi"> DOI: 10.1016/B978-0-12-394308-8.00003-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1016%2FB978-0-12-394308-8.00003-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=22608558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKgtbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2012&pages=83-116&author=T.+Kellyauthor=Y.+Huangauthor=A.+E.+Simmsauthor=A.+Mazur&title=Fibroblast+activation+protein-alpha%3A+a+key+modulator+of+the+microenvironment+in+multiple+pathologies&doi=10.1016%2FB978-0-12-394308-8.00003-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies</span></div><div class="casAuthors">Kelly, Thomas; Huang, Yan; Simms, Avis E.; Mazur, Anna</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-116</span>CODEN:
                <span class="NLM_cas:coden">IRCMAH</span>;
        ISSN:<span class="NLM_cas:issn">1937-6448</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Fibroblast activation protein-α (FAP) is a serine protease that can provide target specificity to therapeutic agents because in adults its expression is restricted to pathol. sites, including cancer, fibrosis, arthritis, wounding, or inflammation.  It is not expressed in most normal tissues.  The majority of FAP is expressed by activated fibroblasts responding to the pathol. situations.  FAP is typically found as a type II transmembrane protein phys. attached to cells and with the bulk of the protein, including the catalytic domain, exposed to the extracellular space and accessible to small mols.  In this chapter, we review the structure, substrate specificities, signaling functions, and current design of FAP inhibitors.  Evidence indicating the presence of FAP in multiple cancers, arthritis, fibrosis, keloids, and other pathologies is described and indicates possible roles for FAP in facilitating cell invasion and growth.  Sep. sections are devoted to the role of FAP in coordinating the stromal response to cancer, including a role in angiogenesis and a potential role in modulation of the antitumor immune response.  Finally studies attempting to demonstrate the clin. potential of FAP are discussed, as well as some novel applications employing FAP in therapy or diagnosis.  Throughout this review, effort is made to highlight areas where information is lacking and to highlight important questions that require further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl6m1rj-1CzLVg90H21EOLACvtfcHk0lhLvngdEvzFow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKgtbjL&md5=e21de80d77e6b473d8c6fc3d17156a36</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-394308-8.00003-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-394308-8.00003-0%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DSimms%26aufirst%3DA.%2BE.%26aulast%3DMazur%26aufirst%3DA.%26atitle%3DFibroblast%2520activation%2520protein-alpha%253A%2520a%2520key%2520modulator%2520of%2520the%2520microenvironment%2520in%2520multiple%2520pathologies%26jtitle%3DInt.%2520Rev.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D297%26spage%3D83%26epage%3D116%26doi%3D10.1016%2FB978-0-12-394308-8.00003-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders</span> <span class="citation_source-journal">Clin. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span><span class="refDoi"> DOI: 10.1042/CS20040302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=10.1042%2FCS20040302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=15584901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisV2jtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2005&pages=277-292&author=M.+D.+Gorrell&title=Dipeptidyl+peptidase+IV+and+related+enzymes+in+cell+biology+and+liver+disorders&doi=10.1042%2FCS20040302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders</span></div><div class="casAuthors">Gorrell, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">277-292</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  DP (dipeptidyl peptidase) IV is the archetypal member of its six-member gene family.  Four members of this family, DPIV, FAP (fibroblast activation protein), DP8 and DP9, have a rare substrate specificity, hydrolysis of a prolyl bond two residues from the N-terminus.  The ubiquitous DPIV glycoprotein has proved interesting in the fields of immunol., endocrinol., haematol. and endothelial cell and cancer biol. and DPIV has become a novel target for Type II diabetes therapy.  The crystal structure shows that the sol. form of DPIV comprises two domains, an α/β-hydrolase domain and an eight-blade β-propeller domain.  The propeller domain contains the ADA (adenosine deaminase) binding site, a dimerization site, antibody epitopes and two openings for substrate access to the internal active site.  FAP is structurally very similar to DPIV, but FAP protein expression is largely confined to diseased and damaged tissue, notably the tissue remodelling interface in chronically injured liver.  DPIV has a variety of peptide substrates, the best studied being GLP-1 (glucagon-like peptide-1), NPY (neuropeptide Y) and CXCL12.  The DPIV family has roles in bone marrow mobilization.  The functional interactions of DPIV and FAP with extracellular matrix confer roles for these proteins in cancer biol.  DP8 and DP9 are widely distributed and indirectly implicated in immune function.  The DPL (DP-like) glycoproteins that lack peptidase activity, DPL1 and DPL2, are brain-expressed potassium channel modulators.  Thus the six members of the DPIV gene family exhibit diverse biol. roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJupx2RWQPHbVg90H21EOLACvtfcHk0lhLvngdEvzFow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisV2jtrY%253D&md5=64bbb7dbec2fa9c0c49a2e54c0be908e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1042%2FCS20040302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20040302%26sid%3Dliteratum%253Aachs%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520and%2520related%2520enzymes%2520in%2520cell%2520biology%2520and%2520liver%2520disorders%26jtitle%3DClin.%2520Sci.%26date%3D2005%26volume%3D108%26spage%3D277%26epage%3D292%26doi%3D10.1042%2FCS20040302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i18"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00767">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_78130"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00767">10.1021/acs.jmedchem.7b00767</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthesis of intermediate compounds, polymers, and polymer conjugates; biochemical methods (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00767/suppl_file/jm7b00767_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00767/suppl_file/jm7b00767_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00767/suppl_file/jm7b00767_si_001.pdf">jm7b00767_si_001.pdf (304.76 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00767/suppl_file/jm7b00767_si_002.csv">jm7b00767_si_002.csv (0.47 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00767&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-20%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00767" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00767" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990d7f5a46248d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
